---
name: >-
  à¸£à¸°à¹€à¸šà¸µà¸¢à¸šà¸à¸£à¸¡à¸§à¸´à¸—à¸¢à¸²à¸¨à¸²à¸ªà¸•à¸£à¹Œà¸à¸²à¸£à¹à¸žà¸—à¸¢à¹Œ à¸§à¹ˆà¸²à¸”à¹‰à¸§à¸¢à¸­à¸±à¸•à¸£à¸²à¸„à¹ˆà¸²à¸šà¸³à¸£à¸¸à¸‡à¸à¸²à¸£à¸•à¸£à¸§à¸ˆà¸§à¸´à¹€à¸„à¸£à¸²à¸°à¸«à¹Œà¹à¸¥à¸°à¹ƒà¸«à¹‰à¸šà¸£à¸´à¸à¸²à¸£
  (à¸‰à¸šà¸±à¸šà¸—à¸µà¹ˆ 18) à¸ž.à¸¨. 2566
date: '2023-11-01'
category: à¸‡ à¸žà¸´à¹€à¸¨à¸©
volume: 140
section: 273
page: 1
source: 'https://ratchakitcha.soc.go.th/documents/9399.pdf'
draft: true
---

# à¸£à¸°à¹€à¸šà¸µà¸¢à¸šà¸à¸£à¸¡à¸§à¸´à¸—à¸¢à¸²à¸¨à¸²à¸ªà¸•à¸£à¹Œà¸à¸²à¸£à¹à¸žà¸—à¸¢à¹Œ à¸§à¹ˆà¸²à¸”à¹‰à¸§à¸¢à¸­à¸±à¸•à¸£à¸²à¸„à¹ˆà¸²à¸šà¸³à¸£à¸¸à¸‡à¸à¸²à¸£à¸•à¸£à¸§à¸ˆà¸§à¸´à¹€à¸„à¸£à¸²à¸°à¸«à¹Œà¹à¸¥à¸°à¹ƒà¸«à¹‰à¸šà¸£à¸´à¸à¸²à¸£ (à¸‰à¸šà¸±à¸šà¸—à¸µà¹ˆ 18) à¸ž.à¸¨. 2566

%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ /N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P 18) . 0 . 2566 P$?PNO@%N/O2#à¸„/%Q/O#?@%%?%BN > P #N>#%@$@%1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹Œ Oà¸¥>Q/O%>@% N A P 1Q/O21à¸„à¸¥O1?/>?@%O@Nà¸„PPà¸¥$?@%%//>Nà¸„%@>/à¹Œ Oà¸¥>"@%>1/N/$@ Q2??%#/>$@0@2%à¹Œ@%O $à¹Œ 1@0?$1O@@@#à¸„/@#Q#@%@ 32 O/N %>%@??>%>N?$%>/@%%@@%ON> . 0 . 2534 @POORN > P #N>#P$ %>%@??>%>N?$%>/@%%@@%ON> ( ??P 5) . 0 . 2545 %>1?%>%/ON2N/%@@%%#/>$@0@2%à¹Œ@%O $à¹Œ %>%/2@@%2B . 0 . 2552 1>?%#/>$@0@2%à¹Œ@%O $à¹Œ @/@%>N?$R/O ?N1R?Q O1 1 %>N?$?QN%?$/N@ Ã¬ %>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B @%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P 18) . 0 . 2566Ã® O1 2 %>N?$?QQ/OQO?à¸„??ON/??@/?%>@0Q%@>@BN1@NOOR O1 3 Q/O$Nà¸¥>à¸„/@#Qà¸¥O@??P 5.4 - 5.10 à¸¥O@??P 16.1 à¸¥O@??P 19.3 Oà¸¥>à¸¥O@? ?P 28.5 %@$@%1?%@à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ@/O1>?>@%?2C%P%à¸„12@?/>?$ />$@0@2%à¹Œ2@@%2B @#1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@%OO@$%>N?$ %#/>$@0@2%à¹Œ@%O $à¹Œ /N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% . 0 . 2562 O1 4 Q/O$Nà¸¥>à¸„/@#Qà¸¥O@??P 22 %@$@%1?%@à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ @/O1>?>@%O@à¸„BO#à¸„%1CO%>P"à¸„12@?/>?$2#BR % @#1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹Œ Oà¸¥>Q/O%>@%OO@$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ /N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹Œ Oà¸¥>Q/O%>@% . 0 . 2562 O1 5 Q/O$Nà¸¥>à¸„/@#Qà¸¥O@??P 66 %@$@%1?%@à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ @/O1>?>@%O@à¸„BO#à¸„%1CO%>P"à¸„12O@?à¸„B"@ Oà¸¥>à¸„/@#à¸¥1"?$1@/@% @#1?%@à¸„N@O@%B @%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@%OO@$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ /N@O/$1?%@à¸„N@O@%B @%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% . 0 . 2562 @POORN > P #N>#P$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ /N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P 7) . 0 . 2564 à¸«à¸™à¹‰à¸² 1 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

O1 6 Q/O$Nà¸¥>à¸„/@#Qà¸¥O@??P 128 %@$@%1?%@à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ @/O1>?>@%O@à¸„BO#à¸„%1CO%>P"à¸„12O@?à¸„B"@ Oà¸¥>à¸„/@#à¸¥1"?$1@/@% @#1?%@à¸„N@O@%B @%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@%OO@$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ /N@O/$1?%@à¸„N@O@%B @%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% . 0 . 2562 @POORN > P #N>#P$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ /N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P 11) . 0 . 2565 Oà¸¥>Q/OQO à¸„/@#N1R?QO à¸¥O@??P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$ à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ /N/$@?P %?>1 1?%@ à¸„N@%>@% ( @ ) 128 à¸¥>"?à¹Œ O@1@/@% Pseudomonas aeruginosa APHA, AWWA, WEF 2017 1@/@% 300 %?# x 1 2O@?à¸„B"@ Oà¸¥>à¸„/@# à¸¥1"?$1@/@% 700 O1 7 Q/O$Nà¸¥>à¸„/@#Qà¸¥O@??P 14.1 Oà¸¥>à¸¥O@??P 38.9 %@$@%1?%@à¸„N@%>@% @%%//>Nà¸„%@>/à¹Œ@/O1>?>@%?2C%P%à¸„12@?/>?$/>$@0@2%à¹Œ2@@%2B @#1?%@à¸„N@O@%B @%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@%OO@$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B @%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% . 0 . 2562 Oà¸¥>Q/OQOà¸„/@#N1R?QO à¸¥à¹@??P #>N / P#à¸„ / #>@# AP/#@"@# #//>Nà¸„#@>à¸«à¹Œ Nà¸„>à¸„ @##//>Nà¸„#@>à¸«à¹Œ >?//"N@ / #>!@ /?#@ à¸„N@#>@# ( @ ) 14.1 RO//? @%%//@2@% ? B%%# R/%?2RO//? O/$Nà¸„>à¸„ Real-time R T -PCR Real-time RT-PCR Swab @%> @N>/@$Q2N/ / 2@%à¸„?/à¸¥?P@%> @N>/@$Q2N/à¸¥N@ 2,500 38.9 @%%/@%@2> Q> QO@ Oà¸¥>2>PO/à¸¥O1# @%%//@NAQ1 Cryptosporidium spp./ Cyclospora spp./ Giardia spp. O/$Nà¸„>à¸„à¸±P>1 Oà¸¥>$O1#2? Concentration technique/ Modified acid fast stain - ?/1$N@> >1> 300 %?# - ?/1$N@QO@ 1 à¸¥>% 200 @%%//@NAQ1 Cryptosporidium spp., Cyclospora spp., Giardia spp. O/$Nà¸„>à¸„à¸±P>1 Oà¸¥>$O1#2? Concentration technique, Modified acid fast stain 200 à¸«à¸™à¹‰à¸² 2 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@??P #>N / P#à¸„ / #>@# AP/#@"@# #//>Nà¸„#@>à¸«à¹Œ Nà¸„>à¸„ @##//>Nà¸„#@>à¸«à¹Œ >?//"N@ / #>!@ /?#@ à¸„N@#>@# ( @ ) @%%//@NAQ1 Cryptosporidium spp. O/$Nà¸„>à¸„à¸±P>1 Oà¸¥>$O1#2? Concentration technique, Modified acid fast stain 200 @%%//@NAQ1 Giardia spp. O/$Nà¸„>à¸„à¸±P>1 Concentration technique 200 @%%//@NAQ1 Cryptosporidium spp. Oà¸¥> Cyclospora spp. O/$Nà¸„>à¸„à¸±P>1 Oà¸¥>$O1#2? Concentration technique, Modified acid fast stain 200 @%%//@NAQ1 Cyclospora spp. Oà¸¥> Giardia spp. O/$Nà¸„>à¸„à¸±P>1 Oà¸¥>$O1#2? Concentration technique, Modified acid fast stain 200 O1 8 Q/O$Nà¸¥>à¸„/@#Qà¸¥O@??P 25 %@$@%1?%@à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ @/O1>?>@%?2C%P%à¸„10C$à¹Œ/>$@0@2%à¹Œ@%O $à¹Œ?P 2 > 1BPà¸¥ @#1?%@à¸„N@O@%B @%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% . 0 . 2562 @POORN > P #N>#P$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ /N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P 2) . 0 . 2563 Oà¸¥>Q/OQOà¸„/@#N1R?QO à¸¥à¹@??P #>N / P#à¸„ / #>@# AP/#@"@# #//>Nà¸„#@>à¸«à¹Œ Nà¸„>à¸„@##/ />Nà¸„#@>à¸«à¹Œ >?//"N@ / #>!@ /?#@ à¸„N@#>@# ( @ ) 25 @%%/ O@ > 1/>$@ @%%//@RP1R$@N O/$Nà¸„>à¸„ UV/VIS Spectrophotometry UV/VIS Spectrophotometry - à¸±22@/> 10 #>à¸¥à¸¥>à¸¥>% - ?%?P# 2 #>à¸¥à¸¥>à¸¥>% 500 O1 9 Q/O$Nà¸¥>à¸„/@#Qà¸¥O@? ?N1R?Q (1) à¸¥O@??P 1 - 5 à¸¥O@??P 7 - 14 à¸¥O@??P 16 - 62 à¸¥O@??P 64 - 65 à¸¥O@??P 67 - 80 à¸¥O@??P 82 - 87 à¸¥O@??P 89 à¸¥O@??P 91 - 127 Oà¸¥>à¸¥O@??P 129 - 142 %@$@%1?%@ à¸«à¸™à¹‰à¸² 3 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ@/O1>?>@%O@à¸„BO#à¸„%1CO%>P"à¸„12O@?à¸„B"@ Oà¸¥>à¸„/@# à¸¥1"?$1@/@% @#1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@%OO@$%>N?$ %#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% . 0 . 2562 (2) à¸¥O@??P 6 à¸¥O@??P 15 Oà¸¥>à¸¥O@??P 63 %@$@%1?%@à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ @/O1>?>@%O@à¸„BO#à¸„%1CO%>P"à¸„12O@?à¸„B"@ Oà¸¥>à¸„/@#à¸¥1"?$1@/@% @#1?%@à¸„N@O@%B @%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@%OO@$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ /N@O/$1?%@à¸„N@O@%B @%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% . 0 . 2562 @POORN > P #N>#P$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ /N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P 5) . 0 . 2_` 3 (3) à¸¥O@??P 66 %@$@%1?%@à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ@/O1>?>@%O@à¸„BO#à¸„%1 CO%>P"à¸„12O@?à¸„B"@ Oà¸¥>à¸„/@#à¸¥1"?$1@/@% @#1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹Œ Oà¸¥>Q/O%>@%OO@$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹Œ Oà¸¥>Q/O%>@% . 0 . 2562 @POORN > P #N>#P$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@ à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P 9) . 0 . 2_` 5 (4) à¸¥O@??P 81 à¸¥O@??P 88 Oà¸¥>à¸¥O@??P 90 %@$@%1?%@à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ @/O1>?>@%O@à¸„BO#à¸„%1CO%>P"à¸„12O@?à¸„B"@ Oà¸¥>à¸„/@#à¸¥1"?$1@/@% @#1?%@à¸„N@O@%B @%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@%OO@$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B @%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% . 0 . 2562 @POORN > P #N>#P$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ /N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P a ) . 0 . 2_`^ (5) à¸¥O@??P 128 %@$@%1?%@à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ@/O1>?>@% O@à¸„BO#à¸„%1CO%>P"à¸„12O@?à¸„B"@ Oà¸¥>à¸„/@#à¸¥1"?$1@/@% @#1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹Œ Oà¸¥>Q/O%>@%OO@$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹Œ Oà¸¥>Q/O%>@% . 0 . 2562 @POORN > P #N>#P$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@ à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P 11) . 0 . 2_` 5 (6) à¸¥O@??P 18 - 26 %@$@%1?%@à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ@/O1>?>@% O@à¸„BO#à¸„%1CO%>P"à¸„ @#%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹Œ Oà¸¥>Q/O%>@% . 0 . 2_`2 @POORN > P #N>#P$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@ à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P 2) . 0 . 2_` 3 (7) à¸¥O@??P 6 - 10 %@$@%1?%@à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ@/O1>?>@% O@à¸„BO#à¸„%1CO%>P"à¸„ @#%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹Œ Oà¸¥>Q/O%>@% . 0 . 2_`2 @POORN > P #N>#P$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@ à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P 5) . 0 . 2_` 3 à¸«à¸™à¹‰à¸² 4 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

(8) à¸¥O@??P 1 - 3 Oà¸¥>à¸¥O@??P 12 %@$@%1?%@à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ @/O1>?>@%O@à¸„BO#à¸„%1CO%>P"à¸„ @#%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B @%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% . 0 . 2_`2 @POORN > P #N>#P$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ /N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P 6) . 0 . 2_` 4 (9) à¸¥O@??P 1 - 15 %@$@%1?%@à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ@/O1>?>@% O@à¸„BO#à¸„%1CO%>P"à¸„ @#%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹Œ Oà¸¥>Q/O%>@% . 0 . 2_`2 @POORN > P #N>#P$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@ à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P a ) . 0 . 2_`^ (10) à¸¥O@??P 1 - 2 %@$@%1?%@à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ@/O1>?>@% O@à¸„BO#à¸„%1CO%>P"à¸„ @#%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹Œ Oà¸¥>Q/O%>@% . 0 . 2_`2 @POORN > P #N>#P$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@ à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P 9) . 0 . 2_` 5 (11) à¸¥O@??P 16 1O1 4 Oà¸¥>à¸¥O@??P 6 - 14 1O1 5 %@$@%1?%@à¸„N@%>@% @%%//>Nà¸„%@>/à¹Œ@/O1>?>@%O@à¸„BO#à¸„%1CO%>P"à¸„ @#%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ /N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% . 0 . 2_`2 @POORN > P #N>#P$%>N?$ %#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P 10) . 0 . 2_` 5 (12) à¸¥O@??P 5 %@$@%1?%@à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ@/O1>?>@%O@?2C%P%à¸„ 12O@?à¸„B"@ Oà¸¥>à¸„/@#à¸¥1"?$1@/@% @#%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ /N@O/$1?%@à¸„N@O@%B @%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% . 0 . 2562 @POORN > P #N>#P$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ /N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P 15) . 0 . 2566 Oà¸¥>Q/OQOà¸„/@#N1R?QO à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) à¸¥>"?à¹ŒO@1@/@% 1 @%21 NAQ1Bà¸¥>%?$à¹Œ Antibacterial Activity /%A1 Antibiotic Activity /%A1 Antimicrobial Activity JECFA (Disk Diffusion) /?BNA11@/@% (enzyme) 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 2,000 à¸«à¸™à¹‰à¸² 5 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 2 @%21 NAQ1Bà¸¥>%?$à¹Œ Bacillus cereus BAM Online 2020 1. 1@/@% 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 2. "@>2?#?21@/@% 1$N@O1$ 5 >Q 800 3 @%21 NAQ1Bà¸¥>%?$à¹Œ Clostridium botulinum BAM Online 2001 1. 1@/@% 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 2. 1@/@%%>à¹‹1 - O1$/N@ 500 %?# x 8 /N/$ - 500 - 1,000 %?# x 6 /N/$ - #@/N@ 1,000 %?# x 3 /N/$ - #@/N@ 3,000 %?# x 2 /N/$ 1,000 4 @%21 NAQ1Bà¸¥>%?$à¹Œ Clostridium perfringens BAM Online 2001 / EA 2021 1. 1@/@% Oà¸¥>QO@ 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 2. "@>2?#?21@/@% 1$N@O1$ 5 >Q 800 5 @%21 NAQ1Bà¸¥>%?$à¹Œ Clostridium spp. USP 43 /NF 38 : 2020 1@/@% 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 700 6 @%21 NAQ1Bà¸¥>%?$à¹Œ Cronobacter sakazakii ISO 22964 : 2017 1@/@% 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 1,300 à¸«à¸™à¹‰à¸² 6 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 7 @%21 NAQ1Bà¸¥>%?$à¹Œ Cronobacter spp. ISO 22964 : 2017 1@/@% 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 1,300 8 @%21 NAQ1Bà¸¥>%?$à¹Œ Enterobacteriaceae APHA 2015 1. 1@/@% 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 2. "@>2?#?21@/@% 1$N@O1$ 5 >Q 500 9 @%21 NAQ1Bà¸¥>%?$à¹Œ Enterococci /%A1 Lancefield group D Streptococci APHA 2015 / APHA, AWWA, WEF 2017 1. 1@/@% / QO@ 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 2. "@>2?#?21@/@% 1$N@O1$ 5 >Q 700 10 @%21 NAQ1Bà¸¥>%?$à¹Œ Flat sour bacteria APHA 2015 1@/@% 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 600 11 @%21 NAQ1Bà¸¥>%?$à¹Œ Listeria monocytogenes ISO 11290 - 1 : 2017 1. 1@/@% 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 2. "@>2?#?21@/@% 1$N@O1$ 5 >Q 1,200 12 @%21 NAQ1Bà¸¥>%?$à¹Œ Pseudomonas aeruginosa ISO 16266 : 2006 QO@ / QO@OO 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 800 à¸«à¸™à¹‰à¸² 7 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 13 @%21 NAQ1Bà¸¥>%?$à¹Œ Salmonella spp. - ISO 6579 - 1 : 2017 / Amd. 1 - 2020 - ISO 19250 : 2010 1. 1@/@% Oà¸¥>QO@ 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 2. "@>2?#?21@/@% 1$N@O1$ 5 >Q 800 14 @%21 NAQ1Bà¸¥>%?$à¹Œ Shigella spp. ISO 21567 : 2004 1@/@% 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 800 15 @%21 NAQ1Bà¸¥>%?$à¹Œ Staphylococcal enterotoxins ELISA /%A1 RPLA >?/1$N@ 1@/@% / NAQ1%>2B>N 300 %?# x 6 /N/$ 3,000 16 @%21 NAQ1Bà¸¥>%?$à¹Œ Staphylococcus aureus BAM Online 2016 / APHA, AWWA, WEF 2017 1. 1@/@% Oà¸¥>QO@ 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 2. "@>2?#?21@/@% 1$N@O1$ 5 >Q 800 17 @%21 NAQ1Bà¸¥>%?$à¹Œ Streptococci /%A1 Fecal Streptococci APHA 2015 / APHA, AWWA, WEF 2017 1@/@% / QO@ 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 700 18 @%21 NAQ1Bà¸¥>%?$à¹Œ Streptococcus suis Culture and PCR technique 1@/@%?P#?NAQ1/#C @P2B@P> 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 1,200 à¸«à¸™à¹‰à¸² 8 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 19 @%21 NAQ1Bà¸¥>%?$à¹Œ Vibrio cholerae ISO 21872 - 1 : 2017 / APHA, AWWA, WEF 2017 1@/@% / QO@ 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 800 20 @%21 NAQ1Bà¸¥>%?$à¹Œ Vibrio parahaemolyticus ISO 21872 - 1 : 2017 / APHA, AWWA, WEF 2017 1@/@% / QO@ 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 800 21 @%21 NAQ1Bà¸¥>%?$à¹Œ NAQ1Bà¸¥>%?$à¹ŒP %RP1> - Bacillus coagulans Food Chemicals Codex/ BD PhoenixTM Automated Microbiology System /%A1 PCR technique 1@/@% / Nà¸„%AP1AP# 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 4,600 22 @%21 NAQ1Bà¸¥>%?$à¹Œ NAQ1Bà¸¥>%?$à¹ŒP %RP1> - Enterococcus faecium APHA 2015 / BD PhoenixTM Automated Microbiology System /%A1 PCR technique 1@/@% / Nà¸„%AP1AP# 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 3,700 23 @%21 NAQ1Bà¸¥>%?$à¹Œ NAQ1Bà¸¥>%?$à¹ŒP %RP1> - Lactobacillus acidophilus ISO 15214 : 1998 / PCR technique 1@/@% / Nà¸„%AP1AP# 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 4,600 à¸«à¸™à¹‰à¸² 9 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 24 @%21 NAQ1Bà¸¥>%?$à¹Œ NAQ1Bà¸¥>%?$à¹ŒP %RP1> - à¸¥BN# Bifidobacterium ( %/@à¸„B"@ ) - à¸¥BN# Bifidobacterium ( %/%>#@ ) @#N12@%O 1 ISO 29981 : 2010 / PCR technique 1@/@% / Nà¸„%AP1AP# 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 1,600 2??2à¹Œà¸¥> 3,000 25 @%21 NAQ1Bà¸¥>%?$à¹Œ NAQ1Bà¸¥>%?$à¹ŒP %RP1> - à¸¥BN# Lactobacillus ( %/@à¸„B"@ ) - à¸¥BN# Lactobacillus ( %/%>#@ ) @#N12@%O 1 ISO 15214 : 1998 / PCR technique 1@/@% / Nà¸„%AP1AP# 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 1,600 2??2à¹Œà¸¥> 3,000 26 @%21 NAQ1Bà¸¥>%?$à¹Œ Oà¸„?N%?$1%O1 APHA SMEDP 2004 1@/@% 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 400 27 @%21 NAQ1Bà¸¥>%?$à¹Œ Oà¸„?N%?$ 1/%A1% ?P 30 10@Nà¸¥N?$2 BAM Online 2001 1@/@%%>à¹‹1 - O1$/N@ 500 %?# x 8 /N/$ - 500 - 1,000 %?# x 6 /N/$ - #@/N@ 1,000 %?# x 3 /N/$ - #@/N@ 3,000 %?# x 2 /N/$ 800 à¸«à¸™à¹‰à¸² 10 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 28 @%21 NAQ1Bà¸¥>%?$à¹Œ Oà¸„?N%?$ 1/%A1% ?P 55 10@Nà¸¥N?$2 BAM Online 2001 1@/@%%>à¹‹1 - O1$/N@ 500 %?# x 8 /N/$ - 500 - 1,000 %?# x 6 /N/$ - #@/N@ 1,000 %?# x 3 /N/$ - #@/N@ 3,000 %?# x 2 /N/$ 800 29 @%21 NAQ1Bà¸¥>%?$à¹Œ Oà¸„?N%?$%O1 APHA 2015 1@/@% 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 400 30 @%21 NAQ1Bà¸¥>%?$à¹Œ Oà¸¥à¸„>O1>Oà¸„?N%?$ - à¸¥BN# Lactobacillus spp. ISO 15214 : 1998 1@/@% 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 1,600 - à¸¥BN# Bifidobacteriums spp. ISO 15214 : 1998 or ISO 29981 : 2010 1,600 - à¸¥BN# Lactobacillus bulgaricus ISO 7889 : 2003 1,600 - à¸¥BN# Streptococcus thermophilus ISO 7889 : 2003 1,600 31 @%21 NAQ1Bà¸¥>%?$à¹Œ Pà¸„à¸¥>!1%à¹Œ# (Coliforms) BAM Online 2020 / APHA, AWWA, WEF 2017 1. 1@/@% Oà¸¥>QO@ 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 2. "@>2?#?21@/@% 1$N@O1$ 5 >Q 400 à¸«à¸™à¹‰à¸² 11 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 32 @%21 NAQ1Bà¸¥>%?$à¹Œ O@/Oà¸„?N%?$ (Total bacteria count) APHA 2015 / BAM Online 2001 / APHA, AWWA, WEF 2017 / ISO 4833 - 1 : 2013 / AMD 1 : 2022 1. 1@/@% Oà¸¥>QO@ 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 2. "@>2?#?21@/@% 1$N@O1$ 5 >Q 400 33 @%21 NAQ1Bà¸¥>%?$à¹Œ O@/Bà¸¥>%?$à¹Œ (Aerobic Plate Count /%A1 Standard Plate Count) APHA 2015 / BAM Online 2001 / ISO 4833 - 1 : 2013 / AMD 1 : 2022 , APHA, AWWA, WEF 2017 / ISO 13559 / IDF 153 : 2002 1. 1@/@% Oà¸¥>QO@ 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 2. "@>2?#?21@/@% 1$N@O1$ 5 >Q 400 34 @%21 NAQ1Bà¸¥>%?$à¹Œ Bà¸¥>%?$à¹ŒN%>?P 35 10@Nà¸¥N?$2 BAM Online 2001 1@/@%%>à¹‹1 - O1$/N@ 500 %?# x 8 /N/$ - 500 - 1,000 %?# x 6 /N/$ - #@/N@ 1,000 %?# x 3 /N/$ - #@/N@ 3,000 %?# x 2 /N/$ 800 35 @%21 NAQ1Bà¸¥>%?$à¹Œ Bà¸¥>%?$à¹ŒN%>?P 55 10@Nà¸¥N?$2 BAM Online 2001 1@/@%%>à¹‹1 - O1$/N@ 500 %?# x 8 /N/$ - 500 - 1,000 %?# x 6 /N/$ - #@/N@ 1,000 %?# x 3 /N/$ - #@/N@ 3,000 %?# x 2 /N/$ 800 à¸«à¸™à¹‰à¸² 12 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 36 @%21 NAQ1Bà¸¥>%?$à¹Œ !?à¸„1à¸¥Pà¸„à¸¥>!1%à¹Œ# (Fecal Coliforms) BAM Online 2020 / APHA, AWWA, WEF 2017 1@/@% / QO@ 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 400 37 @%21 NAQ1Bà¸¥>%?$à¹Œ $?2à¹ŒOà¸¥>%@ (Yeasts & molds) ( %/@à¸„B"@ ) BAM Online 2001 1@/@%%>à¹‹1 - O1$/N@ 500 %?# x 8 /N/$ - 500 - 1,000 %?# x 6 /N/$ - #@/N@ 1,000 %?# x 3 /N/$ - #@/N@ 3,000 %?# x 2 /N/$ 300 38 @%21 NAQ1Bà¸¥>%?$à¹Œ O@/$?2à¹ŒOà¸¥>%@ (Yeasts & molds count) ( %/%>#@ ) BAM Online 2001 / AOAC 2019 1. 1@/@% 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 2. "@>2?#?21@/@% 1$N@O1$ 5 >Q 600 39 @%21 NAQ1Bà¸¥>%?$à¹Œ 2@%O@Bà¸¥? (Antimicrobial) - à¸¥BN# Penicillin - à¸¥BN# Tetracycline - à¸¥BN# Aminoglycoside - à¸¥BN# Macrolide Microbiological assay/DMSc antibiotic test kit 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% à¸¥BN#à¸¥> 500 à¸«à¸™à¹‰à¸² 13 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 40 @%21 NAQ1Bà¸¥>%?$à¹Œ 1? . Pà¸„Rà¸¥ (Escherichia coli) BAM Online 2020 / APHA, AWWA, WEF 2017 1. 1@/@% Oà¸¥>QO@ 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 2. "@>2?#?21@/@% 1$N@O1$ 5 >Q 700 41 @%21 NAQ1Bà¸¥>%?$à¹Œ 1? . Pà¸„Rà¸¥ O 157 (Escherichia coli O 157 ) ISO 16654 : 2001 / AMD 1 : 2017 1@/@% 1$N@O1$ 2 /N/$ %/#?R#NO1$/N@ 300 %?# / #>à¸¥à¸¥>à¸¥>% 2,500 42 @%21 R/%?2 2@% ? B%%#1 NAQ1R/%?2Pà¸„P%@ 2019 (COVID- 19 ) Real-time RT-PCR "@>%%B / %%B"?à¹Œ 1@/@% / 1@/@%2 Oà¸¥>ONOO ( ? / à¸¥R#O / NAQ12?/à¹Œ )/ QO@Oà¸¥>QO@OO @#N12@%O 3 3,000 43 @%21 R/%?2 2@% ? B%%#1 NAQ1R/%?2Pà¸„P%@ 2019 (COVID- 19 ) (Swab) Real-time RT-PCR Swab A Q >/2?#?21@/@% : A Q ?PN1?/1$N@R#NO1$/N@ 100 @%@N>N#% 1,600 44 @%21 R/%?2 2@% ? B%%#1 NAQ1R/%?2PP% (Norovirus) Real-time RT-PCR 1. 1@/@%2Oà¸¥>ONOO ( ? / à¸¥R#O / NAQ12?/à¹Œ ) 500 %?# x 3 /N/$ 2. QO@AP#Q"@>%%B ?P>2> - O1$/N@ 500 #>à¸¥à¸¥>à¸¥>% x 10 /N/$ - 500 - 999 #>à¸¥à¸¥>à¸¥>% x 6 /N/$ - 1 - 2 à¸¥>% x 3 /N/$ - 3 - 6 à¸¥>% x 1 /N/$ - #@/N@ 6 - 20 à¸¥>% x 1 /N/$ /%A1%>#@%%/# R#NO1$/N@ 3 à¸¥>% 5,000 à¸«à¸™à¹‰à¸² 14 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 3. QO@OO 1 - 2 >Pà¸¥%?# x 3 B 4. QO@AP# %>#@%%/# R#NO1$/N@ 3 à¸¥>% %%BQ/%@0@NAQ1 45 @%21 R/%?2 2@% ? B%%#1 NAQ1R/%?2PP% (Norovirus) (Swab) Real-time RT-PCR Swab A Q >/2?#?21@/@% : A Q ?PN1?/1$N@R#NO1$/N@ 100 @%@N>N#% 1,600 46 @%21 R/%?2 2@% ? B%%#1 NAQ1R/%?2?1?N2N1 Real-time RT-PCR 1. 1@/@%2Oà¸¥>ONOO ( ? / à¸¥R#O / NAQ12?/à¹Œ ) 500 %?# x 3 /N/$ 2. QO@AP#Q"@>%%B ?P>2> - O1$/N@ 500 #>à¸¥à¸¥>à¸¥>% x 10 /N/$ - 500 - 999 #>à¸¥à¸¥>à¸¥>% x 6 /N/$ - 1 - 2 à¸¥>% x 3 /N/$ - 3 - 6 à¸¥>% x 1 /N/$ - #@/N@ 6 - 20 à¸¥>% x 1 /N/$ /%A1%>#@%%/# R#NO1$/N@ 3 à¸¥>% 3. QO@OO 1 - 2 >Pà¸¥%?# x 3 B 4. QO@AP# %>#@%%/# R#NO1$/N@ 3 à¸¥>% %%BQ/ %@0@NAQ1 4,500 à¸«à¸™à¹‰à¸² 15 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 47 @%21 R/%?2 2@% ? B%%#1 NAQ1R/%?2?1?N2N1 (Swab) Real-time RT-PCR Swab A Q >/2?#?21@/@% : A Q ?PN1?/1$N@R#NO1$/N@ 100 @%@N>N#% 1,600 48 @#2/ ?/P!Nà¸¥Bà¸¥ ?N/ON/à¹@N@>/A 2?/à¹Œ à¸«#A/2>P!??/> @!N/2@#O 1 ( #>B> ) PCR / Real-time PCR 1. /?B> NN OO O@/ ?P/ O@/P  O@/ 3 /N/$ /N/$à¸¥> 500 %?# 2. 1@/@%O%%C O@/ 3 /N/$ 1,200 >à¸¥> 1,000 49 @%21 ?/P#Nà¸¥Bà¸¥ ?N1ON1O@N @> A ?O% ? B%%# PCR/ Real-time PCR 1. /?B> NN OO O@/ ?P/ O@/P  3 /N/$ /N/$à¸¥> 500 %?# 2. 1@/@%O%%C 3 /N/$ %/#?R#NO1$/N@ 500 %?# / #>à¸¥à¸¥>à¸¥>% 1,200 2@$ ? Bà¹Œ à¸¥> 1,000 50 @%21 ?/P#Nà¸¥Bà¸¥ ?N1ON1O@N @> A ?O% ? B%%# (Screening) @#N12@%O 1 PCR/ Real-time PCR 1. /?B> NN OO O@/ ?P/ O@/P  3 /N/$ /N/$à¸¥> 500 %?# 2. 1@/@%O%%C 3 /N/$ %/#?R#NO1$/N@ 500 %?# / #>à¸¥à¸¥>à¸¥>% 5,200 51 @%21 ?/P#Nà¸¥Bà¸¥ ?N1ON1O@N @> à¸¥@à¸±NO@ - Lagocephalus lunaris - Lagocephalus spadecious PCR/ Real-time PCR /?B>Oà¸¥>1@/@%O%%C 500 %?# / #>à¸¥à¸¥>à¸¥>% 4,200 52 @%21 ?/P#Nà¸¥Bà¸¥ ?N1ON1O@N @>%? Oà¸¥>2>POà¸¥à¸¥1# - @O1N - RN - /#C - N/O/ C / C PCR/ Real-time PCR %?O/O Oà¸¥>%? %O1#%>P"à¸„ 500 %?# / #>à¸¥à¸¥>à¸¥>% 5,200 à¸«à¸™à¹‰à¸² 16 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 53 @%21 ?/P#Nà¸¥Bà¸¥ %>#@?N1ON1O@N @> 1NAQ12?/à¹Œ - /#C : RN : /?/ Digital PCR /?B>Oà¸¥>1@/@%O%%C 500 %?# / #>à¸¥à¸¥>à¸¥>% 5,800 54 @%21 ?/P#Nà¸¥Bà¸¥ ?N1ON1O@N @> ( R#N%@> ) @#N12@%O 1 PCR-sequencing /?B>Oà¸¥>1@/@%O%%C 500 %?# / #>à¸¥à¸¥>à¸¥>% 7,600 55 @%21 ?/P#Nà¸¥Bà¸¥ %>#@2@%N1"C#>O O Q1@/@% > Gluten (mg/kg) ELISA 1. /?B> NN O@/ ?P/ O@/P  3 /N/$ /N/$à¸¥> 500 %?# 2. OOO@1@/@% @O@/ ?P/N/à¸¥A1 O@/P  #?%?P ?P/1AP N 3 /N/$ /N/$à¸¥> 500 %?# 3. #1%1 Oà¸¥> ? A  3 /N/$ %/#?R#NO1$/N@ 500 %?# 3,500 56 @%21 @@$"@ 1OO?Q/# (Total solids) Gravimetry #Pà¸„ / à¸¥>"?à¹Œ# 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 300 %>#@2@%?Q/# (Total solids) Gravimetry QO@ 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 300 57 @%21 @@$"@ à¸„/@#%>O@?Q/# (Total hardness) Titration QO@ 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 300 58 @%21 @@$"@ à¸„à¸¥1%?à¸„O@ (residual chlorine) Turbidimetry QO@ 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 200 59 @%21 @@$"@ à¸„/@#BN (Turbidity) Turbidimetry QO@ 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 200 à¸«à¸™à¹‰à¸² 17 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 60 @%21 @@$"@ à¸„N@à¸„/@#NO% - N@ (pH value) pH meter 1. 1@/@%Q"@> %%B>2> 200 %?# x 4 /N/$ 2. QO@Oà¸¥>Nà¸„%AP1AP# 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 200 61 @%21 @@$"@ à¸„N@@%O@R!!O@ (Conductivity) Conductivity meter QO@ 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 200 62 @%21 @@$"@ %>#@1OO à¸¥>à¸¥@$?Q/# (Total Dissolve Solid) Conductivity meter QO@ 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 200 63 @%21 @@$"@ %>#@QO@1>2%> (Water activity) Water Activity Meter 1@/@%Q"@> %%B>2> 200 %?# x 4 /N/$ 700 64 @%21 @@$"@ QO@/?1@/@% - QO@/?2B> - QO@/?NAQ11@/@% Weighing 1@/@%Q"@> %%B>2> 200 %?# x 4 /N/$ 300 65 @%21 @@$"@ 2@%?Pà¸¥>à¸¥@$RO Refractometer O$# / N$à¸¥à¸¥?P 300 %?# x 4 /N/$ 500 66 @%21 @@$"@ 2>POà¸¥à¸¥1# (Light Filth) - 2>POà¸¥à¸¥1# ?P#1N/OO/$@Nà¸¥N@ - 2>POà¸¥à¸¥1# "@$QOà¸¥O1 Bà¸¥%%0à¹Œ Macroscopic Method/Microscopic Method 1@/@% / Nà¸„%AP1AP# 500 %?# / #>à¸¥à¸¥>à¸¥>% 1,500 à¸«à¸™à¹‰à¸² 18 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 67 @%21 @@$"@ 2>POà¸¥à¸¥1# - 2>POà¸¥à¸¥1# ?P#1N/OO/$@Nà¸¥N@ - 2>POà¸¥à¸¥1# "@$QOà¸¥O1 Bà¸¥%%0à¹Œ Macroscopic Method/Microscopic Method 1@/@% / Nà¸„%AP1AP# 200 %?# / #>à¸¥à¸¥>à¸¥>% 1,500 68 @%21 2@% > 1 / 2@%Nà¸·Q1 3- N/O!??? (3 -MCPD) GC-MS à¸¥>"?à¹Œ%B%2 Oà¸¥>1@/@%?P#?à¸¥>"?à¹Œ %B%2NO2N/%>1 1$N@O1$ 500 %?# / #>à¸¥à¸¥>à¸¥>% 4,000 69 @%21 2@% > 1 / 2@%Nà¸·Q1 Biogenic amines - Histamine - Cadaverine - Putrescine - Tyramine HPLC à¸¥@Oà¸¥>à¸¥>"?à¹Œ@à¸¥@ 1. NAQ1à¸¥@ 500 %?# 2. QO@à¸¥@ 500 #>à¸¥à¸¥>à¸¥>% 3,500 70 @%21 2@% > 1 / 2@%Nà¸·Q1 Dioxins and dioxin- like PCBs - Dioxins - Dioxin-like PCBs @#N12@%O 1 Nà¸„>à¸„ GC-MS 1. NA Q 12?/à¹ŒOà¸¥>à¸¥>"?à¹Œ 2 >Pà¸¥%?# 2. 2?/à¹ŒQO@ 2 >Pà¸¥%?# 3. 1@/@%O/O 500 %?# 4. 1@/@%2?/à¹ŒOà¸¥> /?B> 1,000 %?# 5. QO@#?Oà¸¥>R#? 500 %?# /%A1#>à¸¥à¸¥>à¸¥>% 6. 1@/@%%>à¹‹1 1 >Pà¸¥%?# 31,000 71 @%21 2@% > 1 / 2@%Nà¸·Q1 Dioxins, dioxin-like PCBs and non dioxin-like PCBs - Dioxins - Dioxin-like PCBs - Non dioxin-like PCBs @#N12@%O 1 Nà¸„>à¸„ GC-MS 1. NA Q 12?/à¹ŒOà¸¥> à¸¥>"?à¹Œ 2 >Pà¸¥%?# 2. 2?/à¹ŒQO@ 2 >Pà¸¥%?# 3. 1@/@%O/O 500 %?# 4. 1@/@%2?/à¹ŒOà¸¥> /?B> 1,000 %?# 5. QO@#?Oà¸¥>R#? 500 %?# /%A1#>à¸¥à¸¥>à¸¥>% 6. 1@/@%%>à¹‹1 1 >Pà¸¥%?# 36,000 à¸«à¸™à¹‰à¸² 19 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 72 @%21 2@% > 1 / 2@%Nà¸·Q1 MCPD and Glycidyl fatty acid esters - 2- MCPD fatty acid esters, expressed as 2 -MCPD - 3 -MCPD fatty acid esters, expressed as 3 -MCPD - Glycidyl fatty acid esters, expressed as glycidol GC-MS QO@#?%>P"à¸„ (Edible oil) 1$N@O1$ 500 #>à¸¥à¸¥>à¸¥>% 8,500 73 @%21 2@% > 1 / 2@%Nà¸·Q1 Polycyclic Aromatic Hydrocarbons (PAHs) - Benzo (a) pyrene HPLC NAQ12?/à¹ŒOà¸¥>à¸¥>"?à¹Œ / QO@#?%>P"à¸„ 1$N@O1$ 500 %?# 2,500 74 @%21 2@% > 1 / 2@%Nà¸·Q1 N%@PO1> (Tetrodotoxin) LC-MS/MS 2?/à¹ŒQO@Oà¸¥>à¸¥>"?à¹Œ 300 %?# 5,000 75 @%21 2@% > 1 / 2@%Nà¸·Q1 N#à¸¥@#? (Melamine) Oà¸¥>%?$$@C%>à¸„ (Cyanuric acid) - N#à¸¥@#? (Melamine) - %?$$@C%>à¸„ (Cyanuric acid) LC-MS/MS 1@/@% 250 %?# 4,500 76 @%21 2@% > 1 / 2@%Nà¸·Q1 O1!à¸¥@1> (Aflatoxin) - ? 1 ( B1 ) - ? 2 ( B2 ) - ? 1 ( G1 ) HPLC 1@/@% @#N12@%O 2/ 2#BR % / à¸¥>"?à¹Œ 1$N@O1$ 1,000 %?# / #>à¸¥à¸¥>à¸¥>% 2,000 à¸«à¸™à¹‰à¸² 20 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) - ? 2 ( G2 ) - O1!à¸¥@1> ?Q/# (Aflatoxin total) 77 @%21 2@% > 1 / 2@%Nà¸·Q1 O1!à¸¥@1> N1O# 1 (Aflatoxin M1 ) HPLC # Oà¸¥>à¸¥>"?à¹Œ 1$N@O1$ 1,000 %?# / #>à¸¥à¸¥>à¸¥>% 2,000 78 @%21 2@% > 1 / 2@%Nà¸·Q1 P1à¸„%@1> N1 (Ochratoxin A) HPLC 1@/@% @#N12@%O 2/ 2#BR % / à¸¥>"?à¹Œ / N1R#à¹Œ 1$N@O1$ 1,000 %?# / #>à¸¥à¸¥>à¸¥>% 2,000 79 @%21 2@% > 1 / 2@%Nà¸·Q1 ?11?>/@à¸¥?1à¸¥ (Deoxynivalenol, DON) HPLC ?@> Oà¸¥>à¸¥>"?à¹Œ 1$N@O1$ 1,000 %?# / #>à¸¥à¸¥>à¸¥>% 2,000 80 @%21 2@% > 1 / 2@%Nà¸·Q1 @Cà¸¥> (Patulin) HPLC QO@à¸¥R#O 1$N@O1$ 1,000 #>à¸¥à¸¥>à¸¥>% 2,000 81 @%21 2@% > 1 / 2@%Nà¸·Q1 1>à¸„%>à¸¥@R#à¹Œ (Acrylamide) LC-MS/MS 1@/@% 1$N@O1$ 500 %?# 4,500 82 @%21 2@% > 1 / 2@%Nà¸·Q1 %@à¸¥>>à¸¥>à¸„ (Salicylic acid) Colorimetric method 1. 1@/@% 100 %?# x 2 /N/$ 2. Nà¸„%AP1AP# 250 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 500 83 @%21 2@% > 1 / 2@%Nà¸·Q1 1%à¹ŒO%à¹Œ (Borax) Spectrophotometry 1@/@% 200 %?# 1,000 84 @%21 2@% > 1 / 2@%Nà¸·Q1 !1%à¹Œ#@à¸¥?R2à¹Œ (Formaldehyde) HPLC NAQ12?/à¹ŒOà¸¥>à¸¥>"?à¹Œ 500 %?# 2,000 à¸«à¸™à¹‰à¸² 21 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 85 @%21 O%N@B Pà¸¥/> - Oà¸„N#?$# (Cadmium) - Oà¸„à¸¥N?$# (Calcium) - Pà¸„%N#?$# (Chromium) - PN?$# (Sodium) - >?P/ (Lead) - 1O (Copper) - P O2N?$# (Potassium) - O#@?2 (Manganese) - O#?N?$# (Magnesium) - 2?>2? (Zinc) - 2@%/C (Arsenic) /%A12@%/C?Q/# (Arsenic, total) - N/à¸¥O (Iron) - >N>à¸¥ (Nickel) AAS/ICP A O/O / 2#BR %Oà¸¥> à¸¥>"?à¹Œ / QO@ / /?BNA1 1@/@% 200 %?# x 1 /N/$ /%A1 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ >à¸¥> 800 @%21 O%N@B - ?B (Tin) - %1 (Mercury) /%A1%1?Q/# (Total mercury) ICP Mercury analyzer A O/O / 2#BR % Oà¸¥>à¸¥>"?à¹Œ / /?BNA11@/@% 200 %?# x 1 /N/$ /%A1 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ >à¸¥> 800 @%21 O%N@B - %1 (Mercury) - ON%?$# (Barium) - N> (Silver - 1à¸¥C#>N?$# (Aluminium) AAS/ICP AAS/ICP AAS/ICP ICP QO@1BP"à¸„Oà¸¥>%>P"à¸„ 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ >à¸¥> 800 à¸«à¸™à¹‰à¸² 22 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) - ?à¸¥?N?$# (Selenium) - à¸¥/ (Antimony) ICP ICP @%21 O%N@B - 2@%/C1>%?$à¹Œ LC-ICP-MS 1@/@% @#N12@%O 2 500 %?# /1 ?/1$N@ $N/O 2?/à¹ŒQO@Nà¸¥A1OO NN ( /1$ , C ) 1 >Pà¸¥%?# 6,000 @%21 O%N@B Nà¸¥A1O%N - PN?$# (Sodium) - >?P/ (Lead) - 1O (Copper) - P O2N?$# (Potassium) - O#@?2 (Manganese) - O#?N?$# (Magnesium) - 2?>2? (Zinc) - N/à¸¥O (Iron) ICP-OES 1@/@% 200 %?# / #>à¸¥à¸¥>à¸¥>% x 2 /N/$ >à¸¥> 800 86 @%21 O%N@B 1>11 - à¸„à¸¥1R%à¹Œ (Chloride) - ?à¸¥N! (Sulphate) - RN% P$à¸„O@/ NORP%N Nitrate (as nitrogen) /%A1RN% P$à¸„O@/NO RN% Nitrate (as nitrate) - !à¸¥C11R%à¹Œ (fluoride) IC QO@1BP"à¸„Oà¸¥>%>P"à¸„ 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ >à¸¥> 600 à¸«à¸™à¹‰à¸² 23 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) @%21 O%N@B - P%N# (Bromate) IC QO@%>P"à¸„Q"@>%%B ?P>2> / QO@O%N%%#@> 1. QO@%>P"à¸„Q"@> %%B?P>2> 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 2. QO@O%N%%#@> 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 2,000 87 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% 10 - R2%1? - 2 - N>P 1>O1> ( 10 -hydroxy- 2 - decenoic acid) HPLC #@Q / à¸¥>"?à¹Œ#@Q 200 %?# x 2 /N/$ 4,600 88 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% %à¸¥C@#>à¸„ Enzyme 1@/@% 100 %?# x 1 /N/$ 1,300 89 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% %à¸¥C@#>à¸„N1 RP%N - %à¸¥C@#>à¸„ - RP%N - %à¸¥C@#>à¸„N1 RP%N Enzyme+Kjeldahl QO@à¸¥@ 100 %?# / #>à¸¥à¸¥>à¸¥>% x 3 /N/$ 2,100 90 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% %R#? - %R#?> EPA (Eicosapentaenoic acid) - %R#?> DHA (Docosahexaenoic acid) GC-FID QO@#?à¸¥@ 250 #>à¸¥à¸¥>à¸¥>% x 4 /N/$ 4,500 à¸«à¸™à¹‰à¸² 24 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 91 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% %R#?>%@2à¹Œ GC 1@/@% / à¸¥>"?à¹Œ1@/@% / Nà¸„%AP1AP# 250 %?# / #>à¸¥à¸¥>à¸¥>% x 4 /N/$ 3,500 QO@#?Oà¸¥>R#? 250 %?# / #>à¸¥à¸¥>à¸¥>% x 4 /N/$ 2,000 92 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% %R#?1>2%> (Free fatty acids) Titration, Calculation @à¸„N@ acid value QO@#?Oà¸¥>R#? 250 %?# / #>à¸¥à¸¥>à¸¥>% x 4 /N/$ 700 93 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% %QO@2O# Titration QO@2O#2@$CN?$# / QO@2O#2@$C/#? / QO@2O#2@$Cà¸¥?P 750 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 600 94 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% %O%N1>2%> ( %/@à¸„B"@ ) Colorimetric method QO@2O#2@$C 250 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 100 95 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% %R#? - %Rà¸¥Pà¸¥>1>à¸„ GC #?Oà¸¥2O@/%?@% / 1@/@%2O@/%?@% 250 %?# / #>à¸¥à¸¥>à¸¥>% x 4 /N/$ 3,500 96 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% %1>#>P (Amino acid) UHPLC # / à¸¥>"?à¹Œ# / Nà¸„%AP1AP#%? / 1@/@% 2O@/%?CO?Pà¸„/à¸„B#QO@/? 200 %?# / #>à¸¥à¸¥>à¸¥>% x 4 /N/$ 7,700 97 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% @N!1? (Caffeine) HPLC Nà¸„%AP1AP# 250 %?# / #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 1,200 à¸«à¸™à¹‰à¸² 25 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 98 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% R#? /%A1R#? ?Q/# (Fat or Total fat) Gravimetry # / à¸¥>"?à¹Œ# / 1@/@% / à¸¥>"?à¹Œ1@/@%Oà¸¥> Nà¸„%AP1AP# 250 %?# / #>à¸¥à¸¥>à¸¥>% x 4 /N/$ 900 99 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% R#?1>P#?/ (Saturated fat) GC 1@/@% / à¸¥>"?à¹Œ1@/@% Oà¸¥>Nà¸„%AP1AP# 250 %?# / #>à¸¥à¸¥>à¸¥>% x 4 /N/$ 3,500 100 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% à¸„à¸¥1R%à¹Œ /%A1PN?$# à¸„à¸¥1R%à¹Œ /%A1Nà¸¥A1 PN?$#à¸„à¸¥1R%à¹Œ /%A1Nà¸¥A1O Titration QO@à¸¥@ / N$N?$# / Nà¸¥A1 100 %?# / #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 700 101 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% à¸„/@#AQ (Moisture) - Drying or Gravimetry # / à¸¥>"?à¹Œ# / 1@/@% / à¸¥>"?à¹Œ1@/@% / Nà¸„%AP1AP# 100 %?# / #>à¸¥à¸¥>à¸¥>% x 3 /N/$ 300 - Refractometer QO@@Q 100 %?# x 4 /N/$ 500 102 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% à¸„/@#NO% à¸„O@/NO%Oà¸¥à¸„> Titration #N%?Q$/ / P$N>%à¹Œ 500 %?# / #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 700 103 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% à¸„N@1% (Acid value) Titration QO@#?Oà¸¥>R#? 250 #>à¸¥à¸¥>à¸¥>% x 4 /N/$ 700 104 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% à¸„N@O 1>!?Nà¸„? (Saponification value) Tritration QO@#?Oà¸¥>R#? 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 500 à¸«à¸™à¹‰à¸² 26 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 105 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% à¸„N@N 1%à¹Œ11Rà¹Œ (Peroxide value) Titration QO@#?Oà¸¥>R#? 250 #>à¸¥à¸¥>à¸¥>% x 4 /N/$ 800 106 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% à¸„@%à¹ŒPR2N%?Q/# /%A1à¸„@%à¹ŒPR2N% - à¸„/@#AQ - NO@ - P%? - R#? - à¸„@%à¹ŒPR2N% ?Q/# /%A1 à¸„@%à¹ŒPR2N% ( @%à¸„O@/ ) Combined technique ( à¸„O@/@%@$@% à¸„/@#AQ / NO@ / P%? / R#? ) 1@/@% / à¸¥>"?à¹Œ1@/@% / Nà¸„%AP1AP# 250 %?# / #>à¸¥à¸¥>à¸¥>% x 8 /N/$ 2,500 107 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% Pà¸„Nà¸¥2N1%1à¸¥ (Cholesterol) GC 1@/@% / à¸¥>"?à¹Œ 1@/@%Oà¸¥>Nà¸„%AP1AP# 250 %?# / #>à¸¥à¸¥>à¸¥>% x 4 /N/$ 2,600 108 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% ?à¸¥N!1%à¹ŒR11Rà¹Œ Titration 1. 1@/@% 200 %?# x 2 /N/$ 2. Nà¸„%AP1AP# 250 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 3. >N?$R#O 10 à¸„CN 800 109 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% RO12N2O1>/>? (Diastase activity) Spectrophotometry QO@@Q 100 %?# x 2 /N/$ 600 110 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% NO@ (Ash) Ashing 1@/@% / @ / @O! 250 %?# / #>à¸¥à¸¥>à¸¥>% x 4 /N/$ 500 à¸«à¸™à¹‰à¸² 27 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 111 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% NO@?Pà¸¥>à¸¥@$QO@RO (Water soluble ash) Ashing @O! 100 %?# x 1 /N/$ 500 112 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% ?P1P%#? (Theobromine) HPLC Nà¸„%AP1AP# 250 %?# x 2 /N/$ 1,800 113 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% @BQO@#R#N%/#R#? - NO@ - P%? - QO@@à¸¥ - @BQO@#R#N%/#R#? ( @%à¸„O@/ ) Combined technique ( à¸„O@/@%@$@% NO@ / P%? / QO@@à¸¥ ) R10%?## / O1POà¸¥ 500 %?# / #>à¸¥à¸¥>à¸¥>% x 4 /N/$ 2,800 114 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% QO@@à¸¥ ( # ) - QO@@à¸¥Oà¸¥OP2 HPLC-RI # 200 #>à¸¥à¸¥>à¸¥>% x 5 /N/$ 1,500 115 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% QO@@à¸¥ ( #O//@ ) - QO@@à¸¥Oà¸¥OP2 - QO@@à¸¥CPà¸„%2 HPLC-RI #O//@ / #%BON / #1?N#O Oà¸¥>à¸¥>"?à¹Œ# 200 %?# / #>à¸¥à¸¥>à¸¥>% x 5 /N/$ 1,500 116 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% QO@@à¸¥ ( #%@0@ Oà¸¥OP2 %2A ) - QO@@à¸¥@Oà¸¥OP2 - QO@@à¸¥à¸¥CPà¸„2 HPLC-RI Detector à¸¥>"?à¹Œ# %@0@Oà¸¥OP2 %2A 200 #>à¸¥à¸¥>à¸¥>% x 5 /N/$ 1,500 117 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% QO@@à¸¥ - QO@@à¸¥à¸¥CPà¸„2 - QO@@à¸¥CPà¸„%2 - QO@@à¸¥!%?P2 - QO@@à¸¥#1à¸¥P2 HPLC QO@@Q 500 %?# x 2 /N/$ 1,500 QO@@à¸¥ - QO@@à¸¥à¸¥CPà¸„2 HPLC Nà¸„%AP1AP# / 1@/@% ( $N/O Nà¸„%AP1AP#Nà¸¥A1O%N ) 1,500 à¸«à¸™à¹‰à¸² 28 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) - QO@@à¸¥CPà¸„%2 - QO@@à¸¥!%?P2 - QO@@à¸¥#1à¸¥P2 - QO@@à¸¥Oà¸¥OP2 500 %?# / #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 118 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% QO@#?O%N (mineral oil) Qualitative QO@#?Oà¸¥>R#?%>P"à¸„ 250 #>à¸¥à¸¥>à¸¥>% x 4 /N/$ 200 119 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% QO@Oà¸¥>2>P?P%>N/$RO Drying or Gravimetry QO@#?Oà¸¥>R#? 250 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 300 120 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% NAQ/!R!N#/!R!? / P#?QNAQ/! R!N#/!R!? NAQ/!R!N#/!R!? Oà¸¥>P#?QNAQ/! R!N#/!R!? - NO@ - P#? - Qà¹@@à¸¥ - NAQ/!R!N#/!R!? ( @#à¸„à¹@/ ) - P#?QNAQ/! R!N#/!R!? Combined technique ( à¸„à¹@/@#@"@# NO@ / P#? / Qà¹@@à¸¥ ) #%BON>O/O #O//@ 250 %?# / #>à¸¥à¸¥>à¸¥>% x 8 /N/$ 2,800 NAQ/!R!N#/!R!? - NO@ - P#? - Qà¹@@à¸¥ - NAQ/!R!N#/!R!? ( @#à¸„à¹@/ ) Combined technique ( à¸„à¹@/@#@"@# NO@ / P#? / Qà¹@@à¸¥ ) #%BON>N/à¸¥/ / à¸¥>"?à¹Œ1# 250 %?# / #>à¸¥à¸¥>à¸¥>% x 8 /N/$ 2,800 à¸«à¸™à¹‰à¸² 29 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) NAQ/!R!N#/!R!? - /OO?Qà¸«! - R!? - NAQ/!R!N#/!R!? ( @#à¸„à¹@/ ) Combined technique ( à¸„à¹@/@#@"@# /OO?Qà¸«! / R!? ) #Pà¸„ ( >N/à¸¥/ ) 250 #>à¸¥à¸¥>à¸¥>% x 6 /N/$ 1,300 P#?QNAQ/! R!N#/!R!? - P#? - à¸„/@!AQ - R!? - P#?QNAQ/! R!N#/!R!? ( @#à¸„à¹@/ ) Combined technique ( à¸„à¹@/@#@"@# P#? / à¸„/@!AQ / R!? ) #Pà¸„ ( > ) 250 %?# x 8 /N/$ 2,000 121 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% RP%N /%A1 RP%N?Q/# Kjeldahl technique à¸¥>"?à¹Œ1@/@% / QO@à¸¥@ Oà¸¥>Nà¸„%AP1AP# 200 %?# / #>à¸¥à¸¥>à¸¥>% x 4 /N/$ 700 122 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% RN% /%A1PN?$#R N% /%A1RR%à¹Œ /%A1PN?$#RR%à¹Œ ( %@$@%à¸¥> ) HPLC NAQ12?/à¹Œ / à¸¥>"?à¹Œ@2?/à¹Œ 100 %?# x 2 /N/$ 1,500 123 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% Rà¸„@%à¹Œ1N Titration/ Weighting Nà¸„%AP1AP# 200 %?# x 1 /N/$ 250 #>à¸¥à¸¥>à¸¥>% x 3 /N/$ 500 124 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% %>#@2CN Titration QO@#?Oà¸¥>R#? 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 500 125 @%21 2N/%>1 Oà¸¥>/?BNA1 1@/@% P%? Kjeldahl technique # / #%BON / à¸¥>"?à¹Œ# / 1@/@% / à¸¥>"?à¹Œ1@/@% / à¸¥>"?à¹Œ 700 à¸«à¸™à¹‰à¸² 30 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) %B%2?PRO@@%$N1$ P%?1?P/N/à¸¥A1 / N#à¸¥O? ( N @>?P %>N@>Nà¸¥A111Oà¸¥O/ ) /%A1P%?@N#à¸¥O? 500 %?# / #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 126 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% P%?à¸„O@/ P$R#N%/#QO@ - à¸„/@#AQ - P%? - P%?à¸„O@/ P$R#N%/#QO@ ( @%à¸„O@/ ) Combined technique ( à¸„O@/@%@$@% P%? / à¸„/@#AQ ) %? / Nà¸„%AP1AP#%? 50 %?# / #>à¸¥à¸¥>à¸¥>% x 8 /N/$ 1,100 127 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% !12!1%?2 /%A1 !12!1%?2N 1Rà¹Œ /%A1!12N! Spectrophotometry 1@/@% 100 %?# x 2 /N/$ 1,000 128 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% #?N$ GC N$ / N$N?$# / N$2# / N$OO / N$Q2/%A1?OO 250 %?# x 2 /N/$ 2,900 129 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% #?N$à¸„O@/ P$R#N%/#à¸„/@#AQ - #?N$ - à¸„/@#AQ - #?N$à¸„O@/ P$R#N%/#à¸„/@#AQ ( @%à¸„O@/ ) combined technique ( à¸„O@/@%@$@% #?N$ / à¸„/@#AQ ) N$ / N$N?$# / N$2# / N$OO / N$Q2/%A1?OO 250 %?# x 4 /N/$ 3,300 130 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% Q$1@/@% Enzyme +Gravimetry 1@/@% / à¸¥>"?à¹Œ1@/@% / Nà¸„%AP1AP# 250 %?# x 6 /N/$ 250 #>à¸¥à¸¥>à¸¥>% x 10 /N/$ 4,000 à¸«à¸™à¹‰à¸² 31 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 131 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% /?B?N2?$ - %1%à¹Œ> /%A1 Nà¸¥A11%à¹ŒN - %NP1> /%A1 Nà¸¥A1NPN1 - %>%> /%A1 Nà¸¥A1>N% - %P % > P1>à¸„ /%A1 Nà¸¥A1P % > P1N HPLC 1. 1@/@% 100 %?# x 2 /N/$ 2. Nà¸„%AP1AP# 250 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ %@$@% à¸¥> 1,000 132 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% /?BQ/Oà¸„/@#//@ OQO@@à¸¥ - ?à¸„à¸„@%> - 1>??à¸¥N!# - Nà¸„ - O12 @O# - ?$à¸„à¸¥@N# - Cà¸„à¸¥@Pà¸¥2 - 2?/>P1Rà¹Œ (stevioside) - %?@/>P1Rà¹Œ N1 (rebaudioside A) HPLC 1. 1@/@% 100 %?# x 2 /N/$ 2. Nà¸„%AP1AP# 250 #>à¸¥à¸¥>à¸¥>% x 3 /N/$ %@$@% à¸¥> 1,500 133 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% /?BQ/Oà¸„/@#//@O QO@@à¸¥ à¸¥BN#2?/>11à¸¥ Rà¸¥Pà¸„Rà¹Œ - 2?/>P1Rà¹Œ (stevioside) - %?@/>P1Rà¹Œ N1 (rebaudioside A) - 2?/>11à¸¥Rà¸¥Pà¸„Rà¹Œ HPLC 1. 1@/@% 100 %?# x 2 /N/$ 2. Nà¸„%AP1AP# 250 #>à¸¥à¸¥>à¸¥>% x 3 /N/$ 3,100 134 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% />@#> - N1 - ? 1 - ? 2 - ? - R1>> /%A1 >Pà¸„>@R#à¹Œ - HPLC - Spectroflorometry - Spectroflorometry - HPLC - Microbiological assay 1@/@% / à¸¥>"?à¹Œ1@/@% / Nà¸„%AP1AP# 250 %?# / #>à¸¥à¸¥>à¸¥>% x 2 /N/$ / %@$@%21 %@$@% à¸¥> 1,500 à¸«à¸™à¹‰à¸² 32 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 135 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% 2@%?/A - Propyl gallate - BHA - BHT - T BHQ HPLC QO@#? / R#? 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ %@$@% à¸¥> 1,000 136 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% 2@%?P2?ROO/$QO@%O1 Extraction @ ( Q ) 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 300 137 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% 2@%P à¸¥@%à¹Œ (Polar Compounds) Column Chromatography QO@#?Oà¸¥>R#? 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 1,200 138 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% 2>P1AP?PR#Nà¸¥>à¸¥@$ /%A1 2>PNà¸·Q1?PR#Nà¸¥>à¸¥@$ Gravimetry QO@#?Oà¸¥>R#? 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 600 139 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% 2?1>%?$à¹Œ2?Nà¸„%@>/à¹Œ N12@%O 1 1. 1@/@% 100 %?# x 4 /N/$ 2. Nà¸„%AP1AP# 250 #>à¸¥à¸¥>à¸¥>% x 4 /N/$ - %/@#à¸„B"@ Paper Chromatography 500 - %/%>#@ HPLC 1,700 140 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% 2? Sudan - Sudan I - Sudan II - Sudan III - Sudan IV HPLC Nà¸„%AP1N0 / 12 %> 500 %?# x 1 /N/$ >à¸¥> 1,700 141 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% 1à¸„à¹Œ%>11 %R#? (Fatty acid composition in oils and fats) GC QO@#?Oà¸¥>R#? 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 2,000 à¸«à¸™à¹‰à¸² 33 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 142 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% à¸„N@R1P1? (Iodine value) - 1à¸„à¹Œ%>11% R#? (Fatty acid composition in oils and fats) - à¸„N@R1P1? (Iodine value) ( @%à¸„O@/ ) GC QO@#?Oà¸¥>R#? 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 2,100 143 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% 1Pà¸¥1> ( @%à¹Œ@Pà¸¥1> ) HPLC 1@/@%Oà¸¥>Nà¸„%AP1AP# ?P#?2N/2#1 /N@/@%>NO 200 %?# x 1 /N/$ /%A1 250 #>à¸¥à¸¥>à¸¥>% x 3 /N/$ 2,000 144 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% 1?O 1>!>N1N>à¸¥ O#N1%à¹Œ (Unsaponifiable matter) Extraction QO@#?Oà¸¥>R#? 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 1,100 145 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% N1>à¸¥O1à¸¥121à¸¥à¹Œ Titration QO@à¸¥R#O 250 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 800 146 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% R1P1? Titration - Nà¸¥A1%>P"à¸„ 100 %?# x 2 /N/$ 600 ICP/MS - 1@/@% / 12%B%2 / QO@Nà¸¥A1 / QO@à¸¥@ 500 %?# / #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 4,700 à¸«à¸™à¹‰à¸² 34 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 147 @%21 2N/%>1 Oà¸¥>/?BNA1 Q1@/@% R2%1?N#>à¸¥N!1%à¹Œ !>/%?à¸¥ (Hydroxymethyl furfural) Spectrophotometry QO@@Q 250 %?# x 4 /N/$ 600 148 @#2/ /?BNA/ /@à¸«@# /?BNA11@/@% (Assay) P$Nà¸„>à¸„ Titration @#N12@%O 1 ( %@$@%à¸¥> ) Titration /?BNA11@/@% 100 %?# 900 149 @%21 /?BNA1 1@/@% /?BNA11@/@% (Assay) P$Nà¸„>à¸„ Spectrophotometer @#N12@%O 1 ( %@$@%à¸¥> ) Spectrophotometer /?BNA11@/@% 100 %?# 600 /?BNA11@/@% (Assay) P$Nà¸„>à¸„ Spectrophotometer - Disodium 5' Ribonucleotides Spectrophotometer /?BNA11@/@% 100 %?# 2,400 - Phosphorus pentoxide 1,000 150 @%21 /?BNA1 1@/@% %>#@/?BNA1 1@/@% (Assay) Nà¸„>à¸„ Gravimetry - Potassium sulfate - Sodium sulfate Gravimetry /?BNA11@/@% 100 %?# %@$@% à¸¥> 500 à¸«à¸™à¹‰à¸² 35 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 151 @%21 /?BNA1 1@/@% /?BNA11@/@% (Assay) Nà¸„>à¸„ HPLC - Butylated hydroxyanisole (BHA) - Butylated hydroxytoluene (BHT) - tert- Butylhydroquinon e (TBHQ) - Propyl gallate - Saccharin - Acesulfame-K - Aspartame - Sucralose - Sorbitol - Mannitol - Xylitol - Stevioside - Rebaudioside A - Rebaudioside M - Steviol glycoside HPLC /?BNA11@/@% 100 %?# %@$@% à¸¥> 1,500 $N/O Steviol glycoside 3,000 152 @%21 /?BNA1 1@/@% @%%/N1à¸¥?1à¹Œ (Identification tests) R1111>%?$à¹Œ (Inorganic ions) /%A1 R1111>%?$à¹Œ Oà¸¥>2@%%>1 (Organic ions and compounds) @#N12@%O 1 /?BNA11@/@% 100 %?# 400 à¸«à¸™à¹‰à¸² 36 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) ( %/@à¸„B"@ ) @#N12@%O 1 ( %@$@%à¸¥> ) 153 @%21 /?BNA1 1@/@% 2@%1>%?$à¹Œ (Inorganic substances) 2@%1>%?$à¹Œ/%A1 2@%%>1 (Organic substances or compounds) ( %/%>#@ ) - Acid insoluble substances - Ash or Ash (Total) - Total sulfur - Acetone- insoluble matter - Acid insoluble ash - Acid soluble substances - Calcium - Calcium oxide - Ethanol insoluble residue - Hydrochloric acid soluble substance - Loss on ignition - Magnesium and alkali salts Gravimetry /?BNA11@/@% 100 %?# 700 à¸«à¸™à¹‰à¸² 37 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) - Matter insoluble dilute ammonia - Non-Volatile Residue - Reducing substances/ Reducing sugars - Residue on ignition - Sodium hydroxide insoluble matter - Solid content - Toluene- insoluble matter - Water extractable substances - Water insoluble matter/Water insoluble substances/ Water insoluble - Water soluble substance - Acid insoluble matter - Loss on drying - Sulfate ash Insoluble substance à¸«à¸™à¹‰à¸² 38 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) pH Potentiometer 200 - Insoluble matter / 2>P/AP?P R!Nà¸¥>à¸¥@" Water insoluble Substance Identification 200 Colour intensity Spectrophoto- metry 400 Ether-extractable matter Extraction 900 - Water Karl Fischer technique 1,200 Nitrogen/ Nitrogen (Total)/ Protein Karl Fischer technique 700 Protein residue Karl Fischer technique 700 Melting point Melting point apparatus 400 Reducing sugar/ Reducing substances Titration 800 Sulfur dioxide Titration 800 Acid value Titration 700 Acetyl groups Titration 800 Caboxyl Groups Titration 800 #>!@/?BNA/ /@à¸«@# (Assay) - Total hydrogenated saccharides - Water - Sulfated ash - Reducing sugars - Calculation - Potentiometer - Gravimetry - Gravimetry 2,700 à¸«à¸™à¹‰à¸² 39 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) - Total hydrogenated saccharides ( @#à¸„à¹@/ ) Carbohydrate - Loss on drying - Total ash - Protein - Carbohydrate ( @#à¸„à¹@/ ) - Calculation - Gravimetry - Gravimetry - Kjeldahl technique Calculation 2,200 700 700 700 100 154 @%21 $@2?/à¹Œà¸„O@ / $@Oà¸±B? $@Oà¸±B? @#N12@%O 1 LC-MS/MS 1. à¸¥>"?à¹ŒN2%>#1@/@% >N#O Oà¸¥>Oà¸„Cà¸¥ 1$N@O1$ 50 %?# 2. à¸¥>"?à¹ŒN2%>#1@/@% >QO@ Oà¸¥>Nà¸„%AP1AP# 2#BR % 1$N@O1$ 500 #>à¸¥à¸¥>à¸¥>% 3. à¸¥>"?à¹ŒN2%>#1@/@% >QO@/? 1$N@O1$ 100 %?# 4. @O!%B2O@N%O> 1$N@O1$ 100 %?# @O!%B2O@N%O>QO@ 1$N@O1$ 500 #>à¸¥à¸¥>à¸¥>% 5,000 155 @%21 $@2?/à¹Œà¸„O@ / $@Oà¸±B? 2@%Nà¸„#?à¸¥BN#NO@ 1>P>2à¹Œ @#N12@%O 1 LC/MS/MS NAQ12?/à¹Œ 500 %?# 5,000 156 @%21 $@2?/à¹Œà¸„O@ / $@Oà¸±B? 2@%à¸¥BN#21%à¹ŒP# @#N12@%O 1 LC-MS-MS NAQ12?/à¹Œ 500 %?# 5,000 à¸«à¸™à¹‰à¸² 40 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 157 @%21 $@2?/à¹Œà¸„O@ / $@Oà¸±B? 2@%O@Bà¸¥? 6 à¸¥BN# - à¸¥BN# amphenicol - à¸¥BN# beta-lactam - à¸¥BN# macrolide - à¸¥BN# quinolone - à¸¥BN# sulfonamide - à¸¥BN# tetracycline @#N12@%O 1 LC-MS/MS Multiclass-residues analysis 1. NAQ12?/à¹Œ 500 %?# 2. # 1 à¸¥>% 3. RN 12 !1 à¸¥BN#à¸¥> 5,000 158 @%21 $@2?/à¹Œà¸„O@ / $@Oà¸±B? 2@%O@Bà¸¥? - à¸¥BN#RP%!C%@2à¹Œ N#@PRà¸¥à¹Œ N12@%O 1 LC/MS/MS OO / RN / # / NAQ12?/à¹Œ / Nà¸„%AP1 Q 500 %?# %@$@% à¸¥> 5,000 - #@à¸¥@Rà¸„à¹Œ%?Oà¸¥> à¸¥>/Pà¸„#@à¸¥@Rà¸„à¹Œ%? LC/MS/MS NAQ12?/à¹ŒQO@ 500 %?# 5,000 - à¸¥BN#?à¸¥P!@R#à¹Œ LC/MS/MS QO@@Q 500 %?# 5,000 159 @%21 2@%Nà¸„#?O1? O@?0?%C A  2@%Nà¸„#?O1?O@? 0?%C A à¸„O@ 26 > @#N12@%O 1 LC-MS/MS ? / à¸¥R#O 1 >Pà¸¥%?# 6,000 160 @%21 2@%Nà¸„#?O1? O@?0?%C A  2@%Nà¸„#?O1?O@? 0?%C A à¸„O@ 44 > @#N12@%O 1 LC-MS/MS ? / à¸¥R#O 1 >Pà¸¥%?# 8,000 161 @%21 2@%Nà¸„#?O1? O@?0?%C A  2@%Nà¸„#?O1?O@? 0?%C A à¸„O@ 106 > @#N12@%O 1 GC-MS/MS 1. ? / à¸¥R#O 1 >Pà¸¥%?# 2. A O/O /  50 %?# 3. 2@%2? / QO@#? 10 %?# 4. QO@#?Oà¸¥>R#? 500 #>à¸¥à¸¥>à¸¥>% 9,000 162 @%21 2@%Nà¸„#?O1? O@?0?%C A  2@%Nà¸„#?O1?O@? 0?%C A à¸„O@ 132 > @#N12@%O 1 GC-MS/MS, LC-MS/MS, HPLC 1. ? / à¸¥R#O 1 >Pà¸¥%?# 2. A O/O /  50 %?# 3. 2@%2? / QO@#? 10 %?# 4. QO@#?Oà¸¥>R#? 500 #>à¸¥à¸¥>à¸¥>% 15,000 à¸«à¸™à¹‰à¸² 41 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 163 @%21 2@%Nà¸„#?O1? O@?0?%C A  2@%Nà¸„#?O1?O@? 0?%C A à¸„O@ 144 > @#N12@%O 1 LC-MS/MS ? / à¸¥R#O 1 >Pà¸¥%?# 22,000 164 @%21 2@%Nà¸„#?O1? O@?0?%C A  2@%Nà¸„#?O1?O@? 0?%C A à¸„O@ 250 > @#N12@%O 1 GC-MS/MS, LC-MS/MS ? / à¸¥R#O 1 >Pà¸¥%?# 31,000 165 @%21 2@%Nà¸„#?O1? O@?0?%C A  2@%Nà¸„#?O1? O@?0?%C A à¸„O@ - à¸¥BN#11%à¹Œ@Pà¸„à¸¥1%? (Organochlorine compounds) - à¸¥BN#11@P !12!1%?2 (Organophosphorus compounds) - à¸¥BN#2@%à¸„@%à¹Œ@N# (Carbamates) - à¸¥BN#2@%2?Nà¸„%@>/à¹Œ R %?%1$à¹Œ (Synthetic pyrethroid) - à¸¥BN#2@%2?Nà¸„%@>/à¹Œ R %?%1$à¹Œ - GC - GC - HPLC - GC - HPLC 1. ? / à¸¥R#O 1 >Pà¸¥%?# 2. QO@ 4 à¸¥>% 3. Nà¸„%AP1AP# 1 à¸¥>% 4. NAQ12?/à¹Œ 500 %?# 5. QO@#?Oà¸¥>R#? 500 #>à¸¥à¸¥>à¸¥>% 6. RN 12 !1 7. # 1 à¸¥>% 8. #Oà¸¥>à¸¥>"?à¹Œ 500 %?# 9. A O/O /  50 %?# 10. 2@%2? / QO@#? 10 %?# à¸¥BN#à¸¥> 3,000 166 @%21 2@%Nà¸„#?O1? O@?0?%C A  2@%Nà¸„#?O1?O@? 0?%C A à¸„O@ - Hydrogen phosphide - Bromide ion - Fipronil - Chlorpyrifos Oà¸¥> Chlorpyrifos- methyl - Dithiocarbamates - GC-MS - GC - GC-MS/MS - GC-MS/MS - GC-MS 1. O@/Oà¸¥>? A  1 >Pà¸¥%?# 2. ? / à¸¥R#O 1 >Pà¸¥%?# 3. A O/O /  50 %?# 4. QO@#?Oà¸¥>R#? 500 #>à¸¥à¸¥>à¸¥>% 5. RN 12 !1 à¸¥BN#à¸¥> 3,500 à¸«à¸™à¹‰à¸² 42 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 167 @%21 2@%Nà¸„#?O1? O@?0?%C A  2@%O@?/? A  - Paraquat - Diquat - Chlormequat - Mepiquat LC-MS/MS 1. ? / à¸¥R#O / ? A  1 >Pà¸¥%?# 2. NAQ12?/à¹Œ 500 %?# 3. # 1 à¸¥>% 4. RN 12 !1 5. A O/O 500 %?# 4,000 168 @%21 2@%Nà¸„#?O1? O@?0?%C A  2@%O@?/? A  - Glyphosate LC-MS/MS 1. ? A  1 >Pà¸¥%?# 2. ? à¸¥R#O 1 >Pà¸¥%?# 3. QO@1BP"à¸„Oà¸¥>%>P"à¸„ 1 à¸¥>% 3,500 ELISA 1. ? à¸¥R#O 1 >Pà¸¥%?# 3,500 169 @%21 "@>N#à¸¥@#? - à¸„/@#% - à¸„/@#à¸„/@#%O1 - à¸„/@#QO@NA1 Visual "@> à¸¥@2> %%B1@/@%>N#à¸¥@#? @#N12@%O 3 %@$@% à¸¥> 300 170 @%21 à¸„B"@ 1 NAQ1 à¸¥@2> >?P/ AAS "@> à¸¥@2 > %%B1@/@% B> /?/#$@ #1 . 969-2533 , 1025-2539 Oà¸¥>N%@#> ( $N/O à¸¥@2>?PQO%%B #> PE/PP/PS) @#N12@%O 3 800 171 @%21 à¸„B"@ 1 NAQ1 à¸¥@2> Oà¸„N#?$# AAS "@> à¸¥@2 > %%B1@/@% B> /?/#$@ #1 . 969-2533, 1025-2539 Oà¸¥>N%@#> ( $N/O à¸¥@2>?PQO%%B #> PE/PP/PS) @#N12@%O 3 800 172 @%21 à¸„B"@ 1 NAQ1 à¸¥@2> 2@%%>1R>/>à¸¥> TLC "@> à¸¥@2 >  %%B1@/@%> PVC @#N12@%O 3 500 à¸«à¸™à¹‰à¸² 43 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 173 @%21 à¸„B"@ 1 NAQ1 à¸¥@2> R%à¸„%>>à¸¥!12N! HPLC "@> à¸¥@2 >  %%B1@/@%> PVC @#N12@%O 3 3,000 174 @%21 à¸„B"@ 1 NAQ1 à¸¥@2> R/>à¸¥à¸„à¸¥1R%à¹ŒP#PN#1%à¹Œ GC-MS "@> à¸¥@2 >  %%B1@/@%> PVC @#N12@%O 3 3,900 175 @%21 à¸„B"@ 1 NAQ1 à¸¥@2> 2@%%>N/$RO - Pà¸¥C1? - N1>à¸¥N>à¸¥ - R1PP%>à¸¥N> - 1%à¹Œ#?à¸¥P%>à¸¥N> - 2R%? GC "@> à¸¥@2> %%B1@/@%> PS @#N12@%O 3 3,900 176 @%21 à¸„B"@ 1 NAQ1 à¸¥@2> 2@%?P2?O/$ 1%à¹Œ#?à¸¥N2N Gravimetry "@> à¸¥@2> ?PQO%%B#> PE/PP @#N12@%O 3 1,600 177 @%21 à¸„B"@ 1 NAQ1 à¸¥@2> 2@%?Pà¸¥>à¸¥@$ROQRà¸¥? Gravimetry "@> à¸¥@2 >  ?PQO%%B#> PE/PP @#N12@%O 3 1,600 178 @%21 à¸„B"@ 1 NAQ1 à¸¥@2> 2@%/C ICP "@> à¸¥@2 >  ?PQO%%B#> PE/PP/PS @#N12@%O 3 900 179 @%21 à¸„B"@ 1 NAQ1 à¸¥@2> RP%@#?2à¹Œ GC-TEA /?/#$@ !/ . 969-2533, 1025-2539 20 >Q 6,000 180 @%21 à¸„B"@ @%O %N%>@$ Pà¸¥/>/? ( à¸„O@/NO>?P/ ) Visual estimation "@> à¸¥@2> %%B1@/@%B> /?/#$@ #1 . 969-2533 ( %/# à¸¥@2>?PQO %%B#> PE/PP/PS) @#N12@%O 3 700 à¸«à¸™à¹‰à¸² 44 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 181 @%21 à¸„B"@ @%O %N%>@$ P O2N?$#N1%à¹ŒO# @N?PQOO@>>%>$@ Titration "@> à¸¥@2> %%B1@/@%B> ( %/# à¸¥@2>?PQO %%B#> PE/PP/PS) @#N12@%O 3 700 182 @%21 à¸„B"@ @%O %N%>@$ 2@%à¸„O@ @2@%?P%>N/$RO ( QO@ ) Gravimetry "@> à¸¥@2> %%B1@/@%B> /?/#$@ !/ .969-2533 ( $N/O à¸¥@2> >N#à¸¥@#?Oà¸¥> à¸¥@2>?PQO%%B#> PE/PP/PS) @#N12@%O 3 700 183 @%21 à¸„B"@ @%O %N%>@$ 2@%à¸„O@ @2@%?P%>N/$RO (4% %1>?> ) Gravimetry "@> à¸¥@2> %%B1@/@%B> /?/#$@ !/ .969-2533 ( %/# à¸¥@2>?PQO %%B#> PE/PP/PS) @#N12@%O 3 700 184 @%21 à¸„B"@ @%O %N%>@$ 2@%à¸„O@ @2@%?P%>N/$RO (20% O1à¸¥121à¸¥à¹Œ ) Gravimetry "@> à¸¥@2> %%B1@/@%B> ( $N/O à¸¥@2> >N#à¸¥@#?Oà¸¥> à¸¥@2>?PQO%%B# > PE/PP/PS) @#N12@%O 3 700 à¸«à¸™à¹‰à¸² 45 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 185 @%21 à¸„B"@ @%O %N%>@$ 2@%à¸„O@ @2@%?P%>N/$RO ( 1%à¹Œ#?à¸¥N2N ) Gravimetry "@> à¸¥@2> %%B1@/@%B>Oà¸¥> à¸¥@2>?PQO%%B# > PE/PP ( $N/O à¸¥@2> >N#à¸¥@#?Oà¸¥> à¸¥@2>?PQO%%B# > PS) @#N12@%O 3 700 186 @%21 à¸„B"@ @%O %N%>@$ à¸¥/ GF-AAS "@> à¸¥@2 >  %%B1@/@%> PET @#N12@%O 3 1,500 187 @%21 à¸„B"@ @%O %N%>@$ N1%à¹Œ#@N?$# ICP-OES "@> à¸¥@2 >  %%B1@/@%> PET @#N12@%O 3 900 188 @%21 à¸„B"@ @%O %N%>@$ Oà¸„P %Oà¸¥O# GC "@> à¸¥@2 >  %%B1@/@% >Rà¸¥1 (PA) @#N12@%O 3 3,900 189 @%21 à¸„B"@ @%O %N%>@$ ?2!?1à¸¥N1 ( %/#!?1à¸¥ Oà¸¥> ? - ? - >/>à¸¥!?1à¸¥ ) ?P2?O/$QO@ ( %?1@/@%?P#?à¸„/@# NO% - N@N> 5) HPLC "@> à¸¥@2> %%B1@/@% > 1à¸¥>à¸„@%à¹Œ1N (PC) @#N12@%O 3 3,000 190 @%21 à¸„B"@ @%O %N%>@$ ?2!?1à¸¥N1 ( %/#!?1à¸¥ Oà¸¥> ? - ? - >/>à¸¥!?1à¸¥ ) ?P2?O/$%1>?> à¸„/@#NO#O%O1$à¸¥> 4 ( %?1@/@%?P#?à¸„/@# NO% - N@ R#NN> 5) HPLC "@> à¸¥@2> %%B1@/@% > 1à¸¥>à¸„@%à¹Œ1N (PC) @#N12@%O 3 3,000 191 @%21 à¸„B"@ @%O %N%>@$ ?2!?1à¸¥N1 ( %/#!?1à¸¥ Oà¸¥> ? - ? - >/>à¸¥!?1à¸¥ ) ?P2?O/$N1@1à¸¥ HPLC "@> à¸¥@2> %%B1@/@% > 1à¸¥>à¸„@%à¹Œ1N (PC) 3,000 à¸«à¸™à¹‰à¸² 46 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) à¸„/@#NO#O%O1$à¸¥> 20 ( %?1@/@%?P#? O1à¸¥121à¸¥à¹Œ ) @#N12@%O 3 192 @%21 à¸„B"@ @%O %N%>@$ ?2!?1à¸¥N1 ( %/#!?1à¸¥ Oà¸¥> ? - ? - >/>à¸¥!?1à¸¥ ) ?P2?O/$1%à¹Œ#?à¸¥N2N ( %?R#? QO@#? Oà¸¥>1@/@%?P#?R#? ) HPLC "@> à¸¥@2> %%B1@/@% > 1à¸¥>à¸„@%à¹Œ1N (PC) @#N12@%O 3 3,000 193 @%21 à¸„B"@ @%O %N%>@$ N#>à¸¥N#@à¸„%>Nà¸¥ GC-FID "@> à¸¥@2 >  %%B1@/@% > 1à¸¥>N#>à¸¥N#@à¸„%>Nà¸¥ @#N12@%O 3 3,900 194 @%21 à¸„B"@ @%O %N%>@$ !?1à¸¥ Spectrophotometry "@>%%B1@/@% >N#à¸¥@#? / /?/#$@ #1 . 969-2533 @#N12@%O 3 800 195 @%21 à¸„B"@ @%O %N%>@$ !1%à¹Œ#@à¸¥?R2à¹Œ Spectrophotometry "@>%%B1@/@% >N#à¸¥@#? / /?/#$@ #1 . 969-2533 Oà¸¥> @#%>@0 %>%/2@@%2B ( ??P 369) . 0 . 2558 @#N12@%O 3 800 196 @%21 à¸„B"@ @%O %N%>@$ "@>%%B1@/@% - 2??Pà¸¥>à¸¥@$11#@ Q2@%à¸¥>à¸¥@$ 4 > ( QO@ , 4 % %1>>> , 20 % O1à¸¥121à¸¥à¹Œ , 1%à¹Œ#?à¸¥N2N ) * %?/>Nà¸„%@>/à¹Œ%N/# Q2@%à¸„O@ @2@%?P%>N/$RO Q2@%à¸¥>à¸¥@$ 4 > 1$ C N Oà¸¥O/>R#Nà¸„>%@à¸„@N > P # V isual estimation "@> à¸¥@2> %%B1@/@%B> @#N12@%O 3 >à¸¥> 500 à¸«à¸™à¹‰à¸² 47 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 197 @%21 à¸„B"@ @%O %N%>@$ Pà¸¥/ >Q?/O@à¸¥>à¸¥@$ ?PNO%1>?> à¸„/@#NO#O %O1$à¸¥> 3 (w/v) - >?P/ (Lead; Pb) - ON%?$# (Barium; Ba) - Pà¸„1à¸¥à¹Œ (Cobalt; Co) - 1O (Copper; Cu) - N/à¸¥O (Iron; Fe) - à¸¥>N?$# (Lithium; Li) - O#@?2 (Manganese; Mn) - 2?>2? (Zinc; Zn) ICP - OES //%A1"@>%%B# / @ à¸„%1 */ @$@/?/#$@ */ à¸¥>Q>@/ 6 / /10 >Q ** 7,200 198 @%21 à¸„B"@ @%O %N%>@$ 2@%à¸„O@?PN/à¸¥A1 @@%%>N/$ ?/O@à¸¥>à¸¥@$?PNO N1@1à¸¥ à¸„/@#NO#O %O1$à¸¥> 50 Gravimetry //%A1"@>%%B# / @à¸„%1 */ @$@/?/#$@ */ à¸¥>Q>@/ 6 / /10 >Q ** 600 199 @%21 à¸„B"@ @%O %N%>@$ 2@%à¸„O@?PN/à¸¥A1 @@%%>N/$ ?/O@à¸¥>à¸¥@$ ?PNO%1>?> à¸„/@#NO#O%O1$à¸¥> 3 Gravimetry //%A1"@>%%B# / @à¸„%1 */ @$@/?/#$@ */ à¸¥>Q>@/ 6 / /10 >Q ** 600 200 @%21 à¸„B"@ @%O %N%>@$ 2,2- >2 (4- R2%1 >N!>à¸¥ ) P %N  /%A1>2!?1à¸¥N1 - 2?O/$N1@1à¸¥ à¸„/@#NO#O%O1$à¸¥> - 2?O/$%1>?> à¸„/@#NO#O%O1$à¸¥> 3 HPLC //%A1"@>%%B# / @à¸„%1 */ @$@/?/#$@ */ à¸¥>Q>@/ - 12 / /20 >Q ** - 6 / /10 >Q ** - 6 / /10 >Q ** %@$@% à¸¥> 3,000 201 @%21 à¸„B"@ @%O %N%>@$ 4,4'- Rà¸„à¸¥1P%RN!>à¸¥ ?à¸¥P! /%A1?? ? N12 HPLC //%A1"@>%%B# / @à¸„%1 */ @$@/?/#$@ */ à¸¥>Q>@/ %@$@% à¸¥> 3,000 à¸«à¸™à¹‰à¸² 48 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) - 2?O/$N1@1à¸¥ à¸„/@#NO#O%O1$à¸¥> 50 - 2?O/$%1>?> à¸„/@#NO#O%O1$à¸¥> 3 - 12 / /20 >Q ** - 6 / /10 >Q ** - 6 / /10 >Q ** 202 @%21 à¸„B"@ @%O %N%>@$ 4,4'- RR2%1 >RN!>à¸¥?à¸¥P!/%A1 ?N1 ? N12 /%A1 >2!?1à¸¥N12 - 2?O/$N1@1à¸¥ à¸„/@#NO#O%O1$à¸¥> 50 - 2?O/$%1>?> à¸„/@#NO#O%O1$à¸¥> 3 HPLC //%A1"@>%%B# / @à¸„%1 */ @$@/?/#$@ */ à¸¥>Q>@/ - 12 / /20 >Q ** - 6 / /10 >Q ** - 6 / /10 >Q ** %@$@% à¸¥> 3,000 203 @%21 à¸„B"@ @%O %N%>@$ 4,4'- RR2%1 >RN!>à¸¥ /%A1?N1? ? - 2?O/$N1@1à¸¥ à¸„/@#NO#O%O1$à¸¥> 50 - 2?O/$%1>?> à¸„/@#NO#O%O1$à¸¥> 3 HPLC //%A1"@>%%B# / @à¸„%1 */ @$@/?/#$@ */ à¸¥>Q>@/ - 12 / /20 >Q ** - 6 / /10 >Q ** - 6 / /10 >Q ** %@$@% à¸¥> 3,000 204 @%21 à¸„B"@ @%O %N%>@$ N1O - RP%@#?2à¹Œ ?2O2à¹Œ GC-TEA /?/#$@ @#%>@0 %>%/2@@%2B ( ??P 369) . 0 . 2558 20 >Q 7,500 205 @%21 à¸„B"@ @%O %N%>@$ N1O - RP%ONN>à¸¥ ?2O2à¹Œ GC-TEA /?/#$@ @#%>@0 %>%/2@@%2B ( ??P 369) . 0 . 2558 20 >Q 7,500 206 @%21 à¸„B"@ @%O %N%>@$ %>#@2@%%>N/$RO Gravimetry /?/#$@ @#%>@0 %>%/2@@%2B ( ??P 369) . 0 . 2558 20 >Q 500 à¸«à¸™à¹‰à¸² 49 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 207 @%21 à¸„B"@ @%O %N%>@$ 2- N!/#à¹Œ Oà¸„PNP R1>Pà¸¥ %?à¸¥?2 /%A1N1O#?? %?à¸¥?2 - 2?O/$N1@1à¸¥ à¸„/@#NO#O%O1$à¸¥> 50 - 2?O/$%1>?> à¸„/@#NO#O%O1$à¸¥> 3 HPLC /?/#$@ @#%>@0 %>%/2@@%2B ( ??P 369) . 0 . 2558 20 >Q %@$@% à¸¥> 3,000 208 @%21 à¸„B"@ @%O %N%>@$ O1>11>Oà¹Œ %?à¸¥?2 2,6- ?2 (1,1- RN#>à¸¥N1>à¸¥ ) - 4- N#>à¸¥!?1à¸¥ /%A1 ?N1? - 2?O/$N1@1à¸¥ à¸„/@#NO#O%O1$à¸¥> 50 - 2?O/$%1>?> à¸„/@#NO#O%O1$à¸¥> 3 HPLC /?/#$@ @#%>@0 %>%/2@@%2B ( ??P 369) . 0 . 2558 20 >Q %@$@% à¸¥> 3,000 209 @%21 à¸„B"@ @%O %N%>@$ @%%//>Nà¸„%@>/à¹Œ @Nà¸„#? ( à¸„B"@ @%O %N%>@$ ) 2,2'- N#>à¸¥?>2 (6-(1,1- RN#>à¸¥N1>à¸¥ ) 4 - N#>à¸¥ - !?1à¸¥ /%A1 O1>11>Oà¹Œ 2246 - 2?O/$N1@1à¸¥ à¸„/@#NO#O%O1$à¸¥> 50 - 2?O/$%1>?> à¸„/@#NO#O%O1$à¸¥> 3 HPLC /?/#$@ @#%>@0 %>%/2@@%2B ( ??P 369) . 0 . 2558 20 >Q %@$@% à¸¥> 3,000 210 @%21 à¸„B"@ @%O %N%>@$ 2?>2? AAS /?/#$@ #1 . 969-2533 @#N12@%O 3 1,000 à¸«à¸™à¹‰à¸² 50 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 211 @%21 N1à¸¥?1à¹Œ1 à¸¥@2> %/N1à¸¥?1à¹Œ 1 à¸¥@2> FT-IR "@> à¸¥@2>%%B1@/@% B> ( %/# à¸¥@2>?PQO%%B# > PE/PP/PS) @#N12@%O 3 /# , @à¸„%1 , @Nà¸¥?$/ @#%>@0 %>%/2@@%2B ( ??P 369) . 0 . 2558 1$N@à¸¥> 1 /N/$ 1,000 212 @%21 à¸¥@P"@@% à¸¥@P"@@% @#%>@0%>%/ 2@@%2B ??P 182 . 0 . 2541 - à¸¥?@?Q/# - à¸¥?@@R#? - R#??Q/# - R#?1>P#?/ - Pà¸„Nà¸¥2N1%1à¸¥ - P%? - à¸„@%à¹ŒPR2N%?Q/# - Q$1@/@% - QO@@à¸¥ - PN?$# - />@#> ? 1 - />@#> ? 2 - />@#> N1 - Oà¸„à¸¥N?$# - N/à¸¥O - NO@ - à¸„/@#AQ - à¸„N@à¸„O@/à¸¥@ P"@@%N1 /@P/N/$%>P"à¸„ - 1@/@% R#NO1$/N@ 15 /N/$ Oà¸¥> QO@/?%/#? R#NO1$/N@ 2 >Pà¸¥%?# 1@/@% >1N/à¸¥/ R#NO1$/N@ 15 /N/$Oà¸¥> %>#@%%/#? R#NO1$/N@ 4 à¸¥>% 21,400 à¸«à¸™à¹‰à¸² 51 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 213 @%21 à¸¥@ P"@@% à¸¥@P"@@% O??N1 @#%>@0 %>%/2@@%2B ??P 394 . 0 . 2561 - à¸¥?@?Q/# - à¸„@%à¹ŒPR2N%?Q/# - R#? - Pà¸„Nà¸¥2N1%1à¸¥ - P%? - QO@@à¸¥ - PN?$# - NO@ - à¸„/@#AQ - à¸„N@à¸„O@/ à¸¥@P"@@%N1 /@P/N/$%>P"à¸„ - 1@/@% R#NO1$/N@ 15 /N/$ Oà¸¥>QO@/?%/#? R#NO1$/N@ 2 >Pà¸¥%?# 7,800 214 @%21 N1à¸¥?1à¹Œ N1à¸¥?1à¹Œ?PNN@ - Adenosine - Codycepin UHPLC à¸¥>"?à¹ŒN2%>#1@/@% ?P#?2N/2#1?PNN@ à¸¥?1>O/OOà¸¥> 1?N#O ( $N/O # @O! Oà¸¥>1@/@%N2%>#QO@#? ) 100 %?# x 1 /N/$ 6,000 215 @%21 N1à¸¥?1à¹Œ N1à¸¥?1à¹ŒP2# - %/N1à¸¥?1à¹Œ (Rb 1 , Re, Rc Oà¸¥> Rg 1 ) TLC Nà¸„%AP1AP# 200 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 2,000 - %/N1à¸¥?1à¹Œ Oà¸¥> %>#@ Ginsenoside - Rb 1 - Re - Rc - Rg 1 HPLC 4,500 à¸«à¸™à¹‰à¸² 52 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 216 @%21 N1à¸¥?1à¹Œ N1à¸¥?1à¹Œ%? FT-IR 1. Nà¸„%AP1AP#%? 1$N@O1$ 42 #>à¸¥à¸¥>à¸¥>% x 6 /N/$ 2. /?B>%? 10 - 100 %?# 1,500 217 @%21 N1à¸¥?1à¹Œ 2@% S-allyl cysteine (SAC) UHPLC %>N?$#O@ %CO à¸¥? / /?/ 100 %?# x 4 /N/$ 4,300 218 @%21 2@%2O@à¸„? 2@%2O@à¸„?@?@ /%A1? - Cannabidiol (CBD) - Delta- 9 - tetrahydrocannabi nol (Delta- 9 -THC) HPLC LC-MS/MS 1. à¸¥>"?à¹ŒN2%>#1@/@% >1OO  @POO @PN/à¸¥/ Oà¸¥> QO@#? QO@/? NAQ1?/1$N@?Q/# 1$N@O1$ 100 %?# 2. à¸¥>"?à¹ŒN2%>#1@/@% >QO@ %>#@%%/#?Q/# 1$N@O1$ 250 #>à¸¥à¸¥>à¸¥>% Oà¸¥>#?O@//N/$ R#NO1$/N@ 2 /N/$ 3. 1@/@%Oà¸¥>Nà¸„%AP1AP# 250 %?# x 4 /N/$ , 250 #>à¸¥à¸¥>à¸¥>% x 4 /N/$ 4. A ?@ A ? A 2 1$N@O1$ 200 %?# A O/O 1$N@O1$ 50 %?# 5. 2@%2? ?@ ? 1$N@O1$ 50 %?# 6. QO@#??@ ? 1$N@O1$ 50 %?# %@$@% à¸¥> 5,000 à¸«à¸™à¹‰à¸² 53 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„@%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ 1?%@ à¸„N@%>@% ( @ ) 219 @%21 2@%2O@à¸„? 2@%1B ? à¹Œ@?@ /%A1? @#N12@%O 1 HPLC LC-MS/MS 1. à¸¥>"?à¹ŒN2%>#1@/@% >1OO  @POO @PN/à¸¥/ Oà¸¥>QO@#? QO@/?NAQ1?/1$N@ ?Q/#1$N@O1$ 100 %?# 2. à¸¥>"?à¹ŒN2%>#1@/@% >QO@ %>#@%%/# ?Q/#1$N@O1$ 250 #>à¸¥à¸¥>à¸¥>% Oà¸¥>#?O@//N/$ R#NO1$/N@ 2 /N/$ 3. 1@/@%Oà¸¥>Nà¸„%AP1AP# 250 %?# x 4 /N/$ , 250 #>à¸¥à¸¥>à¸¥>% x 4 /N/$ 4. A ?@ A ? A 2 1$N@O1$ 200 %?# A O/O 1$N@O1$ 50 %?# 5. 2@%2? ?@ ? 1$N@O1$ 50 %?# 6. QO@#??@ ? 1$N@O1$ 50 %?# %@$@% à¸¥> 2,500 220 @%21 2@%2O@à¸„? 2@%>2O@à¸„? @ A %>N1# - mitragynine HPLC Nà¸„%AP1AP# 250 #>à¸¥à¸¥>à¸¥>% x 4 /N/$ 5,000 221 @%21 2@%2O@à¸„? Terpenes GC-MS/MS 1. A ? @ 50 %?# 2. 2@%2??@ QO@#??@ 10 %?# 3,500 à¸«à¸™à¹‰à¸² 54 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„@##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?/1$N@ / %>#@ à¸«N/"@ ?P#?>/ 1?%@ à¸„N@%>@% ( @ ) 222 QO@ / QO@N2?$ / QO@>Q 2@%à¸¥>à¸¥@$RO?Q/# / %>#@2@%?Pà¸¥>à¸¥@$ ?Q/#QQO@ / 1OOà¸¥>à¸¥@$QO@ ?Q/# Dried at 180 o C / Gravimetry QO@ / QO@N2?$ / QO@>Q 1 à¸¥>% 2O@?à¸„B"@ Oà¸¥>à¸„/@# à¸¥1"?$ 1@/@% 250 223 à¸¥>"?à¹ŒO@ 1@/@% $@2?/à¹Œà¸„O@ - 2@%Nà¸„#? à¸¥BN#NO@1>P>2à¹Œ (Beta Agonists) ELISA NAQ12?/à¹Œ 2O@?à¸„B"@ Oà¸¥> à¸„/@# à¸¥1"?$ 1@/@% 2,500 - à¸„à¸¥1O%#N!>à¸„1à¸¥ Chloramphenicol ELISA RN / # / NAQ12?/à¹Œ / QO@@Q 2O@?à¸„B"@ Oà¸¥> à¸„/@# à¸¥1"?$ 1@/@% 1,000 O1 10 Q/O$Nà¸¥>à¸„/@#Qà¸¥O@??P 3 - 4 à¸¥O@??P 8 Oà¸¥>à¸¥O@??P 23 - 29 %@$@%1?%@ à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ@/O1>?>@%O@à¸„BO#à¸„%1CO%>P"à¸„12@?/>?$2#BR % @#1?%@ à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@%OO@$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B @%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% . 0 . 2562 Oà¸¥>Q/OQOà¸„/@#N1R?QO à¸¥O@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„@##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?/1$N@ / %>#@ à¸«N/"@ ?P#?>/ 1?%@ à¸„N@%>@% ( @ ) 3 / ? B>2!BR# / Oà¸„Cà¸¥2!BR# / @2!BR# #>!@NO@ - #>!@NO@#/! - #>!@NO@ ?PR!Nà¸¥>à¸¥@"Q# - #>!@NO@ ?Pà¸¥>à¸¥@"QQà¹@ ( #@"@#à¸¥> ) Gravimetry 10 %?# 2@?/>?$ 2#BR % 1,500 4 /?B>2#BR % / Oà¸„Cà¸¥2#BR % / @2#BR % %>#@2@%2? O/$?/O@à¸¥>à¸¥@$ - N2N - à¸„à¸¥1P%!1%à¹Œ# Gravimetry 30 %?# 2@?/>?$ 2#BR % 2,000 à¸«à¸™à¹‰à¸² 55 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„@##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?/1$N@ / %>#@ à¸«N/"@ ?P#?>/ 1?%@ à¸„N@%>@% ( @ ) -  Q O @ - 50% N1@1à¸¥ - 70% N1@1à¸¥ - 80% N1@1à¸¥ - 85% N1@1à¸¥ - 90% N1@1à¸¥ ( %@$@%à¸¥> ) 8 / ? B>2!BR# / Oà¸„Cà¸¥2!BR# / @2!BR# #>!@à¸„/@!A Q  P"/>?@#à¸¥?P O/"Pà¸¥C/? (Water by A zeotropic) Distillation 50 %?# 2@?/>?$ 2#BR % 2,000 23 2!BR# T otal Aerobic Microbial Count (TAMC) T HP /?B>2#BR % / à¸¥>"?à¹Œ 2#BR % (50 %?# ) 2@?/>?" 2!BR# 1,500 24 2!BR# T otal Yeasts and Moulds Count (TYMC) T HP /?B> 2#BR % / à¸¥>"?à¹Œ 2#BR % (50 %?# ) 2@?/>?" 2!BR# 1,000 25 2!BR# Bile-tolerant gram-negative bacteria T HP /?B> 2#BR % / à¸¥>"?à¹Œ 2#BR % (50 %?# ) 2@?/>?" 2!BR# 1,000 26 2!BR# Escherichia coli T HP /?B> 2#BR % / à¸¥>"?à¹Œ 2#BR % (50 %?# ) 2@?/>?" 2!BR# 1,000 27 2!BR# Staphylococcus aureus T HP /?B> 2#BR % / à¸¥>"?à¹Œ 2#BR % (50 %?# ) 2@?/>?" 2!BR# 1,000 à¸«à¸™à¹‰à¸² 56 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„@##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?/1$N@ / %>#@ à¸«N/"@ ?P#?>/ 1?%@ à¸„N@%>@% ( @ ) 28 2!BR# Salmonella spp. T HP /?B> 2#BR % / à¸¥>"?à¹Œ 2#BR % (75 %?# ) 2@?/>?" 2!BR# 1,500 29 2!BR# Clostridium spp. T HP /?B> 2#BR % / à¸¥>"?à¹Œ 2#BR % (50 %?# ) 2@?/>?" 2!BR# 1,500 O1 11 Q/O$Nà¸¥>à¸„/@#Qà¸¥O@??P 10.8 %@$@%1?%@à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ @/O1>?>@%O@à¸„BO#à¸„%1CO%>P"à¸„12O@?%?2?Oà¸¥>Nà¸„%AP1#A1O $à¹Œ @#1?%@à¸„N@O@%B @%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@%OO@$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B@%%/ />Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% . 0 . 2562 Oà¸¥>Q/OQOà¸„/@#N1R?QO à¸¥O@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?"à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?/1$N@ / %>#@ à¸«N/"@ ?P#?>/ 1?%@ à¸„N@%>@% ( @ ) 10.8 @%Q/O%>@% 21 / 21N?$ Nà¸„%AP1#A1 O $à¹Œ 21NO#?$@ N@QO>//?%@0@ NAQ1>QOà¸„%?QN?$/ ( @!>2>2à¹Œ ) !/ . 1398-2565 180 B 2O@?%?2? Oà¸¥> Nà¸„%AP1#A1 O $à¹Œ 7,800 O1 12 Q/O$Nà¸¥>à¸„/@#Qà¸¥O@??P 10 %@$@%1?%@à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ @/O1>?>@%O@à¸„BO#à¸„%1CO%>P"à¸„12@??//?B @#%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ /N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% . 0 . 2562 @POORN > P #N>#P$%>N?$ %#/>$@0@2%à¹Œ@%O $à¹Œ /N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P 9) . 0 . 2565 Oà¸¥>Q/OQOà¸„/@#N1R?QO à¸«à¸™à¹‰à¸² 57 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„@##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?/1$N@ / %>#@ à¸«N/"@ ?P#?>/ 1?%@ à¸„N@%>@% ( @ ) 10 /?à¸„?Pà¸„/> 19 > DNA/mRNA à¸„/@!O# Restriction enzyme digestion/ Sequencing 1N/à¸¥/ / @%%B 0.5 #>à¸¥à¸¥>à¸¥>% x 50 / 2@? ?//?B 105,000 à¸„/@!à¸¥/ ? " USP/ EP/ BP/ TP 1N/à¸¥/ / @%%B 0.5 #>à¸¥à¸¥>à¸¥>% x 5 / 15,000 Nà¸„!?>2>2à¹Œ USP/ EP/ BP/ TP 1N/à¸¥/ / @%%B 0.5 #>à¸¥à¸¥>à¸¥>% x 30 / 6,000 O1 13 Q/O$Nà¸¥>à¸„/@#Qà¸¥O@??P 8 Oà¸¥>à¸¥O@??P 18 %@$@%1?%@à¸„N@%>@%@%%/ />Nà¸„%@>/à¹Œ@/O1>?>@%O@à¸„BO#à¸„%1CO%>P"à¸„12O@?%?2?Oà¸¥>Nà¸„%AP1#A1O $à¹Œ @#%>N?$ %#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% . 0 . 2562 @POORN > P #N># P$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P 10) . 0 . 2565 Oà¸¥>Q/OQOà¸„/@#N1R?QO à¸¥O@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„@##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?/1$N@ / %>#@ à¸«N/"@ ?P#?>/ 1?%@ à¸„N@%>@% ( @ ) 8 #>@# #/2/ à¸„B @ Nà¸„#AP/N/O!/@#à¹ŒR/ Nà¸„#AP/N/O!/@#à¹ŒR/ O/à¹@à¸«@#à¸„/à¸„B! à¸„B @Nà¸„#AP/N/O!/@#à¹ŒR/ #!/>"@0@2#à¹Œ@#O"à¹Œ #>#/2@@#2B 2566 ( ISBN 978-616-11-5016-7) 1 Nà¸„%AP1 2O@?%?2? Oà¸¥> Nà¸„%AP1#A1 O $à¹Œ 6,000 18 O@#?2? @##/2/ à¸„/@!à¸¥/ ? " à¸«O/N/O!/@#à¹ŒR/ O/à¹@à¸«@#à¸„/à¸„B! à¸„B @Nà¸„#AP/N/O!/@#à¹ŒR/ #!/>"@0@2#à¹Œ@#O"à¹Œ #>#/2@@#2B 2566 ( ISBN 978-616- 11-5016-7) /O1N1O#1@%à¹ŒR1 2O@?%?2? Oà¸¥> Nà¸„%AP1#A1 O $à¹Œ 1,000 à¸«à¸™à¹‰à¸² 58 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

O1 14 Q/O$Nà¸¥>à¸„/@#Qà¸¥O@??P 7.1 à¸¥O@??P 7.6 - 7.7 à¸¥O@??P 7.11 - 7.14 Oà¸¥> à¸¥O@??P 8 %@$@%1?%@à¸„N@%>@%@%%//>Nà¸„%@>/à¹Œ@/O1>?>@%O@à¸„BO#à¸„%1CO%>P"à¸„12O@?%?2? Oà¸¥>Nà¸„%AP1#A1O $à¹Œ @#1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@%OO@$%>N?$ %#/>$@0@2%à¹Œ@%O $à¹Œ /N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% . 0 . 2562 @POORN > P #N>#P$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P 11) . 0 . 2565 Oà¸¥>Q/OQOà¸„/@#N1R?QO à¸¥O@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„@##/ />Nà¸„#@>à¸«à¹Œ / #>@# > ?/1$N@ / %>#@ à¸«N/"@ ?P#?>/ 1?%@ à¸„N@%>@% ( @ ) 7.1 #>@# @##/2/ #//>Nà¸„#@>à¸«à¹Œ O@#?2?/>>?" Nà¸„#AP/N/N#"à¹Œ />>?"?P/R Oà¸¥>à¸¥C//P#2Pà¸„ ? !@#@à¸„B @ Nà¸„#AP/N/N#"à¹Œ/>>?" @@#O"à¹Œ ( Quality Standard of Medical Diagnostic X - ray Machines)  . 0 . 2562 (ISBN 978-616-11-4127-1) 1 Nà¸„%AP1 2O@?%?2? Oà¸¥> Nà¸„%AP1#A1 O $à¹Œ 4,500 7.6 #>@# @##/2/ #//>Nà¸„#@>à¸«à¹Œ O@#?2?/>>?" Nà¸„#AP/N/N#"à¹Œ #>à¸«à¸¥/Nà¸¥A/ Oà¸¥>2/à¸«?/Q #>@N?"/ !@#@à¸„B @ Nà¸„#AP/N/N#"à¹Œ/>>?" @@#O"à¹Œ ( Quality Standard of Medical Diagnostic X - ray Machines)  . 0 . 2562 (ISBN 978-616-11-4127-1) 1 Nà¸„%AP1 2O@?%?2? Oà¸¥> Nà¸„%AP1#A1 O $à¹Œ 4,500 7.7 #>@# @##/2/ #//>Nà¸„#@>à¸«à¹Œ O@#?2? />>?" Nà¸„#AP/N/N#"à¹Œ #>à¸«à¸¥/Nà¸¥A/ Oà¸¥>2/à¸«?/Q 2/#>@ !@#@à¸„B @ Nà¸„#AP/N/N#"à¹Œ/>>?" @@#O"à¹Œ ( Quality Standard of Medical Diagnostic X - ray Machines)  . 0 . 2562 ( ISBN 978-616-11-4127-1) 1 Nà¸„%AP1 2O@?%?2? Oà¸¥> Nà¸„%AP1#A1 O $à¹Œ 9,000 à¸«à¸™à¹‰à¸² 59 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„@##/ />Nà¸„#@>à¸«à¹Œ / #>@# > ?/1$N@ / %>#@ à¸«N/"@ ?P#?>/ 1?%@ à¸„N@%>@% ( @ ) 7.11 #>@# @##/2/ #//>Nà¸„#@>à¸«à¹Œ O@#?2? />>?" Nà¸„#AP/N/N#"à¹Œ ?##! !@#@à¸„B @ Nà¸„#AP/N/N#"à¹Œ/>>?" @@#O"à¹Œ ( Quality Standard of Medical Diagnostic X - ray Machines)  . 0 . 2562 ( ISBN 978-616-11-4127-1) 1 Nà¸„%AP1 2O@?%?2? Oà¸¥> Nà¸„%AP1#A1 O $à¹Œ 2,000 7.12 #>@# @##/2/ #//>Nà¸„#@>à¸«à¹Œ O@#?2? />>?" Nà¸„#AP/N/N#"à¹Œ !/à¸¥#>C !@#@à¸„B @ Nà¸„#AP/N/N#"à¹Œ/>>?" @@#O"à¹Œ ( Quality Standard of Medical Diagnostic X - ray Machines)  . 0 . 2562 ( ISBN 978-616-11-4127-1) 1 Nà¸„%AP1 2O@?%?2? Oà¸¥> Nà¸„%AP1#A1 O $à¹Œ 2,000 7.13 #>@# @##/2/ #//>Nà¸„#@>à¸«à¹Œ O@#?2? />>?" Nà¸„#AP/N/N#"à¹Œ /B2@à¸«##! / Nà¸„#AP/N/N#"à¹Œ #/2/ à¸„/@!à¸¥/ ? " #>@0#!/>"@0@2#à¹Œ @#O"à¹Œ N#AP/!@#@ à¸„B @Nà¸„#AP/N/N#"à¹Œ />>?"  . 0 . 2558 ( ISBN 978-616-11-2332-9) 1 Nà¸„%AP1 2O@?%?2? Oà¸¥> Nà¸„%AP1#A1 O $à¹Œ 2,000 7.14 #>@# @##/2/ #//>Nà¸„#@>à¸«à¹Œ O@#?2?/>>?" Nà¸„#AP/N/N#"à¹Œ />Nà¸„#@>à¸«à¹Œ/>?" #>@0#!/>"@0@2#à¹Œ @#O"à¹Œ N#AP/!@#@ à¸„B @Nà¸„#AP/N/N#"à¹Œ />>?"  . 0 . 2558 (ISBN 978-616-11 - 2332-9 ) 1 Nà¸„%AP1 2à¹@?#?2? Oà¸¥> Nà¸„#AP/!A/ O"à¹Œ 2,000 O1 15 Q/O$Nà¸¥>à¸„/@#Qà¸¥O@??P 1 - 2 %@$@%1?%@à¸„N@%>@%@%%?%1 / @%%>N#> à¸„/@#2@#@%@/O1>?>@%10C$à¹Œ/>$@0@2%à¹Œ@%O $à¹Œ?P 1 N?$Q/#N @#1?%@à¸„N@O@%B@%%/ />Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@%OO@$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥> Q/O%>@% . 0 . 2562 Oà¸¥>Q/OQOà¸„/@#N1R?QO à¸«à¸™à¹‰à¸² 60 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N #>@# #@"@# à¸«N/" à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 1 O21 à¸„/@#O@@ 2O@/%?/N/$%>@%   #" C #> 1) à¸¥CPà¸„2QNà¸¥A1 2) N#ONà¸¥A1O1?ON 1 O (2 %1 / ? ) 121 à¸„/@#O@@Oà¸¥> 0C$à¹Œ/>$@0@2%à¹Œ @%O $à¹Œ 500 2 O21 à¸„/@#O@@2O@/%? /N/$%>@%#"C#> 1) à¸¥CPà¸„2Qà¸±22@/> O/$O21 2) P%?Qà¸±22@/> O/$O21 3) Human Chorionic Gonadotropin (hCG) Q à¸±22@/>O/$O21 1 O (2 %1 / ? ) 121 à¸„/@#O@@Oà¸¥> 0C$à¹Œ/>$@0@2%à¹Œ @%O $à¹Œ 500 O1 16 Q/O$Nà¸¥>à¸„/@#Qà¸¥O@??P 2 %@$@%1?%@à¸„N@%>@%@%%?%1 / @%%>N#> à¸„/@#2@#@%@/O1>?>@%12@?/>?$/>$@0@2%à¹Œ2@@%2B Oà¸¥>à¸¥O@??P 15 %@$@%1?%@ à¸„N@%>@%@%%?%1@%%>N#>à¸„/@#2@#@%@/O1>?>@%10C$à¹Œ/>$@0@2%à¹Œ@%O $à¹Œ?P 10 1Bà¸¥%@@? @#%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹Œ Oà¸¥>Q/O%>@% . 0 . 2562 @POORN > P #N>#P$%>N?$%#/>$@0@2%à¹Œ@%O $à¹Œ/N@O/$1?%@à¸„N@O@%B @%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% ( ??P 2) . 0 . 2563 Oà¸¥>Q/OQOà¸„/@#N1R?QO à¸¥à¹@? ?P #>N #>@# #@"@# à¸«N/" à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 2 O21 à¸„/@#O@@ N"2? ? B0@2%à¹Œ @##/"?OO"@ 1) HLA-B*1502 2) HLA-B*5801 3) HLA-B*5701 1 O (1 %1 / ? ) 121 à¸„/@#O@@ 3,500 15 O21 à¸„/@#O@@ 2O@/%?/N/$%>@%#"C#> 1) à¸¥CPà¸„2QNà¸¥A1 2) N#ONà¸¥A1O1?ON 3) à¸¥CPà¸„2Qà¸±22@/> O/$O21 4) P%?Qà¸±22@/> O/$O21 1 O (2 %1 / ? ) 121 à¸„/@#O@@Oà¸¥> 0C$à¹Œ/>$@0@2%à¹Œ @%O $à¹Œ 1,000 à¸«à¸™à¹‰à¸² 61 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N #>@# #@"@# à¸«N/" à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 5) Human Chorionic Gonadotropin (hCG) Qà¸±22@/>O/$O21 O1 17 Q/ON > P #à¸„/@#N1R?QNO%@$@%OO@$%>N?$%#/>$@0@2%à¹Œ@%O $ à¹Œ /N@O/$1?%@à¸„N@O@%B@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@% . 0 . 2562 /?#@à¸„N@#>@#@##//>Nà¸„#@>à¸«à¹Œ@à¸«O/>?>@#O@?2C#P#à¸„ à¸¥à¹@? ?P #>N / P#à¸„ / #>@# AP/#@"@# #//>Nà¸„#@>à¸«à¹Œ Nà¸„>à¸„@##/ />Nà¸„#@>à¸«à¹Œ > ?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 1 22?"Nà¹‡!>N#O NO@! Oà¸¥>!>N#O #?RN>N@"/  @  ?  B  # # ! (germline mutation) #/@#à¸¥@" ?Bà¹Œ/"? BRCA1 Oà¸¥> BRCA2 O/"Nà¸„>à¸„ />Nà¸„#@>à¸«à¹Œà¸¥à¹@? 2@#?B##! 2!##>2 C  Next Generation Sequencing (NGS) EDTA blood R!NO/"/N@ 3 #>à¸¥à¸¥>à¸¥>% 2@? ?//>"@0@2#à¹Œ @@#O"à¹Œ 10,000 2 %/N1RO%?$@ isoniazid /%A1 CON/$?PN>"@/> ?1?N2@ @%%?$@ isoniazid @%%/ NAT 2 diplotype O/$/>? real-time PCR Haplotype- specific real-time PCR EDTA blood R#NO1$/N@ 1 #>à¸¥à¸¥>à¸¥>% 2@? ?//>$@0@2%à¹Œ @@%O $à¹Œ 1,000 3 @%%/$A$? @%%//@ à¸¥O@?N2?N1ON1 O/$/>?#@%@ Sanger Sequencing />? Sanger Sequencing Nà¸¥A1 Whole Blood 1$N@O1$ 3 #>à¸¥à¸¥>à¸¥>% 2@? ?//>$@0@2%à¹Œ @@%O $à¹Œ 2,500 à¸«à¸™à¹‰à¸² 62 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N / P#à¸„ / #>@# AP/#@"@# #//>Nà¸„#@>à¸«à¹Œ Nà¸„>à¸„@##/ />Nà¸„#@>à¸«à¹Œ > ?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 4 %/%>N#> à¸„/@#N2?P$ N1@%N/$ NO/?P%à¸„ >@# à¸¥@%%?1@Oà¸¥> %>N#> à¸„/@#N2?P$N1@% à¸¥?#@NOQO@1 /?P%à¸„ @%%//? %>?@% O2111$? QNà¸¥A1 N A P 1%>N#> à¸„/@#N2?P$N1 @%N/$NO/?P%à¸„ O/$Nà¸„>à¸„ >>1à¸¥ ? ?1@%à¹Œ Droplet Digital PCR Nà¸¥A1 R#NO1$/N@ 3 #>à¸¥à¸¥>à¸¥>% NOQ/à¸¥1 N @>?P#? 2@%à¸„2"@ 2@% ? B%%# >1@%à¹ŒN1ON1 2@? ?//>$@0@2%à¹Œ @@%O $à¹Œ 7,000 5 @%%/ />>?$P%à¸„>NAQ1 @/O1>?>@% @%%//@2@% ? B%%#R/%?2 N1P%à¸„#A1NO@@ Realtime RT-PCR 1B@%> 8 %?# /%A1NN@? 2 >Q//?/O#N#A1 COQ/N / Swab à¸„1 / Swab P %#C 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 1 N?$Q/#N 2,200 6 /?P%à¸„ @%%//@ NAQ1/?P%à¸„O/$ Nà¸„>à¸„ Loop- mediated isothermal amplification (TB-LAMP) Loop- mediated isothermal amplification (TB-LAMP) 1. N2#/> 3-5 #>à¸¥à¸¥>à¸¥>% 2. 2@%à¸„? /à¸¥?P (Body fluid) 2-3 #>à¸¥à¸¥>à¸¥>% 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 7 1ON 200 à¸«à¸™à¹‰à¸² 63 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

/?#@à¸„N@#>@#@##//>Nà¸„#@>à¸«à¹Œ@à¸«O/>?>@#O@à¸„BO!à¸„#/CO#>P à¸„ à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„ @%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ /N/$@ ?P%?>1 1?%@ à¸„N@%>@% ( @ ) 1 /?B>2#BR % 2@%/C?Q/# (Total Arsenic) ICP-OES 50 %?# 2@?/>?$ 2#BR % 800 2 /?B>2#BR % >?P/ (Lead) ICP-OES 50 %?# 2@?/>?$ 2#BR % 800 3 /?B>2#BR % %1 (Mercury) ICP-OES 50 %?# 2@?/>?$ 2#BR % 800 4 /?B>2#BR % Oà¸„N#?$# (Cadmium) ICP-OES 50 %?# 2@?/>?$ 2#BR % 800 5 @%%/à¸„? %1/@2@%Nà¸„#? O@?O#à¸¥ à¸¥BN#11%à¹Œ@P!12N! Oà¸¥> à¸„@%à¹Œ@N# Spectrophoto- metry ? à¸¥R#O 2#BR % Oà¸¥> ? A  0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 8 1B%@? 500 6 @%%/à¸„? %1/@2@%Nà¸„#? O@?O#à¸¥ à¸¥BN#11%à¹Œ@P!12N! , à¸„@%à¹Œ@N# , 11%à¹Œ@Pà¸„à¸¥1%?Oà¸¥> R N%%1$à¹Œ Thin Layer Chromatogra- phy ? à¸¥R#O 2#BR % Oà¸¥> ? A  0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 8 1B%@? 1,000 7 %//>Nà¸„%@>/à¹Œ %>#@ O1à¸¥121à¸¥à¹Œ Qà¸¥>"?à¹Œ ?P#?O1à¸¥121à¸¥à¹Œ NO2N/%>1 à¸¥>"?à¹Œ?P#? O1à¸¥121à¸¥à¹ŒNO 2N/%>1 N A P 12B1@#?$2O@/%? #A1 - N1>à¸¥O1à¸¥121à¸¥à¹Œ (Ethanol) - N#>à¸¥O1à¸¥121à¸¥à¹Œ (Methanol) - R1PP % @1à¸¥ (Isopropanol) - N1OP % @1à¸¥ (n-propanol) Gas Chromatogra- phy Nà¸¥à¸¥O@#A1 1N/à¸¥/ Oà¸¥>2N%$à¹Œ R#N1?OP2 1,000 #>à¸¥à¸¥>à¸¥>% 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 8 1B%@? 2,500 à¸«à¸™à¹‰à¸² 64 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„ @%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ /N/$@ ?P%?>1 1?%@ à¸„N@%>@% ( @ ) 8 %//>Nà¸„%@>/à¹Œ %>#@ O1à¸¥121à¸¥à¹Œ Q$@QO@ Oà¸¥>Nà¸„%AP1AP# à¸¥>"?à¹Œ$@QO@ Oà¸¥> Nà¸„%AP1AP#?P#?2N/2# O1à¸¥121à¸¥à¹Œ - N1>à¸¥O1à¸¥121à¸¥à¹Œ (Ethanol) - N#>à¸¥O1à¸¥121à¸¥à¹Œ (Methanol) - R1PP % @1à¸¥ (Isopropanol) - N1OP % @1à¸¥ (n-propanol) Gas Chromatogra- phy $@QO@ Oà¸¥> Nà¸„%AP1AP# 5,000 #>à¸¥à¸¥>à¸¥>% 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 8 1B%@? 2,500 9 @%%/ />Nà¸„%@>/à¹Œ Nà¸„%AP1#A1O $à¹Œ Nà¸„%AP12N1R!2O@/%? NO"@/>?/N/à¸¥A1 Phototherapy Physics: Principles, Dosimetry, Source and Safety. IPEM Report Number 101. Institute of Physics and Engineering in Medicine 2010. 1 Nà¸„%AP1 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 8 1B%@? 1,000 10 à¸¥> ? à¹Œ O@Nà¸„#AP/2à¹@/@ 1,4-dioxane GC-MS-HS - O# C O# C ? %?Oà¸„ à¸„%?#/ - $@2?!à¸± - QO@$@O/@ - 1N/à¸¥/Nà¸¥ Oà¸¥>à¸„%?# O@/ 50 %?# 2à¹@? Nà¸„#AP/2à¹@/@ Oà¸¥>/?B /?#@" 3,500 à¸«à¸™à¹‰à¸² 65 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„ @%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ /N/$@ ?P%?>1 1?%@ à¸„N@%>@% ( @ ) 11 à¸¥> ? à¹Œ O@Nà¸„#AP/2à¹@/@ - 2@#à¸«C (arsenic) - Oà¸„N!?"! (cadmium) - >?P/ (lead) - #/ (mercury) ( #@"@#à¸¥> ) GF- A AS, CV-AAS à¸¥>"?à¹Œ Nà¸„%AP12O@1@ Oà¸¥>/?B> %>N"QO@#? O@/ 50 %?# 2à¹@? Nà¸„#AP/2à¹@/@ Oà¸¥>/?B /?#@" 2,500 12 à¸¥> ? à¹Œ O@Nà¸„#AP/2à¹@/@ #/N/à¸¥?1à¹Œ Î³ -oryzanol HPLC 2@%2?O@/ Oà¸¥>à¸¥>"?à¹Œ Nà¸„%AP12O@1@ 2#O@/ O@/ 30 %?# 2à¹@? Nà¸„#AP/2à¹@/@ Oà¸¥>/?B /?#@" 3,000 13 à¸¥> ? à¹Œ O@Nà¸„#AP/2à¹@/@ #/N/à¸¥?1à¹Œ Î± -terthienyl HPLC 2@%2?1 @/N%A1Oà¸¥> à¸¥>"?à¹Œ Nà¸„%AP12O@1@ 1@/N%A1 O@/ 30 %?# 2à¹@? Nà¸„#AP/2à¹@/@ Oà¸¥>/?B /?#@" 4 ,000 1 4 2!BR# Pseudomonas aeruginosa T HP /?B>2#BR % Oà¸¥>à¸¥>"?à¹Œ 2#BR % O@/ 50 %?# 2@?/>?" 2!BR# 1,000 1 5 /?à¸„?O/? P#à¸„N"AP/à¸«BO!2!/ /?N2@ NAQ/0> (Hib) à¸„/@!O# HPLC 1N/à¸¥/ - @%%B 0.5 #>à¸¥à¸¥>à¸¥>% x 16 / - @%%B 5.0 #>à¸¥à¸¥>à¸¥>% x 2 / 2@??//?B 25,000 16 /?à¸„?O/? P#à¸„//?N2 (Pneumococcal) à¸„/@!O# Slot bot 1N/à¸¥/ / @%%B 0.5 #>à¸¥à¸¥>à¸¥>% x 30 / 2@??//?B 22,000 17 /?à¸„?Pà¸„/> 19 à¸„/@!O# W estern blot 1N/à¸¥/ / @%%B 0.5 #>à¸¥à¸¥>à¸¥>% x 10 / 2@??//?B 21,000 à¸«à¸™à¹‰à¸² 66 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@? ?P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„ @%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ /N/$@ ?P%?>1 1?%@ à¸„N@%>@% ( @ ) 18 /?à¸„?Pà¸„/> 19 à¸„/@!O# Flow cytometry 1N/à¸¥/ / @%%B 0.5 #>à¸¥à¸¥>à¸¥>% x 10 / 2@??//?B 2 5 ,000 19 /?à¸„?Pà¸„/> 19 à¸„/@!O# Reverse- transcription PCR 1N/à¸¥/ / @%%B 0.5 #>à¸¥à¸¥>à¸¥>% x 10 / 2@??//?B 6,000 20 >12B?O@ (Rabies) à¸„/@!O# ELISA O/O , 1N/à¸¥/ / @%%B 0.5 #>à¸¥à¸¥>à¸¥>% x 20 / 2@??//?B 14,000 21 T rastuzumab à¸„/@!O# Binding assay by Flow cytometry 1N/à¸¥/ / %>#@?/1$N@ 1 / P$%>#@% %/#R#NO1$/N@ 10 #>à¸¥à¸¥>à¸¥>% 2@??//?B 13,000 22 Rituximab Nà¸„!?>2>2à¹Œ UHPLC- Q/TOF 1N/à¸¥/ / %>#@?/1$N@ 1 / P$%>#@% %/#R#NO1$/N@ 10 #>à¸¥à¸¥>à¸¥>% 2@??//?B 17,000 23 /?B> 2#BR % / Oà¸„Cà¸¥ 2#BR % / @2#BR % / 2@%2? 2#BR % %>#@2@% Mitragynine Q%>N1# ( %/#/>Nà¸„%@>/à¹Œ%>#@ à¸„/@#AQ ) HPLC - A 2 6 0 0 - 1,0 00 %?# - A O/O 50 %?# - Oà¸„Cà¸¥ / @ 100 /N/$%%B - 2@%2? 1 5 - 50 %?# 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 12 2à¸¥@ 6,500 à¸«à¸™à¹‰à¸² 67 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@??P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$ à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„ @%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ /N/$@ ?P%?>1 1?%@ à¸„N@%>@% ( @ ) à¸¥>"?à¹Œ O@1@/@% 1 @%21 R/%?2 @%%//@2@% ? B%%#1 NAQ1R/%?2P%O@ group A (Rotavirus group A) Real-time RT-PCR QO@Oà¸¥>QO@OO 1. QO@AP#Q"@> %%B?P>2> - O1$/N@ 500 #>à¸¥à¸¥>à¸¥>% x 10 /N/$ - 500 - 999 #>à¸¥à¸¥>à¸¥>% x 6 /N/$ - 1 - 2 à¸¥>% x 3 /N/$ - 3 - 6 à¸¥>% x 1 /N/$ - #@/N@ 6 - 20 à¸¥>% x 1 /N/$ /%A1%>#@%%/# R#NO1$/N@ 3 à¸¥>% 2. QO@OO 1 - 2 >Pà¸¥%?# x 3 B 3. QO@AP# %>#@% %/#R#NO1$/N@ 3 à¸¥>% %%BQ /%@0@NAQ1 2O@?à¸„B"@ Oà¸¥> à¸„/@#à¸¥1"?$ 1@/@% 2,200 2 @%21 2@% > 1 / 2@%Nà¸·Q1 @%212@% > 1 / 2@%Nà¸·Q1 2@% > 1@NAQ1%@ (Mycotoxins) - Citrinin LC-MS/MS ? A  O@/ 1$N@O1$ 500 %?# 2O@?à¸„B"@ Oà¸¥> à¸„/@#à¸¥1"?$ 1@/@% %@$@%à¸¥> 3,000 à¸«à¸™à¹‰à¸² 68 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@??P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$ à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„ @%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ /N/$@ ?P%?>1 1?%@ à¸„N@%>@% ( @ ) - HT- 2 Toxin - T- 2 Toxin - Zearalenone - Deoxynivalenol - Ochratoxin A - Fumonisin ( B1+B2 Total) 3 @%21 2@% > 1 / 2@%Nà¸·Q1 %R2P%R$@> ?Q/# (Total Hydrocyanic acid) Ion Chromatogra- phy OO#?2O@>/à¸¥? 1$N@O1$ 500 %?# 2O@?à¸„B"@ Oà¸¥> à¸„/@#à¸¥1"?$ 1@/@% 1,500 4 @%21 /?BNA1 1@/@% - N#@1à¸¥ (Methanol) - N1@1à¸¥ (Ethanol) GC/MS- Headspace /?BNA11@/@% 100 %?# 2O@?à¸„B"@ Oà¸¥> à¸„/@#à¸¥1"?$ 1@/@% %@$@%à¸¥> 1,600 5 @%%/ />Nà¸„%@>/à¹Œ à¸¥>"?à¹Œ O@1@/@% @%21 2N/%>1 1@/@%Oà¸¥>/?B NA1Q1@/@% - à¸„@%à¹Œ#? (Carmine) HPLC Nà¸„%AP1AP# 500 %?# / #>à¸¥à¸¥>à¸¥>% 2O@?à¸„B"@ Oà¸¥> à¸„/@#à¸¥1"?$ 1@/@% 1,000 6 @%21 à¸„B"@ @%O %N %>@$ %>#@@% O %N%>@$ ?Q/#@ à¸¥@2> ?PQO2?#?21@/@% P$?/O1@/@% O@à¸¥1> Gravimetry 1. "@> à¸¥@2> %%B1@/@%> PE/ PP/ PVC/ PS/ PET/ PA /%A1Rà¸¥1 2. "@> à¸¥@2> %%B#> 2O@?à¸„B"@ Oà¸¥> à¸„/@#à¸¥1"?$ 1@/@% %1>>> à¸„/@#NO#O 1,100 à¸«à¸™à¹‰à¸² 69 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@??P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$ à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„ @%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ /N/$@ ?P%?>1 1?%@ à¸„N@%>@% ( @ ) %O1$à¸¥> 3 ( QO@/?N1 %>#@% ) (3% acetic acid (w/v)) PE/ PP/ PS/ PET N12@%O N1@1à¸¥ à¸„/@#NO#O %O1$à¸¥> 10 ( QO@/?N1 %>#@% ) (10% ethanol (v/v)) 1,100 N1@1à¸¥ à¸„/@#NO#O %O1$à¸¥> 20 ( QO@/?N1 %>#@% ) (20% ethanol (v/v)) 1,100 N1@1à¸¥ à¸„/@#NO#O %O1$à¸¥> 50 ( QO@/?N1 %>#@% ) (50% ethanol (v/v)) 1,300 7 @%21 2N/%>1 1@/@%Oà¸¥> /?BNA1 Q1@/@% @%%//>Nà¸„%@>/à¹Œ à¸„N@R1P1? O />2à¹Œ (Iodine value, Wijs) Titration QO@#?Oà¸¥>R#? 500 #>à¸¥à¸¥>à¸¥>% x 2 /N/$ 2O@?à¸„B"@ Oà¸¥> à¸„/@#à¸¥1"?$ 1@/@% 1,500 à¸«à¸™à¹‰à¸² 70 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@??P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$ à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„ @%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ /N/$@ ?P%?>1 1?%@ à¸„N@%>@% ( @ ) 8 @%21 2N/%>1 1@/@%Oà¸¥> /?BNA1 Q1@/@% @##//>Nà¸„#@>à¸«à¹Œ #R!? - #Rà¸¥PNà¸¥/> (Linoleic acid) - #O/à¸¥N@ - Rà¸¥PNà¸¥> (alpha-Linolenic acid) GC QO@#?@N#à¸¥O ??PQONO 2N/%>1Q à¸¥>"?à¹ŒN2%>#1@/@% 250 #>à¸¥à¸¥>à¸¥>% x 4 /N/$ 2O@?à¸„B"@ Oà¸¥> à¸„/@#à¸¥1"?$ 1@/@% 3,500 9 à¸¥> ? à¹Œ O@/@à¸«@# Sialic acid Q/?B>#? à¸«#A/Nà¸„#AP/AP!#? HPLC /?B>%? 10 %?# / Nà¸„%AP1AP# %? 3 / 2à¹@?à¸„B @ Oà¸¥>à¸„/@! à¸¥/ ? "/@à¸«@# 4,000 10 à¸¥> ? à¹Œ O@/@à¸«@# N-Acetyl galactosamine Oà¸¥> N-Acetyl glucosamine Q/?B>#? GC-MS /?B>%? 10 %?# 2à¹@?à¸„B @ Oà¸¥>à¸„/@! à¸¥/ ? "/@à¸«@# 5,000 11 à¸¥> ? à¹Œ O@/@à¸«@# 2@#Nà¸·à¹‰/?/O (Surrogate contaminants) - Benzophenone - Chlorobenzene - Toluene - Methyl Salicylate - Lindane ( 2@#?/OQ à¸¥BN!2@##>Nà¸«"N@" O!??Q/ (Volatile polar), GC-MS à¸¥@2>>QNà¸¥O N (flakes) /%A1 N#O à¸¥@2> (pellets) PET O@/ 50 %?# 2à¹@?à¸„B @ Oà¸¥>à¸„/@! à¸¥/ ? "/@à¸«@# 7,000 à¸«à¸™à¹‰à¸² 71 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@??P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$ à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„ @%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ /N/$@ ?P%?>1 1?%@ à¸„N@%>@% ( @ ) à¸¥BN!2@##>Nà¸«" N@"OR!N!??Q/ (Volatile non-polar), à¸¥BN!2@#R!N#>Nà¸«" N@"O!??Q/ (Non-volatile polar), à¸¥BN!2@#R!N#>Nà¸«" N@"OR!N!??Q/ (Non-volatile non-polar) Qà¸¥@2>>QNà¸¥O N ( fl ake) à¸«#A/ N!Oà¸¥@2> (pellets) PET 12 à¸¥> ? à¹Œ O@/@à¸«@# 2@#Nà¸·à¹‰/?/O (Surrogate contaminants) - Copper (II) 2-ethylhexanoate ( à¸¥BN!Nà¸¥A// Pà¸¥à¸«>à¸«? (Heavy metal salt) Qà¸¥@2>>QNà¸¥O N (flakes) à¸«#A/ N!Oà¸¥@2> (pellets) PET ICP-OES à¸¥@2>>QNà¸¥O N (flakes) /%A1 N#O à¸¥@2> (pellets) PET O@/ 20 %?# 2à¹@?à¸„B @ Oà¸¥>à¸„/@! à¸¥/ ? "/@à¸«@# 2,300 13 à¸¥> ? à¹Œ O@/@à¸«@# R "@Rà¹Œ (Cyanide) Ion Chromatograph y  Q O @1BP"à¸„ %>P"à¸„ ( $N/OQO@N2?$ ) 2à¹@?à¸„B @ Oà¸¥>à¸„/@! à¸¥/ ? "/@à¸«@# 800 à¸«à¸™à¹‰à¸² 72 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@??P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$ à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„ @%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ /N/$@ ?P%?>1 1?%@ à¸„N@%>@% ( @ ) 1 4 @% ? @ />?%/ Bà¸¥>%?$à¹Œ ?O% ? B%%# @% ? @/>?%/ Bà¸¥>%?$à¹Œ?O% ? B%%# Q 1@/@%%>N"?P 1 Oà¸¥> 2 @#N12@%O 4 * %>1?NOCO?/@ 1@/@%Nà¸¥?Q$NAQ1 2@%Nà¸„#? R %N#1%à¹Œ Oà¸¥>Bà¸„/à¸„B# control positive Culture and PCR technique 1@/@%? P R O @2>P#??/> ?O% ? B%%# QO@/?%/# R#NO1$/N@ 300 %?# /%A1 300 #>à¸¥à¸¥>à¸¥>% 2O@?à¸„B"@ Oà¸¥>à¸„/@# à¸¥1"?$1@/@% 6,600 @% ? @/>?%/ Bà¸¥>%?$à¹Œ?O% ? B%%# Q1@/@%%>N" ?P 3 Oà¸¥> 4 @#N12@%O 4 * %>1?NOCO?/@ 1@/@%Nà¸¥?Q$NAQ1 2@%Nà¸„#? R %N#1%à¹Œ Oà¸¥>Bà¸„/à¸„B# control positive 12,500 1 5 @%21 ?/P#Nà¸¥Bà¸¥ %/?N1ON1 A  ?O% ? B%%# Q1@/@% ( P$%/?Q screening Oà¸¥>%>B2@$ ? Bà¹Œ ) PCR /%A1 Real-time PCR 1. /?B> NN OO O@/ ?P/ O@/P  3 /N/$ /N/$à¸¥> 500 %?# 2. 1@/@%O%%C 3 /N/$ %/#? R#NO1$/N@ 500 %?# / #>à¸¥à¸¥>à¸¥>% 2O@?à¸„B"@ Oà¸¥>à¸„/@# à¸¥1"?$1@/@% 17,200 à¸«!@"Nà¸«B 1. #/N@>A?O#?B##!? P /"CNQ?à¸?#@"@#A?O#?B##!? P @ Q >N?"? 2à¹@?@à¸„>##!@#/@à¸«@#Oà¸¥>"@ ( /" .) 2. ? N/ON/à¹@N@>A?O#?B##! (Screening) Oà¸¥>?N/ON/à¹@N@>A?O#?B##! #>B2@"?Bà¹Œ @!N/2@#O 1 à¸«à¸™à¹‰à¸² 73 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@??P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$ à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„ @%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ /N/$@ ?P%?>1 1?%@ à¸„N@%>@% ( @ ) à¸„/@#O% / N1à¸¥?1à¹Œ 16 à¸¥>"?à¹Œ ?//?B / /?à¸„? / ?//?B N A P 1@% %?1@ / N%BN# / à¸¥>"?à¹Œ Nà¸¥A1 / B%/ />>?$ P%à¸„>N1 @Nà¸¥A1 à¸„/@#O% Ranibizumab Vascular endothelial growth factor inhibition à¸¥>"?à¹Œ2O@N%O%C O@/ 5 ?/1$N@ P$%>#@%%/# R#NO1$/N@ 1 #>à¸¥à¸¥>à¸¥>% 2@??//?B 22,000 17 à¸¥>"?à¹Œ ?//?B / /?à¸„? / ?//?B N A P 1@% %?1@ / N%BN# / à¸¥>"?à¹Œ Nà¸¥A1 / B%/ />>?$ P%à¸„>N1 @Nà¸¥A1 à¸„/@#O%/?à¸„? Pà¸„/> 19 Sandwich ELISA à¸¥>"?à¹Œ2O@N%O%C O@/ 10 ?/1$N@ P$%>#@%%/# R#NO1$/N@ 5 #>à¸¥à¸¥>à¸¥>% 2@??//?B 28,000 18 à¸¥>"?à¹Œ ?//?B / /?à¸„? / ?//?B N A P 1@% à¸„/@#O%/?à¸„? > 12B?O@2O@/%? /?à¸„?2?/à¹Œ Serology test à¸¥>"?à¹Œ2O@N%O%C O@/ 10 ?/1$N@ P$%>#@%%/# R#NO1$/N@ 5 #>à¸¥à¸¥>à¸¥>% 2@??//?B 52,000 à¸«à¸™à¹‰à¸² 74 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@??P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$ à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„ @%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ /N/$@ ?P%?>1 1?%@ à¸„N@%>@% ( @ ) %?1@ / N%BN# / à¸¥>"?à¹Œ Nà¸¥A1 / B%/ />>?$ P%à¸„>N1 @Nà¸¥A1 19 à¸¥>"?à¹Œ ?//?B / /?à¸„? / ?//?B N A P 1@% %?1@ / N%BN# / à¸¥>"?à¹Œ Nà¸¥A1 / B%/ />>?$ P%à¸„>N1 @Nà¸¥A1 à¸„/@#O%/?à¸„? RO@0/à¸¥?O1N (Meningococcal) N1 1 serotype HPAEC-PAD à¸¥>"?à¹Œ2O@N%O%C O@/ 10 ?/1$N@ P$%>#@%%/# R#NO1$/N@ 5 #>à¸¥à¸¥>à¸¥>% 2@??//?B 23,000 20 à¸¥>"?à¹Œ ?//?B / /?à¸„? / ?//?B N A P 1@% %?1@ / N%BN# / à¸¥>"?à¹Œ Nà¸¥A1 / B%/ / > >?$ à¸„/@#O%/?à¸„? ?$!1$à¹Œ (Typhoid) HPAEC-PAD à¸¥>"?à¹Œ2O@N%O%C O@/ 10 ?/1$N@ P$%>#@%%/# R#NO1$/N@ 5 #>à¸¥à¸¥>à¸¥>% 2@??//?B 19,000 à¸«à¸™à¹‰à¸² 75 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@??P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$ à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„ @%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ /N/$@ ?P%?>1 1?%@ à¸„N@%>@% ( @ ) P %à¸„>N1 @Nà¸¥A1 21 à¸¥>"?à¹Œ ?//?B / /?à¸„? / ?//?B N A P 1@% %?1@ / N%BN# / à¸¥>"?à¹Œ Nà¸¥A1 / B%/ />>?$ P%à¸„>N1 @Nà¸¥A1 à¸„/@#O%/?à¸„? 1/>/@à¹Œ (Cholera) N1 1 serotype ELISA à¸¥>"?à¹Œ2O@N%O%C O@/ 10 ?/1$N@ P$%>#@%%/# R#NO1$/N@ 5 #>à¸¥à¸¥>à¸¥>% 2@??//?B 13,000 22 à¸¥>"?à¹Œ ?//?B / /?à¸„? / ?//?B N A P 1@% %?1@ / N%BN# / à¸¥>"?à¹Œ Nà¸¥A1 / B%/ />>?$ P%à¸„>N1 @Nà¸¥A1 N1à¸¥?1à¹Œ/?à¸„? 1/>/@à¹Œ (Cholera) N1 1 serotype Agglutination à¸¥>"?à¹Œ2O@N%O%C O@/ 10 ?/1$N@ P$%>#@%%/# R#NO1$/N@ 5 #>à¸¥à¸¥>à¸¥>% 2@??//?B 8,000 23 à¸¥>"?à¹Œ ?//?B / /?à¸„? / ?//?B N A P 1@% N1à¸¥?1à¹Œ/?à¸„? ??? (BCG) Acid fast à¸¥>"?à¹Œ2O@N%O%C O@/ 10 ?/1$N@ P$%>#@%%/# R#NO1$/N@ 5 #>à¸¥à¸¥>à¸¥>% 2@??//?B 500 à¸«à¸™à¹‰à¸² 76 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@??P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$ à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„ @%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ /N/$@ ?P%?>1 1?%@ à¸„N@%>@% ( @ ) %?1@ / N%BN# / à¸¥>"?à¹Œ Nà¸¥A1 / B%/ />>?$ P%à¸„>N1 @Nà¸¥A1 24 à¸¥>"?à¹Œ ?//?B / /?à¸„? / ?//?B N A P 1@% %?1@ / N%BN# / à¸¥>"?à¹Œ Nà¸¥A1 / B%/ />>?$ P%à¸„>N1 @Nà¸¥A1 N1à¸¥?1à¹Œ/?à¸„? R1% (Pertussis) Agglutination à¸¥>"?à¹Œ2O@N%O%C O@/ 10 ?/1$N@ P$%>#@%%/# R#NO1$/N@ 5 #>à¸¥à¸¥>à¸¥>% 2@??//?B 800 25 à¸¥>"?à¹Œ ?//?B / /?à¸„? / ?//?B N A P 1@% %?1@ / N%BN# / à¸¥>"?à¹Œ Nà¸¥A1 / N1à¸¥?1à¹Œ/?à¸„? RO@0/à¸¥?O1N (Meningococcal) N1 4 serotype ELISA à¸¥>"?à¹Œ2O@N%O%C O@/ 10 ?/1$N@ P$%>#@%%/# R#NO1$/N@ 5 #>à¸¥à¸¥>à¸¥>% 2@??//?B 6,500 à¸«à¸™à¹‰à¸² 77 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@??P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$ à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„ @%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ /N/$@ ?P%?>1 1?%@ à¸„N@%>@% ( @ ) B%/ />>?$ P%à¸„>N1 @Nà¸¥A1 26 à¸¥>"?à¹Œ ?//?B / /?à¸„? / ?//?B N A P 1@% %?1@ / N%BN# / à¸¥>"?à¹Œ Nà¸¥A1 / B%/ />>?$ P%à¸„>N1 @Nà¸¥A1 à¸„/@#O%/?à¸„? R%BN (House dust mite) ELISA à¸¥>"?à¹Œ2O@N%O%C O@/ 2 ?/1$N@ P$%>#@%%/# R#NO1$/N@ 20 #>à¸¥à¸¥>à¸¥>% 2@??//?B 6,000 27 à¸¥>"?à¹Œ ?//?B / /?à¸„? / ?//?B N A P 1@% %?1@ / N%BN# / à¸¥>"?à¹Œ Nà¸¥A1 / B%/ />>?$ P%à¸„>N1 @Nà¸¥A1 à¸„/@#O% Anti-D Immunoglobulin Competitive ELISA à¸¥>"?à¹Œ2O@N%O%C O@/ 2 ?/1$N@ P$%>#@%%/# R#NO1$/N@ 20 #>à¸¥à¸¥>à¸¥>% 2@??//?B 23,000 à¸«à¸™à¹‰à¸² 78 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@??P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$ à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„ @%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ /N/$@ ?P%?>1 1?%@ à¸„N@%>@% ( @ ) 28 à¸¥>"?à¹Œ ?//?B / /?à¸„? / ?//?B N A P 1@% %?1@ / N%BN# / à¸¥>"?à¹Œ Nà¸¥A1 / B%/ />>?$ P%à¸„>N1 @Nà¸¥A1 à¸„/@#O% Hepatitis B immunoglobulin ELISA à¸¥>"?à¹Œ2O@N%O%C O@/ 2 ?/1$N@ P$%>#@%%/# R#NO1$/N@ 20 #>à¸¥à¸¥>à¸¥>% 2@??//?B 17,000 à¸„/@#à¸¥1"?$ 29 à¸¥>"?à¹Œ ?//?B / /?à¸„? / ?//?B N A P 1@% %?1@ / N%BN# / à¸¥>"?à¹Œ Nà¸¥A1 / B%/ />>?$ P%à¸„>N1 @Nà¸¥A1 Bacterial endotoxin test Recombinant Factor C à¸¥>"?à¹Œ2O@N%O%C O@/ 2 ?/1$N@ P$%>#@%%/# R#NO1$/N@ 1 #>à¸¥à¸¥>à¸¥>% 2@??//?B 15,000 Nà¸„#?!>2>2à¹Œ 30 à¸¥>"?à¹Œ ?//?B / /?à¸„? / Protein content Biuret method à¸¥>"?à¹Œ2O@N%O%C O@/ 2 ?/1$N@ P$%>#@%%/# 2@??//?B 4,000 à¸«à¸™à¹‰à¸² 79 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@??P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$ à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„ @%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ /N/$@ ?P%?>1 1?%@ à¸„N@%>@% ( @ ) ?//?B N A P 1@% %?1@ / N%BN# / à¸¥>"?à¹Œ Nà¸¥A1 / B%/ />>?$ P%à¸„>N1 @Nà¸¥A1 R#NO1$/N@ 20 #>à¸¥à¸¥>à¸¥>% 31 à¸¥>"?à¹Œ ?//?B / /?à¸„? / ?//?B N A P 1@% %?1@ / N%BN# / à¸¥>"?à¹Œ Nà¸¥A1 / B%/ />>?$ P%à¸„>N1 @Nà¸¥A1 Degree Adsorption ELISA à¸¥>"?à¹Œ2O@N%O%C O@/ 10 ?/1$N@ P$%>#@%%/# R#NO1$/N@ 5 #>à¸¥à¸¥>à¸¥>% 2@??//?B 13,000 32 à¸¥>"?à¹Œ ?//?B / /?à¸„? / ?//?B N A P 1@% %?1@ / N%BN# / Anti-D antibody Microplate method à¸¥>"?à¹Œ2O@N%O%C O@/ 2 ?/1$N@ P$%>#@%%/# R#NO1$/N@ 20 #>à¸¥à¸¥>à¸¥>% 2@??//?B 4,000 à¸«à¸™à¹‰à¸² 80 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥O@??P %>N" à¸¥>"?à¹Œ / %>@% %@$à¸¥>N1?$ à¸¥>"?à¹Œ / @%Q/O%>@% Nà¸„>à¸„ @%%/ />Nà¸„%@>/à¹Œ / %>@% >?/1$N@ / %>#@ /N/$@ ?P%?>1 1?%@ à¸„N@%>@% ( @ ) à¸¥>"?à¹Œ Nà¸¥A1 / B%/ />>?$ P%à¸„>N1 @Nà¸¥A1 33 à¸¥>"?à¹Œ ?//?B / /?à¸„? / ?//?B N A P 1@% %?1@ / N%BN# / à¸¥>"?à¹Œ Nà¸¥A1 / B%/ />>?$ P%à¸„>N1 @Nà¸¥A1 Anti A - B Hemagglutinin Direct method à¸¥>"?à¹Œ2O@N%O%C O@/ 2 ?/1$N@ P$%>#@%%/# R#NO1$/N@ 20 #>à¸¥à¸¥>à¸¥>% 2@??//?B 8,000 34 à¸¥>"?à¹Œ ?//?B / /?à¸„? / ?//?B N A P 1@% %?1@ / N%BN# / à¸¥>"?à¹Œ Nà¸¥A1 / B%/ />>?$ P%à¸„>N1 @Nà¸¥A1 Anti A - B Hemagglutinin Indirect method à¸¥>"?à¹Œ2O@N%O%C O@/ 2 ?/1$N@ P$%>#@%%/# R#NO1$/N@ 20 #>à¸¥à¸¥>à¸¥>% 2@??//?B 2,000 à¸«à¸™à¹‰à¸² 81 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

/?#@à¸„N@#>@##//>Nà¸„#@>à¸«à¹Œ@à¸«O/>?>@#O@à¸„BO!à¸„#/CO#>P à¸„ à¸¥O@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„@# #//>Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ à¸«N/"@ ?P#?>/ 1?%@ à¸„N@%>@% ( @ ) @%Q/O%>@%N@%>N0 1 à¸¥> ? à¹Œ?//?B @à¸«N/"@ N@#>N0 - /?à¸„?Oà¸„?N#?" Oà¸¥>O//"à¹Œ (Bacterial Vaccines and Toxoids) - /?à¸„?R/#?2 (Viral Vaccines) - N#BN!Oà¸¥> à¸¥> ? à¹ŒNà¸¥A/ (Plasma - derived products) - Biotherapeutic products - /AP N #//>Nà¸„#@>à¸«à¹Œ O@à¸„/@!O# à¸„/@!à¸¥/ ? " Oà¸¥>Nà¸„!?>2>2à¹Œ @!> /à¸¥> ? à¹Œ ?PRO#>@0R/O @!> /à¸¥> ? à¹Œ ?PRO#>@0R/O 2@??//?B 2 NN@ 11?%@ > /?#@à¸„N@#>@#@##?#/ / @##>N!>à¸„/@!2@!@#@à¸«O/>?>@# à¸¥à¹@? ?P #>N  #>@# #@"@# à¸«N/" à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 1 @#2/ à¸„/@!à¹@@à¸ @#2/à¸„/@!à¹@@à¸ #@"@#2/ Direct antiglobulin test (DAT) O /2/ à¸„/@!à¹@@à¸ 700 2 @%21 à¸„/@#O@@ @/O1   > ?>@% @%%/O1à¸¥121à¸¥à¹ŒQNà¸¥A1 1 O (2 %1 / ? ) 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 1 N?$Q/#N 2,000 à¸«à¸™à¹‰à¸² 82 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  #>@# #@"@# à¸«N/" à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 3 @%21 à¸„/@#O@@ @/O1 >?>@% @%%//>Nà¸„%@>/à¹Œ%>#@2@%>2O@à¸„? Q A ?@? P%O%# 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 1 N?$Q/#N 5,000 @#Qà¸«O#>@#2/à¸„/@!à¹@@à¸ / N#?"N?"à¸¥#>à¸«/N@à¸«O/>?>@# / #>N!>à¸„/@!à¸¥/ ? " / ?@/>? à¸¥O@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?"à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##//>Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ /N/$@ ?P%?>1 1?%@ à¸„N@%>@% ( @ ) 1 @#?@ />?#/A ?O# ?B##! @#?@/>?#/A?O# ?B##! @!/>?!@#@ (ISO à¸«#A/ EU/JRC) - #>1??à¸«@2@#à¸„/à¸„B!Qà¸« O PCR / Real - T ime PCR / > ?N/"? 2O@? à¸„B"@ Oà¸¥>à¸„/@# à¸¥1"?$ 1@/@% 17,000 - Qà¸«O#!/>"@0@2#à¹Œ@#O"à¹Œ ?à¸«@2@#à¸„/à¸„B!N/ PCR / Real-Time PCR />?N/"? 45,000 @#?@/>?#/A?O# ?B##!N/"? @!/>?/ #>1? PCR / Real-Time PCR />?N/"? 45,000 /?#@@#Qà¸«O#>@#à¸¥> ? à¹ŒOà¸¥>#>@#/AP N à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?"à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„@##/ />Nà¸„#@>à¸«à¹Œ / #>@# > / à¹@/ ?//"N@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 1 2@#N2> Qà¸±22@/> #>N!>à¸„B @ B2/NAQ/O 2@#N2>Qà¸±22@/> >O/" ( T est Cup) Immunochro- matography B21 NAQ1O 200 B 2O@?$@Oà¸¥> /?BN2 > 30,000 2 #>@#/A P  N @#à¸„à¹@/à¸¥#@"@# 2/ - N1 1 %@$@% 2O@? à¸„B"@ Oà¸¥>à¸„/@# à¸¥1"?$ 1@/@% 100 à¸«à¸™à¹‰à¸² 83 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

%@$@%%//>Nà¸„%@>/à¹ŒOà¸¥>Q/O%>@%ON%NN/ (Fast Track) à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„@##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@à¸„N@#>@# ( @ ) 1 à¸„N@%>@%11 /?2A1%?%1 %BN@%à¸¥> ?//?B (Lot release) %?O@NO@ @N@%>N0 %//>Nà¸„%@>/à¹Œ à¸„B"@ Oà¸¥> à¸„/@#à¸¥1"?$ USP/ EP/ BP O/O , 1N/à¸¥/ 2 / 2@??/?B 10,000 2 @%21 O%N@B 2@%/C1>%?$à¹Œ LC-ICP-MS 1@/@% @#N12@% O 2 500 %?# / 1 ?/1$N@ $N/O 2?/à¹Œ QO@Nà¸¥A1OO NN ( /1$ , C ) 1 >Pà¸¥%?# 2O@?à¸„B"@ Oà¸¥>à¸„/@# à¸¥1"?$ 1@/@% 12,000 ( %? 2N?/1$N@ "@$Q%>N0 ) 24,000 ( %? 2N?/1$N@ @N@%>N0 ) 3 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ />>?$?P/R Oà¸¥>N@$"@ ONN%A1O2 #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ />>?$@ @%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Nà¸„%AP1 2O@?%?2? Oà¸¥>Nà¸„%AP1#A1 O $à¹Œ 9,000 à¸«à¸™à¹‰à¸² 84 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„@##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@à¸„N@#>@# ( @ ) Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) 4 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ O C-Arm, O-Arm #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ />>?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 2O@?%?2? Oà¸¥>Nà¸„%AP1#A1 O $à¹Œ 9,000 5 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ />>?$?P/R #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ />>?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 2O@?%?2? Oà¸¥>Nà¸„%AP1#A1 O $à¹Œ 7,000 à¸«à¸™à¹‰à¸² 85 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 6 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ Nà¸„à¸¥AP1?P #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 2O@?%?2? Oà¸¥>Nà¸„%AP1#A1 O $à¹Œ 7,000 7 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ2?/à¹Œ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 2O@?%?2? Oà¸¥>Nà¸„%AP1#A1 O $à¹Œ 7,000 8 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ2/ /?/Q %>@N?$/ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 2O@?%?2? Oà¸¥>Nà¸„%AP1#A1 O $à¹Œ 9,000 à¸«à¸™à¹‰à¸² 86 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 9 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ 2//?/Q21%>@ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 2O@?%?2? Oà¸¥>Nà¸„%AP1#A1 O $à¹Œ 18,000 10 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ O@à¸¥1@%@$%?2? (x-ray simulator) #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 2O@?%?2? Oà¸¥>Nà¸„%AP1#A1 O $à¹Œ 8,000 11 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ à¸„1# > /N1%à¹Œ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 2O@?%?2? Oà¸¥>Nà¸„%AP1#A1 O $à¹Œ 12,000 à¸«à¸™à¹‰à¸² 87 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 12 #>@# #/2/ #//>Nà¸„#@>à¸«à¹Œ O@#?2?/>>?" Nà¸„#AP/N/N#"à¹ŒNO@! !@#@à¸„B @ Nà¸„#AP/N/N#"à¹Œ / > >?"@@#O"à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines)  . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„#AP/ 2O@?%?2? Oà¸¥>Nà¸„%AP1#A1 O $à¹Œ 12,000 13 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ!à¸± #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 2O@?%?2? Oà¸¥>Nà¸„%AP1#A1 O $à¹Œ 4,000 14 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ /?à¸„/@#/@ON %>C #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 2O@?%?2? Oà¸¥>Nà¸„%AP1#A1 O $à¹Œ 4,000 à¸«à¸™à¹‰à¸² 88 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 15 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ 1B2@/%%# #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 2O@?%?2? Oà¸¥>Nà¸„%AP1#A1 O $à¹Œ 4,000 16 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ />Nà¸„%@>/à¹Œ/>?$ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 2O@?%?2? Oà¸¥>Nà¸„%AP1#A1 O $à¹Œ 4,000 17 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ à¸„O@/%/21 OOà¸¥/O1 N1N%$à¹Œ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) /O1 2O@?%?2? Oà¸¥>Nà¸„%AP1#A1 O $à¹Œ 4,000 à¸«à¸™à¹‰à¸² 89 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 18 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ %/21à¸„/@#à¸¥1"?$ @%?2?1 /O1N1N%$à¹Œ/>>?$ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) /O1 2O@?%?2? Oà¸¥>Nà¸„%AP1#A1 O $à¹Œ 2,000 19 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ à¸„/@#à¸¥1"?$@ %?2? 1%N1N%$à¹Œ />>?$ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 2O@?%?2? Oà¸¥>Nà¸„%AP1#A1 O $à¹Œ 2,000 20 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ N1N%$à¹Œ1AP N #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 2O@?%?2? Oà¸¥>Nà¸„%AP1#A1 O $à¹Œ 10,000 à¸«à¸™à¹‰à¸² 90 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 21 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ />>?$?P/R #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 0C"à¹Œ/>"@0@2#à¹Œ @#O"à¹Œ ?P 2 > 1BPà¸¥ 7,000 22 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ2/ /?/Q21%>@ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 0C"à¹Œ/>"@0@2#à¹Œ @#O"à¹Œ ?P 2 > 1BPà¸¥ 18,000 23 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ2/ /?/Q%>@N?$/ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 0C"à¹Œ/>"@0@2#à¹Œ @#O"à¹Œ ?P 2 > 1BPà¸¥ 9,000 à¸«à¸™à¹‰à¸² 91 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 24 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ!à¸± #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 0C"à¹Œ />"@0@2#à¹Œ @#O"à¹Œ ?P 2 > 1BPà¸¥ 4,000 25 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ à¸„1# > /N1%à¹Œ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 0C"à¹Œ />"@0@2#à¹Œ @#O"à¹Œ ?P 2 > 1BPà¸¥ 12,000 26 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ />>?$?P/R Oà¸¥>N@$"@ ON N%A1O2 #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 0C"à¹Œ />"@0@2#à¹Œ @#O"à¹Œ ?P 2 > 1BPà¸¥ 9,000 à¸«à¸™à¹‰à¸² 92 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 27 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ Nà¸„à¸¥AP1?P #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 0C"à¹Œ/>"@0@2#à¹Œ @#O"à¹Œ ?P 2 > 1BPà¸¥ 7,000 28 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ2?/à¹Œ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 0C"à¹Œ/>"@0@2#à¹Œ @#O"à¹Œ ?P 2 > 1BPà¸¥ 7,000 29 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹ŒNO@# #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 0C"à¹Œ/>"@0@2#à¹Œ @#O"à¹Œ ?P 2 > 1BPà¸¥ 12,000 à¸«à¸™à¹‰à¸² 93 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 30 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ /?à¸„/@#/@ON %>C #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ />>?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 0C"à¹Œ />"@0@2#à¹Œ @#O"à¹Œ ?P 2 > 1BPà¸¥ 4,000 31 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ 1B2@/%%# #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) Nà¸„%AP1 0C"à¹Œ />"@0@2#à¹Œ @#O"à¹Œ ?P 2 > 1BPà¸¥ 4,000 32 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ %/21à¸„/@# à¸¥1"?$ @%?2?1 /O1N1N%$à¹Œ/>>?$ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11- 4127-1) /O1 0C"à¹Œ />"@0@2#à¹Œ @#O"à¹Œ ?P 2 > 1BPà¸¥ 2,000 à¸«à¸™à¹‰à¸² 94 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 33 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ />>?$?P/R Oà¸¥>N@$"@ ON N%A1O2 #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 5 2#B%2à¸„%@# 9,000 34 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ O C-Arm,O-Arm #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978 - 616 - 11 - 4127 - 1 ) Nà¸„%AP1 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 5 2#B%2à¸„%@# 9,000 35 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ />>?$?P/R #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 5 2#B%2à¸„%@# 7,000 à¸«à¸™à¹‰à¸² 95 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 36 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ Nà¸„à¸¥AP1?P #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 5 2#B%2à¸„%@# 7,000 37 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ2?/à¹Œ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 5 2#B%2à¸„%@# 7,000 38 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ2//?/Q  %>@N?$/ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 5 2#B%2à¸„%@# 9,000 à¸«à¸™à¹‰à¸² 96 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 39 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ2/ /?/Q21%>@ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 5 2#B%2à¸„%@# 18,000 40 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ O@à¸¥1@%@$%?2? (x-ray simulator) #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 5 2#B%2à¸„%@# 8,000 41 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ à¸„1# > /N1%à¹Œ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 5 2#B%2à¸„%@# 12,000 à¸«à¸™à¹‰à¸² 97 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 42 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ NO@# #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ />>?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 5 2#B%2à¸„%@# 12,000 43 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ!à¸± #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 5 2#B%2à¸„%@# 4,000 44 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ /?à¸„/@#/@ON %>C #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 5 2#B%2à¸„%@# 4,000 à¸«à¸™à¹‰à¸² 98 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 45 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ 1B2@/%%# #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 5 2#B%2à¸„%@# 4,000 46 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ />Nà¸„%@>/à¹Œ/>?$ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ />>?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 5 2#B%2à¸„%@# 4,000 47 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ %/21à¸„/@# à¸¥1"?$@%?2?1 /O1N1N%$à¹Œ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 5 2#B%2à¸„%@# 2,000 à¸«à¸™à¹‰à¸² 99 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 48 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ %/21à¸„/@# à¸¥1"?$ @%?2?1% N1N%$à¹Œ/>>?$ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C$à¹Œ />$@0@2%à¹Œ @%O $à¹Œ?P 5 2#B%2à¸„%@# 2,000 49 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ />>?$?P/ROà¸¥> N@$"@ ONN%A1O2 #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C"à¹Œ />"@0@2#à¹Œ @#O"à¹Œ?P 6 à¸¥B#? 9,000 50 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ O C-arm, O-arm #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C"à¹Œ />"@0@2#à¹Œ @#O"à¹Œ?P 6 à¸¥B#? 9,000 à¸«à¸™à¹‰à¸² 100 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 51 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ />>?$?P/R #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C"à¹Œ />"@0@2#à¹Œ @#O"à¹Œ?P 6 à¸¥B#? 7,000 52 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ Nà¸„à¸¥AP1?P #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C"à¹Œ />"@0@2#à¹Œ @#O"à¹Œ?P 6 à¸¥B#? 7,000 53 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ2?/à¹Œ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C"à¹Œ />"@0@2#à¹Œ @#O"à¹Œ?P 6 à¸¥B#? 7,000 à¸«à¸™à¹‰à¸² 101 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 54 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ2/ /?/Q%>@N?$/ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C"à¹Œ />"@0@2#à¹Œ @#O"à¹Œ?P 6 à¸¥B#? 9,000 55 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ2/ /?/Q21%>@ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978 - 616 - 11 - 4127 - 1 ) Nà¸„%AP1 0C"à¹Œ />"@0@2#à¹Œ @#O"à¹Œ?P 6 à¸¥B#? 18,000 56 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ à¸„1# > /N1%à¹Œ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C"à¹Œ />"@0@2#à¹Œ @#O"à¹Œ?P 6 à¸¥B#? 12,000 à¸«à¸™à¹‰à¸² 102 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 57 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹ŒNO@# #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C"à¹Œ />"@0@2#à¹Œ @#O"à¹Œ?P 6 à¸¥B#? 12,000 58 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ!à¸± #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978 - 616 - 11 - 4127 - 1 ) Nà¸„%AP1 0C"à¹Œ />"@0@2#à¹Œ @#O"à¹Œ?P 6 à¸¥B#? 4,000 59 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ /?à¸„/@#/@ON %>C #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978 - 616 - 11 - 4127 - 1 ) Nà¸„%AP1 0C"à¹Œ />"@0@2#à¹Œ @#O"à¹Œ?P 6 à¸¥B#? 4,000 à¸«à¸™à¹‰à¸² 103 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

à¸¥à¹@? ?P #>N  à¸¥> ? à¹Œ / #>@# #@"à¸¥>N/?" à¸¥> ? à¹Œ / @#Qà¸«O#>@# Nà¸„>à¸„ @##/ />Nà¸„#@>à¸«à¹Œ / #>@# >?//"N@ / #>!@ à¸«N/"@ ?P#?>/ /?#@ à¸„N@#>@# ( @ ) 60 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ %/21à¸„/@# à¸¥1"?$ @%?2? 1 /O1N1N%$à¹Œ/>>?$ #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) /O1 0C"à¹Œ />"@0@2#à¹Œ @#O"à¹Œ?P 6 à¸¥B#? 2,000 61 %>@% %/21 %//>Nà¸„%@>/à¹Œ O@%?2?/>>?$ Nà¸„%AP1N1N%$à¹Œ 1B2@/%%# #@%@à¸„B"@ Nà¸„%AP1N1N%$à¹Œ / > >?$@@%O $à¹Œ (Quality Standard of Medical Diagnostic X-ray Machines) . 0 . 2562 (ISBN 978-616-11-4127-1) Nà¸„%AP1 0C"à¹Œ />"@0@2#à¹Œ @#O"à¹Œ?P 6 à¸¥B#? 4,000 %>@0  /??P 28 ?$@$ . 0 . 2_`` 0B"> 0>%>à¸¥?1à¹Œ 1>?%#/>$@0@2%à¹Œ@%O $à¹Œ à¸«à¸™à¹‰à¸² 104 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 273 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 1 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

N/2@/O%& 1 1@0@1#1//>Nà¸„1@>à¸«à¹Œ 1. 1@0@1%"2à¸­(Nà¸Š?Oà¸­@à¸¥>'%1?0à¹Œ NAQ/Bà¸¥>%#/?.à¹ŒP*/R&P/!> - à¸¥BN- Bifidobacterium 8 2'??2à¹Œ R O ON Bifidobacterium adolescentis Bifidobacterium animalis Bifidobacterium bifidum Bifidobacterium breve Bifidobacterium infantis Bifidobacterium lactis Bifidobacterium longum Bifidobacterium pseudolongum - à¸¥BN- Lactobacillus 9 2'??2à¹Œ R O ON Lactobacillus crispatus Lactobacillus gasseri Lactobacillus johnsonii Lactobacillus paracasei Lactobacillus reuteri Lactobacillus rhamnosus Lactobacillus salivarius Lactobacillus zeae Lactobacillus plantarum

N/2@/O%& 1 ( !N/ ) 2. 1@0@1%"2à¸­(à¸Š?/P/Nà¸¥@à¸¥ 2.1 ? N/O%N/O@N*@>*A ? O'/*?%$B//- (Screening) 1. CaMV-35S promoter 2. NOS terminator 3. CTP2-CP4-EPSPS 4. Bar 5. Pat 6. npt II 2.2 ? N/O%N/O@N*@>*A ? O'/*?%$B//- />&B2@.*?%$Bà¹Œ O@/P( 1 3272 2 5307 3 Bt11 4 DAS-40278-9 5 DAS-59122-7 6 DP4114 7 GA21 8 LY038 9 MIR162 10 MIR604 11 MON810 12 MON863 13 MON87411 14 MON87427 15 MON87460 16 MON88017 17 MON89034 18 MZHG0JG 19 MZIR098 20 NK603 21 T25 22 TC1507 23 VCO-01981-5 24 Bt176 25 Starlink (Cry9C) ? N /Nà¸«à¸¥Aà¸­ 1 A2704-12 2 A5547-127 3 DAS-44406-6 4 DAS-81419-2 5 DP-305423-1 6 FG72 7 GTS40-3-2 (RRs) 8 MON87701 9 MON87705 10 MON87708 11 MON87751 12 MON87769 13 MON89788 14 SYHT0H2 15 DAS68416-4 16 DP-356043-5 /?#'1?N 1 EH92527-1 />à¸¥>à¸­ 1 55-1 O@/à¸ª@à¸¥? 1 MON71800 O@/ 1 Bt63 1 llrice62 à¸«/@0à¹€à¸«à¸¸ 1@0@1(A?O%1!?Oà¸«/@/$?à¸?#?O !@1//>!0@0@à¸ª1à¹Œ@1O(!0à¹Œà¸ª@/@1 1//>Nà¸„1@>à¸«à¹Œ R O!?OO$$!?NN%à¹‡# single gene Oà¸¥>O$$ stacked gene ( !?NN>@@1#à¹@à¸ª@0(?#"Bà¹Œà¸­(A#>N?0/?#Q#$?à¸?#?O /@&à¸ª/?#O$$ conventional breeding)

N/2@/O%& 1 ( !N/ ) 2.3 ? N/O%N/O@N*@>/*A 2?!/à¹Œ à¸«/A/2>P-??/>! 1 à¸ª>N/??/>#> eukaryote ( R/N1>$B#> ) 2 0?#à¹@N(@>à¸­(A ( R/N1>$B#> ) 3 O@/ 4 O@/P( 5 O@/à¸ª@à¸¥? 6 ? N /Nà¸«à¸¥Aà¸­ 7 /?#à¸ªà¹@%>à¸«à¸¥? 8 à¸«/C 9 RN 10 /?/ 11 %à¸¥@ 12 %à¸¥@ %à¸¥@à¸«/@à¸«1Aà¸­BO 13 à¸ªB#? 14 /O@ 15 N%à¹‡ 16 à¸«#C 17 O(> 18 O> 2.4 ? N/O%N/O@N*@> ( R-N#/@&%> ) 1 #>à¸ª@0(?#"Bà¹Œà¸­%à¸¥@ 2 CNà¸«N@ 3 CNà¸«à¸¥Aà¸­/ 3. 1@0@1%"2à¸­(2@1à¸ž>1 / 2@1)'N)à¸·à¹‰à¸­' Dioxins R O ON 1. 2,3,7,8-Tetrachlorodibenzo- p-dioxin (2,3,7,8-TCDD) 2. 1,2,3,7,8-Pentachlorodibenzo- p-dioxin (1,2,3,7,8-PeCDD) 3. 1,2,3,4,7,8-Hexachlorodibenzo-p-dioxin (1,2,3,4,7,8-HxCDD) 4. 1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin (1,2,3,6,7,8-HxCDD)

N/2@/O%& 1 ( !N/ ) 5. 1,2,3,7,8,9-Hexachlorodibenzo-p-dioxin (1,2,3,7,8,9-HxCDD) 6. 1,2,3,4,6,7,8-Heptachlorodibenzo-p-dioxin (1,2,3,4,6,7,8-HpCDD) 7. Octachlorodibenzo-p-dioxin (OCDD) 8. 2,3,7,8-Tetrachlorodibenzofuran (2,3,7,8-TCDF) 9. 1,2,3,7,8-Pentachlorodibenzofuran (1,2,3,7,8-PeCDF) 10. 2,3,4,7,8-Pentachlorodibenzofuran (2,3,4,7,8-PeCDF) 11. 1,2,3,4,7,8-Hexachlorodibenzofuran (1,2,3,4,7,8-HxCDF) 12. 1,2,3,6,7,8-Hexachlorodibenzofuran (1,2,3,6,7,8-HxCDF) 13. 1,2,3,7,8,9-Hexachlorodibenzofuran (1,2,3,7,8,9-HxCDF) 14. 2,3,4,6,7,8-Hexachlorodibenzofuran (2,3,4,6,7,8-HxCDF) 15. 1,2,3,4,6,7,8-Heptachlorodibenzofuran (1,2,3,4,6,7,8-HpCDF) 16. 1,2,3,4,7,8,9-Heptachlorodibenzofuran (1,2,3,4,7,8,9-HpCDF) 17. Octachlorodibenzofuran (OCDF) 18. Sum of dioxins (WHO-PCDD/F-TEQ), Lower-bound 19. Sum of dioxins (WHO-PCDD/F-TEQ), Medium-bound 20. Sum of dioxins (WHO-PCDD/F-TEQ), Upper-bound Dioxin-like PCBs R O ON 21. 3,3',4,4' -Tetrachlorobiphenyl (PCB 77) 22. 3,4,4',5-Tetrachlorobiphenyl (PCB 81) 23. 3,3',4,4',5 - Pentachlorobiphenyl (PCB 126) 24. 3,3',4,4',5,5'-Hexachlorobiphenyl (PCB 169) 25. 2,3,3',4,4'-Pentachlorobiphenyl (PCB 105) 26. 2,3,4,4',5-Pentachlorobiphenyl (PCB 114) 27. 2,3',4,4',5-Pentachlorobiphenyl (PCB 118) 28. 2',3,4,4',5-Pentachlorobiphenyl (PCB 123) 29. 2,3,3',4,4',5-Hexachlorobiphenyl (PCB 156) 30. 2,3,3',4,4',5'-Hexachlorobiphenyl (PCB 157) 31. 2,3',4,4',5,5'-Hexachlorobiphenyl (PCB 167) 32. 2,3,3',4,4',5,5'-Heptachlorobiphenyl (PCB 189) 33. Sum of dioxins and dioxin-like PCBs (WHO-PCDD/F-PCB-TEQ), Lower-bound 34. Sum of dioxins and dioxin-like PCBs (WHO-PCDD/F-PCB-TEQ), Medium-bound 35. Sum of dioxins and dioxin-like PCBs (WHO-PCDD/F-PCB-TEQ), Upper-bound

N/2@/O%& 1 ( !N/ ) Non dioxin-like PCBs R O ON 36. 2,4,4'-Trichlorobiphenyl (PCB 28) 37. 2,2',5,5'-Tetrachlorobiphenyl (PCB 52) 38. 2,2',4,5,5'-Pentachlorobiphenyl (PCB 101) 39. 2,2',3,4,4',5'-Hexachlorobiphenyl (PCB 138) 40. 2,2',4,4',5,5'-Hexachlorobiphenyl (PCB 153) 41. 2,2',3,4,4',5,5'-Heptachlorobiphenyl (PCB 180) 42. Sum of non dioxin-like PCBs, Lower-bound 43. Sum of non dioxin-like PCBs, Medium-bound 44. Sum of non dioxin-like PCBs, Upper-bound 4. 1@0@1%"2à¸­(/?#$@N?à¸­)'Q'à¸­@à¸«@1 2?/>%#/?.à¹Œ2?Nà¸„/@>à¸«à¹Œ '/>/& O /. - N/P/C&?% ( à¸„@/à¹ŒP-/>?% ) - O/> N1 52 - O/à¸¥à¸¥C/@ N/ N/? - />-@O/%#à¹Œ - /?/>P#/>% - ?%N! N.à¸¥Pà¸¥/à¹Œ N/+?N/+ - !@/à¹Œ!/@?% - &/>à¸¥Nà¸¥?.%!à¹Œ &à¸¥C N/+?N/+ - '/P 4 à¸­@1à¹Œ - *@N#%#à¹Œ &Cà¸¥ /? - +@2!à¹Œ /?% N/+?N/+ - P1@/?#$? 5. /@.@/# 2/&/?!"BNA/'%/@à¸«@/ 5.1 /@.@/!///>Nà¸„/@>à¸«à¹Œ'/>-@/?!"BNA/'%/@à¸«@/ (Assay) !///>Nà¸„/@>à¸«à¹ŒP .N#à¸„%>à¸„ Titration Acetic acid dl-Malic acid Sodium bicarbonate Adipic acid Erythorbic acid Sodium bisulfate Ammonium dihydrogenphosphate Free acetic acid Sodium bisulfite Ammonium hydrogen carbonate Fumaric acid Sodium carbonate Ascorbic acid Glucono delta lactone Sodium chloride Ascorbyl palmitate Glycine Sodium citrate/ Trisodium citrate

N/2@/O%& 1 ( !N/ ) Benzoic acid Iron oxide Sodium cyclamate Calcium acetate L-Calcium lactate Sodium dihydrogen citrate Calcium ascorbate L-Cysteine monohydrochloride Sodium dihydrogen phosphate Calcium carbonate L-Glutamic acid Sodium erythrobate Calcium chloride L-Lactic acid Sodium hydrogen carbonate Calcium citrate Magnesium carbonate Sodium hydroxide Calcium dihydrogen phosphate Magnesium chloride Sodium lactate Calcium hydrogen phosphate Magnesium hydrogen carbonate Sodium metabisulfite Calcium hydroxide Magnesium hydrogen phosphate Sodium nitrate Calcium lactate Magnesium oxide Sodium nitrite Calcium oxide Magnesium sulfate Sodium propionate Calcium phosphate Monosodium L- glutamate Sodium pyrophosphate Calcium propionate Monosodium phosphate Sorbic acid Calcium sulfate Phosphoric acid Succinic acid Citric acid Potassium chloride Tartaric acid Cream of tartar Potassium citrate Tetrapotassium pyrophosphate Diammonium hydrogen phosphate Potassium hydroxide Tetrasodium pyrophosphate Dipotassium phosphate anh y drous Potassium iodate Triacetin Disodium ethylenediaminetetraacetate Potassium lactate Tricalcium citrate Disodium phosphate Potassium sorbate Tricalcium phosphate Disodium pyrophosphate Propionic acid Tripotassium citrate Disodium succinate Sodium acetate Tripotassium phosphate DL- Alanine Sodium ascorbate Trisodium citrate Sodium benzoate Trisodium phosphate

N/2@/O%& 1 ( !N/ ) 5.2 1@0@1#1//>Nà¸„1@>à¸«à¹Œ)1>/@!/?#$@N?à¸­)'à¸­@à¸«@1 (Assay) P"0N%à¸„'>à¸„ Spectrophotometry Allura red AC Colouring matter/ Total colouring matters Ponceau 4R Alum lake Colouring matters, Total content by spectrophotometry Quinoline yellow Amaranth Content of red colour Red 2 G Annatto extracts Curcumin Riboflavin Beet red Disodium 5'-guanylate Riboflavin 5'-phosphate sodium Beta-carotene Disodium 5'-inosinate Riboflavin from Bacillus subtilis Brilliant bule FCF Erythrosine Sodium copper chlorophyllin Brown HT Fast green FCF Sunset yellow FCF Carmine/ Carminic acid Green S Tartrazine Carmoisine (Azorubine) Indigotine (Indigocarmine) Titanium dioxide Colour value Patent blue V 5.3 1@0@1#1/Nà¸­à¸¥?1!à¹Œ (Identification tests) Rà¸­à¸­à¸­'à¸­'>'%1?0à¹Œ (Inorganic ions) Rà¸­à¸­à¸­'à¸­>'%1?0à¹ŒOà¸¥>2@1)1>à¸­( (Organic ions and compounds) Q'/?#$@N?à¸­)'à¸­@à¸«@1 Absorption of iodine Precipitate formation Test for ferric and ammonium salt Acidity Readily oxidizable substances Test for ferric salt/ Ferric salt Acidity or alkalinity Reducing sugars Test for ferrocyanide/ Ferrocyanide Adsorption Resorcinol and other phenol Test for ferrous salt/ Ferrous salt Alkali and alkali earths Solubility Test for glutamate Alkali and rare earths Solubility in alkali Test for guanylic acid Alkalinity Solution in chloroform Test for hypochlorite Alkalis (free) and soluble salts Spectrophotometry Test for inosinic acid Amino acid Starch or dextrin Test for lactate/ Lactate Ascorbate Starch/ Starch and dextrins Test for magnesium salt Barium Sugar Test for magnesium/ Magnesium Basic coloring Tannin-bearing gums Test for nitrate/ Nitrate Basic coloring matter Test for acetate/ Acetate Test for nitrite/ Nitrite Basic dye Test for acid Test for organic phosphate Benzoic and salicylic acid Test for alginate/ Alginate Test for peroxide/ Peroxide Bicarbonate/Carbonate Test for alkali Test for phosphate/ orthophosphate/ Test for phosphorus/Test for orthophosphate/ Phosphate

N/2@/O%& 1 ( !N/ ) Chelating activity to metal ions Test for aluminium/ Aluminium Test for potassium salt/ Potassium Citric, oxalic, phosphoric or tartaric acid Test for amino acid Test for reducing sugar Colour intensity Test for ammonium/ Ammonium/ Ammonia/ Ammonium salts Test for ribose Colour reaction Test for benzoate/ Benzoate Test for sodium Colour test Test for bicarbonate Test for succinate Copper reduction Test for bromate/ Bromate Test for sulfate/ Sulfate limit test/ Sulfite/Bisulfite Derivation to salicylic acid Test for calcium salt/ Calcium Test for sulfite/ Test for sulfite and bisulfite Fatty acids and esters Test for carbon dioxide Test for tartrate/ Tartrate Formic acid and oxidizable impurities Test for carbonate Test for thiocyanate Free acid and alkali Test for carotenoids/ Carotenoids Test for thiosulfate/ Thiosulfate Free alkali Test for chloride/ Chloride limit test/Chlorides Test for zinc salt/ Zinc Gelatinization Test for chlorite Transmittance Identification of colouring matter Test for citrate/ Citrate Ultraviolet absorption Nitric acid test Test for copper/ Copper UV/VIS absorption Oxalate/ Oxalate limit test Test for cupric salt Water absorption 6. 1@0@1%"2à¸­(0@2?#/à¹Œ#à¸„O@ / 0@O*')à¸±@(?' .@O(%'à¸±B&?% 17 %> '/>/& O /. 1. Alprazolam 2. Bisacodyl 3. Diazepam 4. Dexamethasone 5. Desoxy-D2PM 6. Ephedrine 7. Fenfluramine 8. Fluoxetine 9. Orlistat 10. Phenolphthalein 11. Phentermine 12. Prednisolone

N/2@/O%& 1 ( !N/ ) 13. Pseudoephedrine 14. Sibutramine 15. Sildenafil 16. Tadalafil 17. Vardenafil 2@/Nà¸„-?à¸¥BN-N&!O@/>P%>2!à¹Œ 4 %> '/>/& O /. 1. Clenbuterol 2. Salbutamol 3. Brombuterol 4. Ractopamine 2@/à¸¥BN-0//à¹ŒP-% 4 %> '/>/& O /. 1. 17 -Alpha-estradiol 2. 17- Beta-estradiol 3. Diethylstilbestrol 4. Zeranol 2@/!O@%Bà¸¥?* à¸¥BN- Amphenicol 3 %> '/>/& O /. 1. Chloramphenicol 2. Florfenicol 3. Thiamphenicol à¸¥BN- Beta-lactam 9 %> '/>/& O /. 1. Cephalexin 2. Cefazolin 3. Cloxacillin 4. Dicloxacillin 5. Nafcillin 6. Oxacillin 7. Ampicillin 8. Amoxicillin 9. Cefapirin à¸¥BN- Macrolide 4 %> '/>/& O /. 1. Erythromycin 2. Josamycin 3. Lincomycin 4. Tilmicosin

N/2@/O%& 1 ( !N/ ) à¸¥BN- Quinolone 12 %> '/>/& O /. 1. Danofloxacin 2. Difloxacin 3. Enrofloxacin 4. Flumequine 5. Levofloxacin 6. Marbofloxacin 7. Nalidixic acid 8. Norfloxacin 9. Ofloxacin 10. Oxolinic acid 11. Sarafloxacin 12. Ciprofloxacin à¸¥BN- Sulfonamide 15 %> '/>/& O /. 1. Sulfadiazine 2. Sulfadimethoxine 3. Sulfadimidine (or Sulfamethazine) 4. Sulfadoxine 5. Sulfamerazine 6. Sulfamethizole 7. Sulfamethoxazole 8. Sulfamonomethoxine 9. Sulfapyridine 10. Sulfaquinoxaline 11. Sulfathiazole 12. Sulfisoxazole 13. Trimethoprim 14. Ormetoprim 15. Dapsone à¸¥BN- Tetracycline 4 %> '/>/& O /. 1. Chlortetracycline 2. Doxycycline 3. Oxytetracycline 4. Tetracycline

N/2@/O%& 1 ( !N/ ) à¸¥BN-R%P!/+C/@%2à¹Œ N-!@P&Rà¸¥!à¹Œ 4 %> '/>/& O /. 1. 3-Amino-2-oxazolidinone (AOZ) 2. 3-Amino-5-morpholinomethyl-2-oxazolidinone (AMOZ) 3. 1-Amino hydantoin (AHD) 4. Semicarbazide (SEM ) 7. 1@0@1%"2à¸­(2@1Nà¸„/?à¹@?"0?#1Aà¸ž?à¸Š / /?à¸Šà¸ž?à¸Š 7.1 2@/Nà¸„-?'à¹‰/?%O@? 0?!/C*A!à¸„O@ 26 %> 1. Aldicarb 2. Atrazine 3. Bendiocarb 4. Bromacil 5. Carbaryl 6. Carbendazim 7. Carbofuran-3-hydroxy 8. carbofuran 9. carboxin 10. Fenobucarb 11. Hexazinone 12. Isoprocarb 13. Metalaxyl 14. Methiocarb 15. Methomyl 16. Metolachlor 17. Monocrotophos 18. Omethoate 19. Oxamyl 20. Phenthoate 21. Pyrimethanil 22. Simazine 23. Tebufenpyrad 24. Thiabendazole 25. Thiophanate-methyl 26. Tolclofos-methyl 7.2 2@/Nà¸„-?'à¹‰/?%O@? 0?!/C*A!à¸„O@ 44 %> 1. Abamectin 2. Acetamiprid 3. Aldicarb 4. Aldicarb-sulfone 5. Aldicarb-sulfoxide 6. Atrazine 7. Azoxystrobin 8. Bendiocarb 9. Boscalid 10. Bromacil 11. Carbaryl 12. Carbendazim 13. Carbofuran 14. Carbofuran-3-hydroxy 15. carbosulfan 16. Carboxin 17. Clothianidin 18. Famoxadone 19. Fenhexamid 20. Fenobucarb 21. Fludioxonil 22. Flusilazole 23. Hexazinone 24. Imazalil 25. Imidacloprid 26. Isoprocarb 27. Metalaxyl 28. Methiocarb 29. Methomyl 30. Metolachlor

N/2@/O%& 1 ( !N/ ) 31. Monocrotophos 32. Monolinuron 33. Omethoate 34. Oxamyl 35. Phenthoate 36. Pyrimethanil 37. Simazine 38. Tebuconazole 39. Tebufenpyrad 40. Thiabendazole 41. Thiacloprid 42. Thiamethoxam 43. Thiophanate-methyl 44. Tolclofos-methyl 7.3 2@/Nà¸„-?'à¹‰/?%O@? 0?!/C*A!à¸„O@ 106 %> 1. 4,4'-DDD (4,4'-TDE) 2. 4,4'-DDE (p,p'-DDE) 3. 4,4'-DDT (p,p'-DDT) 4. Acephate 5. Alachlor 6. Aldrin 7. Ametryn 8. Azinphos-ethyl 9. Azinphos-methyl 10. BHC-alpha (alpha-HCH) 11. BHC-beta (beta-HCH) 12. BHC-delta (delta-HCH) 13. BHC-gamma (gamma-HCH, Lindane) 14. Bifenazate 15. Bifenthrin 16. Bromophos-ethyl 17. Bromopropylate 18. Buprofezin 19. Butachlor 20. Cadusafos 21. Chlordane-cis 22. Chlordane-oxy 23. Chlordane-trans 24. Chlorfenapyr 25. Chlorfenvinphos 26. Chlorobenzilate 27. Chloroneb 28. Chlorothalonil 29. Chlorpropham 30. Chlorpyrifos 31. Chlorpyrifos-methyl 32. Cyanophos 33. Cyfluthrin 34. Cyhalothrin, lambda 35. Cypermethrin 36. DCPA (Dacthal), Cholrthal-dimethyl 37. Deet (DEET) 38. Deltamethrin 39. Demeton-S-methyl 40. Diazinon 41. Dichlorvos 42. Dicofol 43. Dicrotophos 44. Dieldrin 45. Dimethoate 46. Dioxathion 47. Disulfoton 48. Ditalimfos 49. Endosulfan sulfate 50. Endosulfan-alpha 51. Endosulfan-beta 52. Endrin 53. EPN 54. Ethion 55. Ethoprofos 56. Etrimfos 57. Fenchlorphos, Ronnel 58. Fenitrothion

N/2@/O%& 1 ( !N/ ) 59. Fenpropathrin 60. Fenthion 61. Fenvalerate 62. Fipronil 63. Folpet 64. Fosthiazate 65. Heptachlor 66. Heptachlor epoxide-cis 67. Heptachlor epoxide-trans 68. Heptenophos 69. Hexachlorobenzene (HCB) 70. Isofenphos 71. Isoxathion 72. Malathion 73. Methacrifos 74. Methamidophos 75. Methidathion 76. Methoxychlor 77. Metribuzin 78. Mevinphos 79. Naled 80. Parathion 81. Parathion-methyl 82. Permethrins-cis 83. Phorate 84. Phosalone 85. Phosmet 86. Phosphamidon 87. Picoxystrobin 88. Pirimiphos-Ethyl 89. Pirimiphos-methyl 90. Profenofos 91. Propachlor 92. Propargite 93. Propetamphos 94. Prothiofos 95. Quinalphos 96. Quintozene 97. Tecnazen 98. Terbacil 99. Terbufos 100. Tetrachlorvinphos 101. Tetradifon 102. Thiometon 103. Tolylfluanid 104. Triadimefon 105. Triazophos 106. Trifluralin 7.4 2@/Nà¸„-?'à¹‰/?%O@? 0?!/C*A!à¸„O@ 132 %> 1. 4,4'-DDD (4,4'-TDE) 2. 4,4'-DDE (p,p'-DDE) 3. 4,4'-DDT (p,p'-DDT) 4. Acephate 5. Alachlor 6. Aldicarb 7. Aldrin 8. Ametryn 9. Atrazine 10. Azinphos-ethyl 11. Azinphos-methyl 12. Bendiocarb 13. BHC-alpha (alpha-HCH) 14. BHC-beta (beta-HCH) 15. BHC-delta (delta-HCH) 16. BHC-gamma (gamma-HCH, Lindane) 17. Bifenazate 18. Bifenthrin 19. Bromacil 20. Bromophos-ethyl 21. Bromopropylate 22. Buprofezin 23. Butachlor 24. Cadusafos 25. Carbaryl 26. Carbendazim

N/2@/O%& 1 ( !N/ ) 27. carbofuran 28. Carbofura n-3-hydroxy 29. carboxin 30. Chlordane-cis 31. Chlordane-oxy 32. Chlordane-trans 33. Chlorfenapyr 34. Chlorfenvinphos 35. Chlorobenzilate 36. Chloroneb 37. Chlorothalonil 38. Chlorpropham 39. Chlorpyrifos 40. Chlorpyrifos-methyl 41. Cyanophos 42. Cyfluthrin 43. Cyhalothrin, lambda 44. Cypermethrin 45. DCPA (Dacthal), Cholrthal-dimethyl 46. Deet (DEET) 47. Deltamethrin 48. Demeton-S-methyl 49. Diazinon 50. Dichlorvos 51. Dicofol 52. Dicrotophos 53. Dieldrin 54. Dimethoate 55. Dioxathion 56. Disulfoton 57. Ditalimfos 58. Endosulfan sulfate 59. Endosulfan-alpha 60. Endosulfan-beta 61. Endrin 62. EPN 63. Ethion 64. Ethoprofos 65. Etrimfos 66. Fenchlorphos, Ronnel 67. Fenitrothion 68. Fenobucarb 69. Fenpropathrin 70. Fenthion 71. Fenvalerate 72. Fipronil 73. Folpet 74. Fosthiazate 75. Heptachlor 76. Heptachlor epoxide-cis 77. Heptachlor epoxide-trans 78. Heptenophos 79. Hexachlorobenzene (HCB) 80. Hexazinone 81. Isofenphos 82. Isoprocarb 83. Isoxathion 84. Malathion 85. Metalaxyl 86. Methacrifos 87. Methamidophos 88. Methidathion 89. Methiocarb 90. Methomyl 91. Methoxychlor 92. Metolachlor 93. Metribuzin 94. Mevinphos 95. Monocrotophos 96. Naled 97. Omethoate 98. Oxamyl 99. Parathion 100. Parathion-methyl 101. Permethrins-cis 102. Phenthoate

N/2@/O%& 1 ( !N/ ) 103. Phorate 104. Phosalone 105. Phosmet 106. Phosphamidon 107. Picoxystrobin 108. Pirimiphos-Ethyl 109. Pirimiphos-methyl 110. Profenofos 111. Propachlor 112. Propargite 113. Propetamphos 114. Prothiofos 115. Pyrimethanil 116. Quinalphos 117. Quintozene 118. Simazine 119. Tebufenpyrad 120. Tecnazen 121. Terbacil 122. Terbufos 123. Tetrachlorvinphos 124. Tetradifon 125. Thiabendazole 126. Thiometon 127. Thiophanate-methyl 128. Tolclofos-methyl 129. Tolylfluanid 130. Triadimefon 131. Triazophos 132. Trifluralin 7.5 2@/Nà¸„-?'à¹‰/?%O@? 0?!/C*A!à¸„O@ 144 %> 1. Abamectin 2. Acetamiprid 3. Acibenzolar-S-methyl 4. Aldicarb 5. Aldicarb-sulfone 6. Aldicarb-sulfoxide 7. Ametoctradin 8. Aminocarb 9. Anilazine 10. Atrazine 11. Azamethiphos 12. Azoxystrobin 13. Bendiocarb 14. Bentrazone 15. Bioresmethrin 16. Bixafen 17. Boscalid 18. Bromacil 19. Bupirimate 20. Carbaryl 21. Carbendazim 22. Carbetamide 23. Carbofuran 24. Carbofuran -3-hydroxy 25. Carbofuran-3-keto 26. Carbosulfan 27. Carboxin 28. Chlorbromuron 29. Chloridazon 30. Chlorotoluron 31. Chloroxuron 32. Clethodim 33. Clothianidin 34. Cyanazine 35. Cycluron 36. Cyflumetofen 37. Cyproconazole 38. Demeton-S-methyl sulfone 39. Demeton-S-Methyl sulfoxid 40. Diethofencarb 41. Dimefox 42. Dimethachlor 43. Dimethomorph 44. Diphenamid

N/2@/O%& 1 ( !N/ ) 45. Diuron 46. Epoxiconazole 47. Ethiofencarb 48. Ethiofencarb-sulfone 49. Ethiofencarb-sulfoxide 50. Ethirimol 51. Ethofumesate 52. Etofenprox 53. Etoxazole 54. Famoxadone 55. Fenamidone 56. Fenamiphos 57. Fenarimol 58. Fenbuconazole 59. Fenhexamid 60. Fenobucarb 61. Fenothiocarb 62. Fenoxycarb 63. Fenpropidin 64. Fensulfothion 65. Fenthion-Sulfoxide 66. Flubendiamide 67. Fludioxonil 68. Flufenacet 69. Flufenoxuron 70. Fluometuron 71. Fluopyram 72. Fluquinconazole 73. Fluridone 74. Flurtamone 75. Flusilazole 76. Hexazinone 77. Hexythiazox 78. Imazalil 79. Imidacloprid 80. Indoxacarb 81. Iprovalicarb 82. Isoprocarb 83. Isoproturon 84. Linuron 85. Lufenuron 86. Malaoxon 87. Mepanipyrim 88. Metaflumizone 89. Metalaxyl 90. Methiocarb 91. Methomyl 92. Methoxyfenozide 93. Metobromuron 94. Metolachlor 95. Metrafenone 96. Monocrotophos 97. Monolinuron 98. Novaluron 99. Omethoate 100. Oxamyl 101. Penconazole 102. Phenthoate 103. Pirimicarb 104. Promecarb 105. Prometon 106. Prometryn 107. Propiconazole 108. Propoxur 109. Propyzamide 110. Prosulfucarb 111. Prothoate 112. Pyraclostrobin 113. Pyridaben 114. Pyrifenox 115. Pyrimethanil 116. Rotenone 117. Sedaxane 118. Simazine 119. Spinetoram 120. Spinozad

N/2@/O%& 1 ( !N/ ) 121. Spiroxamine 122. Tebuconazole 123. Tebufenozide 124. Tebufenpyrad 125. Terbumeton 126. Terbuthylazine 127. Tetraconazole 128. Thiabendazole 129. Thiacloprid 130. Thiamethoxam 131. Thiobencarb 132. Thiodicarb 133. Thiofanox 134. Thiofanox-sulfone 135. Thiofanox-sulfoxide 136. Thiophanate-methyl 137. Tolclofos-methyl 138. Triadimenol 139. Tri-Allate 140. Tricyclazole 141. Trifloxystrobin 142. Triflumizole 143. Triticonazole 144. Vamidothion 7.6 2@/Nà¸„-?'à¹‰/?%O@? 0?!/C*A!à¸„O@ 250 %> 1. 4,4'-DDD (4,4'-TDE) 2. 4,4'-DDE (p,p'-DDE) 3. 4,4'-DDT (p,p'-DDT) 4. Abamectin 5. Acephate 6. Acetamiprid 7. Acibenzolar-S-methyl 8. Alachlor 9. Aldicarb 10. Aldicarb-sulfone 11. Aldicarb-sulfoxide 12. Aldrin 13. Ametoctradin 14. Ametryn 15. Aminocarb 16. Anilazine 17. Atrazine 18. Azamethiphos 19. Azinphos-ethyl 20. Azinphos-methyl 21. Azoxystrobin 22. Bendiocarb 23. Bentrazone 24. BHC-alpha (alpha-HCH) 25. BHC-beta (beta-HCH) 26. BHC-delta (delta-HCH) 27. BHC-gamma (gamma-HCH, Lindane) 28. Bifenazate 29. Bifenthrin 30. Bioresmethrin 31. Bixafen 32. Boscalid 33. Bromacil 34. Bromophos-ethyl 35. Bromopropylate 36. Bupirimate 37. Buprofezin 38. Butachlor 39. Cadusafos 40. Carbaryl 41. Carbendazim 42. Carbetamide 43. Carbofuran 44. Carbofuran-3-hydroxy 45. Carbofuran-3-keto 46. Carbosulfan 47. Carboxin 48. Chlorbromuron 49. Chlordane-cis 50. Chlordane-oxy

N/2@/O%& 1 ( !N/ ) 51. Chlordane-trans 52. Chlorfenapyr 53. Chlorfenvinphos 54. Chloridazon 55. Chlorobenzilate 56. Chloroneb 57. Chlorothalonil 58. Chlorotoluron 59. Chloroxuron 60. Chlorpropham 61. Chlorpyrifos 62. Chlorpyrifos-methyl 63. Clethodim 64. Clothianidin 65. Cyanazine 66. Cyanophos 67. Cycluron 68. Cyflumetofen 69. Cyfluthrin 70. Cyhalothrin, lambda 71. Cypermethrin 72. Cyproconazole 73. DCPA (Dacthal), Cholrthal-dimethyl 74. Deet (DEET) 75. Deltamethrin 76. Demeton-S-methyl 77. Demeton-S-methyl sulfone 78. Demeton-S-Methyl sulfoxid 79. Diazinon 80. Dichlorvos 81. Dicofol 82. Dicrotophos 83. Dieldrin 84. Diethofencarb 85. Dimefox 86. Dimethachlor 87. Dimethoate 88. Dimethomorph 89. Dioxathion 90. Diphenamid 91. Disulfoton 92. Ditalimfos 93. Diuron 94. Endosulfan sulfate 95. Endosulfan-alpha 96. Endosulfan-beta 97. Endrin 98. EPN 99. Epoxiconazole 100. Ethiofencarb 101. Ethiofencarb-sulfone 102. Ethiofencarb-sulfoxide 103. Ethion 104. Ethirimol 105. Ethofumesate 106. Ethoprofos 107. Etofenprox 108. Etoxazole 109. Etrimfos 110. Famoxadone 111. Fenamidone 112. Fenamiphos 113. Fenarimol 114. Fenbuconazole 115. Fenchlorphos, Ronnel 116. Fenhexamid 117. Fenitrothion 118. Fenobucarb 119. Fenothiocarb 120. Fenoxycarb 121. Fenpropathrin 122. Fenpropidin 123. Fensulfothion 124. Fenthion 125. Fenthion-Sulfoxide 126. Fenvalerate

N/2@/O%& 1 ( !N/ ) 127. Fipronil 128. Flubendiamide 129. Fludioxonil 130. Flufenacet 131. Flufenoxuron 132. Fluometuron 133. Fluopyram 134. Fluquinconazole 135. Fluridone 136. Flurtamone 137. Flusilazole 138. Folpet 139. Fosthiazate 140. Heptachlor 141. Heptachlor epoxide-cis 142. Heptachlor epoxide-trans 143. Heptenophos 144. Hexachlorobenzene (HCB) 145. Hexazinone 146. Hexythiazox 147. Imazalil 148. Imidacloprid 149. Indoxacarb 150. Iprovalicarb 151. Isofenphos 152. Isoprocarb 153. Isoproturon 154. Isoxathion 155. Linuron 156. Lufenuron 157. Malaoxon 158. Malathion 159. Mepanipyrim 160. Metaflumizone 161. Metalaxyl 162. Methacrifos 163. Methamidophos 164. Methidathion 165. Methiocarb 166. Methomyl 167. Methoxychlor 168. Methoxyfenozide 169. Metobromuron 170. Metolachlor 171. Metrafenone 172. Metribuzin 173. Mevinphos 174. Monocrotophos 175. Monolinuron 176. Naled 177. Novaluron 178. Omethoate 179. Oxamyl 180. Parathion 181. Parathion-methyl 182. Penconazole 183. Permethrins-cis 184. Phenthoate 185. Phorate 186. Phosalone 187. Phosmet 188. Phosphamidon 189. Picoxystrobin 190. Pirimicarb 191. Pirimiphos-Ethyl 192. Pirimiphos-methyl 193. Profenofos 194. Promecarb 195. Prometon 196. Prometryn 197. Propachlor 198. Propargite 199. Propetamphos 200. Propiconazole 201. Propoxur 202. Propyzamide

N/2@/O%& 1 ( !N/ ) 203. Prosulfucarb 204. Prothiofos 205. Prothoate 206. Pyraclostrobin 207. Pyridaben 208. Pyrifenox 209. Pyrimethanil 210. Quinalphos 211. Quintozene 212. Rotenone 213. Sedaxane 214. Simazine 215. Spinetoram 216. Spinozad 217. Spiroxamine 218. Tebuconazole 219. Tebufenozide 220. Tebufenpyrad 221. Tecnazen 222. Terbacil 223. Terbufos 224. Terbumeton 225. Terbuthylazine 226. Tetrachlorvinphos 227. Tetraconazole 228. Tetradifon 229. Thiabendazole 230. Thiacloprid 231. Thiamethoxam 232. Thiobencarb 233. Thiodicarb 234. Thiofanox 235. Thiofanox-sulfone 236. Thiofanox-sulfoxide 237. Thiometon 238. Thiophanate-methyl 239. Tolclofos-methyl 240. Tolylfluanid 241. Triadimefon 242. Triadimenol 243. Tri-Allate 244. Triazophos 245. Tricyclazole 246. Trifloxystrobin 247. Triflumizole 248. Trifluralin 249. Triticonazole 250. Vamidothion 8. 1@0@1%"2à¸­(2@12à¹@à¸„?à¸ 2@//%B*?%$à¹Œ@?à¸@à¸«/A/?à¸ 4 %> '/>/& O /. - Cannabidiolic acid (CBDA) - Cannabinol (CBN) - Delta- 8 -tetrahydrocannabinol ( Delta-8-THC) - Tetrahydrocannabinolic acid (THCA) - Tetrahydrocannabivarin (THCV)

N/2@/O%& 2 à¸Š>?à¸§à¸­0N@ 1@0à¸¥>à¹€à¸­?0à¸@1à¹ƒà¸«O 1>à¸@1 à¸Š>?à¸§à¸­0N@ à¹@à¸§?à¸§à¸­0N@ Oà¸­)à¸¥@!à¸­># (Aflatoxin) - $? 1 (B1) - $? 2 (B2) - ? 1 (G1) - ? 2 (G2) - Oà¸­)à¸¥@!à¸­>#!?Oà¸«/ ( Aflatoxin total ) 1. /@à¸«@/ R O ON "?P/Oà¸¥>(à¸¥>!,?à¹Œ$?à¸@!> Oà¸¥>(à¸¥>!,?à¹ŒNà¸„/AP/N#0 */>O 2O@N/O/C' %QO@-?%*A (à¸¥>!,?à¹Œ N2/>-/@à¸«@/#?P-?*AN'à¹‡%2N/%'/>/& Oà¸¥>/@à¸«@/#?PN'à¹‡%(à¸¥>!,?à¹Œ@*A (à¸¥>!,?à¹Œ@N%AQ/2?!/à¹Œ Oà¸«O / ( *AOà¸«O Oà¸¥>(à¸¥>!,?à¹Œ 2. 2-B%R*/ Oà¸¥>(à¸¥>!,?à¹Œ NN% - ?à¸@ / ?à¸ - %QO@-?%?à¸@ /.N@%O/. 1 >Pà¸¥/?- à¸«/A/ 1 à¸¥>!/ 500 /?- 50 /?- à¸«/A/ 50 ->à¸¥à¸¥>à¸¥>!/ Pà¸­à¸„1@!à¸­># Nà¸­ (Ochratoxin A) 1. /@à¸«@/ R O ON @O+ @ */>Oà¸«O Nà¸„/AP/N#0 $?à¸@!>Oà¸¥>(à¸¥>!,?à¹Œ 2. N/%R-à¹Œ 3. *AOà¸«O 4. 2-B%R*/Oà¸«O 5. *A?à¸@ Oà¸¥>?à¸ /@à¸«@/ R-N%O/./N@ 1 >Pà¸¥/?- à¸«/A/ 1 à¸¥>!/ N/%R-à¹Œ *AOà¸«O 2-B%R*/ Oà¸«O *A?à¸@Oà¸¥>?à¸ /.N@%O/. 500 /?- à¸«/A/ 500 ->à¸¥à¸¥>à¸¥>!/ Pà¸¥à¸«>Oà¸¥>O1N"@B 1. (à¸¥>!,?à¹Œ%-Oà¸¥>(à¸¥>!,?à¹Œ #?PQOO#%%- (Dairy products and analogues) 2. %QO@-?%Oà¸¥>R-?% Oà¸¥>(à¸¥>!,?à¹Œ />-?à¸¥?% (Fats and oils, and fat emulsions) 3. R/0/?-à¸«/@%N.O% (Edible ices, including sherbet and sorbet) 200 /?- x 1 à¸«%N/. à¸«/A/ 500 ->à¸¥à¸¥>à¸¥>!/ x 2 à¸«%N/.

N/2@/O%& 2 ( !N/ ) 1@0à¸¥>à¹€à¸­?0à¸@1à¹ƒà¸«O 1>à¸@1 à¸Š>?à¸§à¸­0N@ à¹@à¸§?à¸§à¸­0N@ Pà¸¥à¸«>Oà¸¥>O1N"@B ( Nà¸­ ) 4. (à¸¥R-O (? 2@à¸«/N@. %?#Oà¸¥>N-à¸¥O (Fruits and vegetables (including mushrooms and fungi, roots and tubers, pulse sand legumes, and aloe Vera), seaweeds, and nuts and seeds) 5. à¸¥C/@ à¸¥C/- O/POà¸¥! (Confectionery) 6. $?à¸@!> Oà¸¥>(à¸¥>!,?à¹Œ$?à¸@!> (Cereals and cereal products, derived from cereal grains, from roots and tubers, pulses, legumes and pith or soft core of palm tree) 7. (à¸¥>!,?à¹Œ%-/& (Bakery wares) 8. N%AQ/2?!/à¹ŒOà¸¥>(à¸¥>!,?à¹ŒN%AQ/2?!/à¹Œ (Meat and meat products, including poultry and game) 9. 2?!/à¹Œ%QO@Oà¸¥>(à¸¥>!,?à¹Œ2?!/à¹Œ%QO@ (Fish and fish products, including mollusks, crustaceans, and echinoderms) 10. RNOà¸¥>(à¸¥>!,?à¹ŒRN (Eggs and egg products) 11. 2@/Qà¸«Oà¸„/@-à¸«/@% Oà¸¥>%QO@(@Q (Sweeteners, including honey 12. Nà¸¥A/ Nà¸„/AP/N#0 B' /2 2à¸¥? Oà¸¥>(à¸¥>!,?à¹Œ @P'/!?% (Salts, spices, soups, sauces, salads and protein products) /@à¸«@/#?P-?/?!"B'/>2à¸„à¹ŒN*@> #@ O @% P,%@@/ (Foodstuffs intended for particular nutritional uses) 13. Nà¸„/AP/ A P - (Beverages, excluding dairy products) 14. %-&Nà¸„?Q./ (Ready-to-eat savouries) 15. /@à¸«@/N!/?.-2O@N/O (Prepared foods)

N/2@/O%& 3 à¹@'/'#?/à¸­0N@ 1. 1@0@1%"2à¸­(R/1?2 '/>-@!?//.N@N*AP/2N!//à¸«@2@/*?%$B//-/NAQ/R//?2Pà¸„P/%@ 2019 (COVID- 19 ) -?/@.à¸¥>N/?. ? %?Q )1>N.% 1@0@1 )1>/@!#Nà¸­à¸«'N/0 à¹@'/''à¹@2N ( à¸«'N/0 ) /@à¸«@/ ( 2 ONN.O% ONOO ) 1. /@à¸«@/#>Nà¸¥ : 'à¸¥@ BO à¸«-@ à¸«/. 'C ( 'C??P% ) 500 /?- 3 2. N%AQ/2?!/à¹Œ : N%AQ/à¸«-C N%AQ/RN N%AQ//?/ N%AQ/O> /@à¸«@/*/O/-&/>P,à¸„ C> @>-> 'C/? 2@à¸«/N@. N'à¹‡%!O% 500 /?- 3 (? ( 2 ONN.O% ONOO ) (?@ à¸«/- (?@ OO/ à¸«%N/R-O)/?P 500 /?- 3 (à¸¥R-O ( 2 ONN.O% ONOO ) #BN/?.% &à¸¥CN&//à¹Œ/? 2!///à¹ŒN&//à¹Œ/? /@2'PN&//à¹Œ/? N//à¹Œ/? à¸¥C*? à¸¥C*à¸¥?- /BN% 2?&'>/ ->-N/ à¸¥>Q%?P N@> %B% 2@à¸¥?P O/'N'>à¹‰à¸¥ 500 /?- 3 R/0/?- R/0/?-%- R/0/?-à¸«/@%N.O% 500 /?- 3 %QO@ %QO@ A P - %QO@ > & 2 à¸¥>!/ 3 %QO@OO %QO@OO&/>P,à¸„ ( %QO@OO& %QO@OOà¸«à¸¥/ ) 2 >Pà¸¥/?- 3 ,@%> Oà¸¥>&//B ,?à¹Œ/@à¸«@/ 1. "B / / %@ Nà¸¥O #O@@+/. à¹Œ à¸«/A/*à¸¥@2!> 200 /?- 3 2. O/% / 2O/- *à¸¥@2!> 200 /?- 3 3. @% : *AQ%#?P!N/!?//.N@R-N%O/./N@ 100 !@/@N%!>N-!/ 3 Q& 3 4. à¸¥N/ #O@@/> @1 *à¸¥@2!> à¸«/A/P+- 4.1 *AQ%#?P!N/!?//.N@ -@/N@ 200 !@/@N%!>N-!/ 3 à¸¥N/ 3 4.2 *AQ%#?P!N/!?//.N@ %O/./N@ 200 !@/@N%!>N-!/ 6 à¸¥N/ 3 5. / OO/ 3 Q& 3 6. />'O/Pà¸¥à¸«> 3 Q& 3 *AQ%(>/2?-(?2/@à¸«@/ Swab *AQ%(>/2?-(?2/@à¸«@/ : *AQ%#?P!N/!?//.N@ R-N%O/./N@ 100 !@/@N%!>N-!/ 1 à¸«à¸¥/ 1 à¸«-@.Nà¸«!B %> !?//.N@#?P/.CN%/Nà¸«%A/@/@.@/O@!O% P'/ !> !N/NO@à¸«%O@#?PN/%@/NO&!?//.N@2N!//

N/2@/O%& 3 ( !N/ ) 2. 1@0@1%"2à¸­(à¸„@!.@à¸žà¸«1?à¸­/@#1@'.@à¸Š'>(11@à¸­@à¸«@1 / /"'/ / à¸«?/'/0@ à¸«à¸¥?N!à¹Œ@12N#?/à¸­0N@Nà¸ž?Nà¸­#1//>Nà¸„1@>à¸«à¹Œà¸„@!.@à¸ž/@#1@'à¸­.@à¸Š'>(11@à¸­@à¸«@1 1. 2>N%?N#Oà¸­OOQ'Q('à¹@2N#?/à¸­0N@ (CO2N!?//.N@!O/OO %> //?2 B #?PQO(à¸¥>! /?!"B'/>2à¸„à¹Œ/@/!///>Nà¸„/@>à¸«à¹Œ /Bà¸«,C-> #?P2@-@/"QO@%R O 2C2B "O@!O/@//?&!?//.N@à¸„A% /Qà¸«OOOà¸„/@-O@%R/OOà¸¥>-@/?&à¸„A%R O Q%/?%#?P-@/?& (à¸¥/>Nà¸„/@>à¸«à¹Œ*/O/-#?Qà¸¥%@-(CO-@/?&!?//.N@à¸„A% 2. à¹@'/'#?/à¸­0N@%?N2N#1/ 2.1 ,@%>*à¸¥@2!>#?P-?à¸„/@-à¸«%@R-NN>% 0.3 N%!>N-!/ 2.1.1 / '/>N,#!N@ N NN% #?PQO&//B%QO@-?% %QO@2O-2@.C %QO@ A P - %QO@'à¸¥@ Nà¸„/AP/ A P - Oà¸¥>/>!>%QO@%?N/?.% - #?P-?à¸„/@-B%O/./N@ 250 ->à¸¥à¸¥>à¸¥>!/ O@%/%#?P2N 30 >Q% - #?P-?à¸„/@-B-@/N@ 250 ->à¸¥à¸¥>à¸¥>!/ O@%/%#?P2N 15 >Q% 2.1.2 "@ à¸¥N//@à¸«@/ @% @- "O/. OO/Q2NNà¸„/AP/ A P - Oà¸¥>/AP% N - #?P-?à¸„/@-B%O/./N@ 250 ->à¸¥à¸¥>à¸¥>!/ O@%/%#?P2N 30 >Q% - #?P-?à¸„/@-B-@/N@ 250 ->à¸¥à¸¥>à¸¥>!/ O@%/%#?P2N 15 >Q% 2.1.3 O/% 2O/- !>N?.& /#?PQON'à¹‡%à¸„CN O@%/%#?P2N 30 à¸„CN 2.1.4 "? %> #?P-?-A/?& -?à¸«Cà¸«>Q/ >à¸¥>-? #?P-?à¸„/@-B-@/N@ 2.5 à¸¥>!/ O@%/%#?P2N 6 >Q% 2.1.5 "B*à¸¥@2!>&//B/@à¸«@/ Oà¸¥>O(N%*à¸¥@2!>#?PQOO#%Q&!/ O@%/%#?P2N 250 /?- 2.1.6 +>à¸¥à¹Œ-*à¸¥@2!> à¸«N//@à¸«@/ #O@"B&//B%- "B&//B/@à¸«@/ O@%/%#?P2N 1 -O/%Qà¸«à¸N %@ /O@R-N%O/./N@ 15 N%!>N-!/ 2.1.7 B )@ Oà¸¥>)@à¸„//& O@%/%#?P2N 250 /?- à¸«/A/ 30 )@ "O@N'à¹‡%)@%@ Qà¸«à¸N 2.1.8 à¸«à¸¥/ C Nà¸„/AP/ A P - O@%/%#?P2N 250 /?- 2.1.9 #N/%QO@ A P - #N/2N/@à¸«@/ à¸«/A/2@.*@%à¸¥O@Nà¸¥?. @Q%/.CN?&%@ - "O@%@ Nà¸¥ON2O%(N@%0C%.à¹Œà¸¥@R-NN>% 1 N%!>N-!/ O@%/%#?P2N 1 -O/% - "O@-?%@ Qà¸«à¸NQà¸«O!? N'à¹‡%#N/% N à¸¥> 50 N%!>N-!/ O@%/% 10 #N/% 2.1.10 '>N% Oà¸¥>)@//Q%/)@/ '/>N,#!N@ N O@%/%#?P2N 250 /?- 2.1.11 / %-N O  20 / 2.1.12 /B'/à¹Œ'/>/&// %- NN% à¸¥>Q%'> '@/ )@à¸„//& )@Nà¸¥?./ O@%/%#?P2N!?//.N@à¸¥> 30 >Q% - /?2 B %> N ? ./?%O!N2?R-NNà¸«-A/%?%2N!?//.N@O.%> à¸¥> 30 >Q% - /?2 B %> N ? ./?%Oà¸¥>2?Nà¸«-A/%?%2N!?//.N@//-?%R O O@%/%R-N%O/./N@ 10 B ( B '/>/& O /. à¸¥>Q%'> '@/ )@à¸„//& )@Nà¸¥?./ ) 2.1.13 O(N%*à¸¥@2!> %@ A4 O@%/%#?P2N 30 >Q%

N/2@/O%& 3 ( !N/ ) 2.1.14 R-OR/0à¸„/?- O#N/-.>Q- O@%/%#?P2N 250 >Q% 2.1.15 /&//B2@/ C à¸„/@-AQ% O@%/%#?P2N 50 / à¸«/A/ 1 -O/%Qà¸«à¸N 2.1.16 "@ Q2NO/POà¸¥! O@%/%#?P2N 30 >Q% 2.1.17 à¸¥N/Q2Nà¸¥C/- à¸«/A/%-%@ Nà¸¥O O@%/%#?P2N 50 >Q% 2.1.18 />2/&2@% Oà¸¥>/>2/&/AP% N #?P-?%@ Qà¸«à¸N O@%/%#?P2N 6 >Q% 2.1.19 ,@%>N-à¸¥@-?% O@%/%#?P2N 50 >Q% 2.1.20 Nà¸„/AP/à¸„/?/N/%'/>2à¸„à¹Œ O@%/%#?P2N 12 >Q% @Q%/.CN?&%@ Oà¸¥>/C'/N@ 2.2 ,@%>*à¸¥@2!>#?P-?à¸„/@-à¸«%@N>% 0.3 N%!>N-!/ 2.2.1 "? / à¸¥N/ à¸«/A//C'O&&Q O!@- O@%/%#?P2N - Qà¸«O!? %@ 4 x 4 N%!>N-!/ O@%/% 40 >Q% Oà¸¥> - Qà¸«O!? %@ 0.5 x 0.5 N%!>N-!/ O@%/% 20 /?- 2.2.2 O#Oà¹Œ%QO@*à¸¥@2!>N2/>-O/ O@%/%#?P2N - Qà¸«O!? %@ 15 x 20 N%!>N-!/ O@%/% 10 >Q% Oà¸¥> - Qà¸«O!? %@ 0.5 x 0.5 N%!>N-!/ O@%/% 30 >Q% 2.2.3 N-O *à¸¥@2!> Oà¸¥> Resin '/>N,#!N@ N Qà¸«O@Q%/C'Qà¸«ON'à¹‡%,@%>!@-#?PQO@%/> Oà¸¥>? 2N!@-/@.à¸¥>N/?. Q%O/ 2.1 2.3 ,@%>'/>N,#.@ 2.3.1 à¸«?/%-.@2O@à¸«/?&/ %- O@%/%#?P2N 80 >Q% 2.3.2 à¸«?/%-.@ C Nà¸¥N% O@%/%#?P2N 100 >Q% 2.2.3 .@'/>N,#/AP% N QOà¸«à¸¥?@/N ? ./?&*à¸¥@2!> 2.4 ,@%>N/@->Oà¸¥>Nà¸„/AP/à¸„/?/ 2.4.1 ,@%>N/@-> O@%/%#?P2N 15 >Q% 2.4.2 ,@%>à¸«B!O- O@%/%#?P2N 3 >Q%

N/2@/O%& 4 1. @1à¸ž? '@/>&?#1/à¸ž?à¸Š"?"O)1à¸ž?'&@11/ 1. '/>-@2@//O@/>-@!/@% 1.1 N'à¹‡%O&&(à¸¥>N/?. (powder) &//BQ%/ OO/ /N@N!/?.-@2N/%Q /*A ( NN% N-à¸¥O Q& N'à¹‡%!O% ) 1.2 -?'/>-@//-R-N%O/./N@ 10 /?- 1.3 />&B %GM 2. O/-Cà¸¥N*>P-N!>-/?R-N-?/>$?-@!/@% ISO à¸«/A/ EU/JRC 2.1 />$?/>Nà¸„/@>à¸«à¹Œ //-"@à¸¥O@ ? &N&2/ PCR-product 2.2 O/-Cà¸¥!@-/>&B!@- &?à¸?à¸«-@.Nà¸¥ 2 O%&#O@.'/>@0/>#//2@$@/2B ( &?&#?P 431) * . 0 . 2565 '/>@0/>#//2@$@/2B ( &?&#?P 431) * . 0 . 2565 //!@-à¸„/@-Q%*/>/@&?à¸à¸?!>/@à¸«@/ * . 0 . 2522 N/AP/ /@à¸«@/#?PR O @2>P-??/>! ? O'/*?%$B//- Q%O/!N/R'%?Q 2.2.1 à¸¥O@ ? & 1 /@.à¸¥>N/?. /*A ? O'/*?%$B//- 1.1 %> /*A ? O'/*?%$B//- 1.2 />N/%!à¹Œ (event) /@/ ? O'/*?%$B//- 1.3 à¸¥?1>*?%$B//-#?P ? O'/ 1.4 /?!"B'/>2à¸„à¹Œ/@/ ? O'/*?%$B//- 2.2.2 à¸¥O@ ? & 2 /@.à¸¥>N/?. /*ANO@&O@% (Host plant) 2.1 AP/2@-?à¸Oà¸¥>AP//>#.@0@2!/à¹Œ 2.2.3 à¸¥O@ ? & 3 /@.à¸¥>N/?. /2>P-??/>!(COQà¸«O2@/*?%$B//- (donor) à¸«/A/Oà¸«à¸¥N#?P-@/2@/*?%$B//- 3.1 AP/2@-?à¸Oà¸¥>AP//>#.@0@2!/à¹Œ à¸«/A/ 3.2 Q%/?#?PN'à¹‡% ? N/O%N/2?Nà¸„/@>à¸«à¹ŒOà¸¥>R-N-?#?P-@@2@/*?%$B//-#?P-?/.CN!@-$//-@!> Qà¸«O/>&B 3.2.1 à¸«%O@#?POà¸¥>&#&@#/ ? N/O%N/2?Nà¸„/@>à¸«à¹Œ 3.2.2 à¸¥O@ ? &N&2/ ? N/O%N/2?Nà¸„/@>à¸«à¹Œ Oà¸¥O/O!N/? 2.2.4 à¸¥O@ ? & 4 /@.à¸¥>N/?. /@/ ? O'/*?%$B//- 4.1 O/-Cà¸¥/ ? N/O%N/#?PQO R O ON (  ) ? N/O%N/#?PQOQ%@/ ? O'/ P ./>&B/@.à¸¥>N/?. Oà¸¥>à¸«%O@#?P#?P!O/@/ Qà¸«OO2 // (  ) Oà¸«à¸¥N#?P-@ ( NN% *A Bà¸¥>%#/?.à¹Œ R//?2 2?Nà¸„/@>à¸«à¹Œ ) P ./>&B/@.à¸¥>N/?. Oà¸¥> 4.2 à¸¥?1>Oà¸¥>/à¸„à¹Œ'/>/&/2@/*?%$B//-#?PQOQ%@/"N@..?% (  ) .?%N'à¹‰@à¸«-@.#?Pà¸„/&à¸„B-à¸¥?1>#?P!O/@/ (  ) .?%Nà¸„/AP/à¸«-@. ( à¸„ ) P*/P-N!//à¹Œ (  ) N#//à¹Œ->N%N!//à¹Œ (  ) /à¸„à¹Œ'/>/&#?PN?P./O/?&@/#O@@%/.?% (  ) /à¸„à¹Œ'/>/&/AP% N

N/2@/O%& 4 ( !N/ ) 2.2.5 à¸¥O@ ? & 5 à¸¥?1>/@/ ? O'/*?%$B//- 5.1.1 à¸¥?1>Oà¸¥>/@.à¸¥>N/?. /2@/*?%$B//-#?P2/ O#/ Oà¸¥> 5.1.2 O@%/%!O@Oà¸«%N#?P-?@/2/ O#/ 2.3 2@//O@/>-@!/@%!@-NAP/%RQ%O/ 1 2. @1à¸ž? '@/>&?#1/@à¸¥>'%1?0à¹Œ"?"O)1à¸ž?'&@11/ /@à¸«@/#?PR O @Bà¸¥>%#/?.à¹Œ ? O'/*?%$B//- O&NN'à¹‡% 4 '/>N,# ? %?Q '/>N,##?P 1 /@à¸«@/#?P.?-?Bà¸¥>%#/?.à¹Œ ? O'/*?%$B//-N'à¹‡%2N/%'/>/& @PBà¸¥>%#/?.à¹Œ ? O'à¸¥*?%$B//- #?P/.CNQ%(à¸¥>!,?à¹Œ.?2@-@/"N*>P-O@%/%à¸«/A/"N@.P/%2@/*?%$B//- !?//.N@NN% Bà¸¥>%#/?.à¹Œ ? O'/*?%$B//-#?P-??/>! #?PQON'à¹‡%2N/%'/>/&/@à¸«@/ (probiotic) à¸«/A/ NAQ/!?Q!O%#?P-??/>! (live starter culture) @PQOQ%@/à¸«-?/@à¸«@/ NN% P.N>/à¹Œ! '/>N,##?P 2 /@à¸«@/#?P.?-?Bà¸¥>%#/?.à¹Œ ? O'/*?%$B//-N'à¹‡%2N/%'/>/& O!NBà¸¥>%#/?.à¹Œ ? O'/*?%$B//- Oà¸¥>.?%Qà¸«-N#?PQOQ%@/ ? O'/*?%$B//-%?Q%R-N2@-@/"N*>P-O@%/% (multiplication) Oà¸¥>R-N2@-@/""N@.P/% 2@/*?%$B//- (transfering gene) !?//.N@NN% NAQ/!?Q!O%#?PQOQ%@/à¸«-?/@à¸«@/NN% %QO@2O-2@.C à¸«/A/Nà¸„/AP/ A P - O/à¸¥0/à¸¥à¹Œ @P"C#O@Qà¸«O2>Q%2,@* O /.à¸„/@-/O/% (heat- inactivated starter culture) à¸«/A/-?@/? Bà¸¥>%#/?.à¹Œ ? O'/*?%$B//-// O!N/@-?.?%à¸«à¸¥Nà¸«à¸¥A//.CN '/>N,##?P 3 /@à¸«@/#?PN'à¹‡%2@/N>O/% (complex product) @PR-N-?Bà¸¥>%#/?.à¹Œ ? O'/*?%$B//-Oà¸¥>.?%Qà¸«-N #?PQOQ%@/ ? O'/ (newly introduced gene) Nà¸«à¸¥A/Q%(à¸¥>!,?à¹Œ !?//.N@NN% 2@/2? @Nà¸¥à¸¥à¹Œ (cell extracts) /?!"BNA/'%/@à¸«@/ (food additive) Oà¸¥>2@/N/.Q%/>&/%@/(à¸¥>! (processing aid) &@%> #?P-?à¸¥?1> N'à¹‡%2@/'/>/&N>O/% NN% N/%R-à¹Œ Oà¸¥>2@//@à¸«@/ NN% Q./@à¸«@/ N'à¹‡%!O% '/>N,##?P 4 /@à¸«@/#?PN'à¹‡%2@/'/>/&&/>2B#$>N#@Nà¸„-? (chemically defined purified compound) Oà¸¥>2@/#?PR O @@/(2-2@/'/>/&Nà¸«à¸¥N@%?Q% @P-?@/? Bà¸¥>%#/?.à¹Œ ? O'/*?%$B//-Oà¸¥>.?%Qà¸«-N #?PQOQ%@/ ? O'/*?%$B//- (newly introduced gene) !?//.N@NN% / O/->P% />!@->% /?!"BNA/'%/@à¸«@/ (food additive) Oà¸¥>2@/N/.Q%/>&/%@/(à¸¥>! (processing aid) &@%> #?P-?à¸¥?1>N'à¹‡%2@/'/>/&&/>2B#$>N NN% / />>!> Oà¸¥>2@//@à¸«@/ NN% / O/->P% N'à¹‡%!O% Powered by TCPDF (www.tcpdf.org)
